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Part 1  
DESIGN, SYNTHESIS, AND VALIDATION OF POLYMER-
SUPPORTED SILOXANE TRANSFER AGENTS FOR 
TRANSITION-METAL-MEDIATED CROSS-COUPLING 
REACTIONS OF ORGANOLITHIUMS 
 
1-1: Background 
1-1-a: Introduction of Anion Relay Chemistry (ARC) 
Anion Relay Chemistry (ARC), an effective, multi-component union tactic, introduced 
and developed by the Smith Laboratory for the rapid elaboration of structurally complex 
scaffolds in a “single-flask”, entails the ability to control the migration of negative charge.1 
In a broad sense, Anion Relay Chemistry provides organic chemists the ability to control, 
in a synthetically useful fashion, the flow and reactivity of an anionic site within a growing 
molecule. Conceptually, ARC can be divided into two general categories: “through-bond”, 
which encompasses the transfer of negative charge through the electronic framework of a 
molecule (e.g., conjugate addition) and “through-space”, which comprises the relay of 
negative charge across space by exploiting a carrier species. The through-space ARC tactic 
can be further divided into two fundamentally different types of negative charge migration. 
Type I Anion Relay Chemistry (Scheme 1-1, Eq 1) entails a multi-component coupling 
protocol that involves nucleophilic attack of a stabilized α-silyl linchpin to an electrophile 
capable of generating an anionic species (e.g., alkoxide) that can relay the negative charge  
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Scheme 1-1. Type I and Type II “Through-Space” Anion Relay Chemistry (ARC) 
 
back to the originating locus, α to the anion stabilizing group (ASG). Reaction with a 
second electrophile furnishes the tri-component adduct. This strategy was employed as the 
key reaction in the gram-scale synthesis of ()-spongistatin 1 (Scheme 1-2, Eq 1).2 In this 
example, treatment of TBS-dithiane anion 1.1 with epoxide 1.2, followed by 1,4-Brook 
rearrangement triggered by HMPA and trapping the resulting anion with a second epoxide 
(1.3) generates tri-component adduct 1.4, the precursor for the C,D-spiroketal in the natural 
product. 
Type II Anion Relay Chemistry (Scheme 1-1, Eq 2) is a multi-component reaction 
involving nucleophilic addition of an external nucleophile to a bifunctional linchpin to 
generate an anionic species that can relay the negative charge to a new locus on the linchpin, 
α to the anion stabilizing group (ASG). Subsequent trapping with an electrophile yields a 
tri-component adduct. An example of this strategy in natural product synthesis is the 
construction of the B,C-spiroketal of ()-spirastrellolide A (Scheme 1-2, Eq 2),3 in which 
deprotonation of dithiane 1.6 with Schlosser base, followed in turn by addition of 
bifunctional linchpin 1.7 and epoxide 1.8 generates tri-component adduct 1.9 in one-flask. 
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Scheme 1-2. Examples of Type I and Type II ARC 
 
Importantly, both the Type I and Type II ARC tactics hold the potential for multiple 
“iterations” by employing sequential addition of linchpins. Also of significance, ARC 
circumvents the need for excessive protecting groups and purification steps, as well as 
permits access to a wide variety of scaffolds via ready customization of the coupling 
partners. 
1-1-b: Identification of Siloxane Transfer Agents  
One of the ongoing goals of the Anion Relay Chemistry program in the Smith 
Laboratory is the identification and validation of novel linchpins. During the investigation 
of ortho-TMS benzaldehyde 1.11 as a bifunctional linchpin for Type II ARC (Scheme 1-
3), it was demonstrated that treatment of this aldehyde with n-BuLi generates alkoxide 1.12 
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that in turn can relay the negative charge to a sp2-hybridized carbon atom (1.14) via an 
equilibrium with a pentavalent silicon-ate species 1.13. This carbon anion can then be 
trapped with an electrophile followed by hydrolysis to generate a tri-components adduct 
(1.15). Importantly, the pentavalent siliconate 1.13 could also be accessed from 1-oxa-2-
silacyclopentane 1.16 via treatment with methyllithium.4 By this alternative reaction 
pathway, a series of electrophiles could be trapped to generate various tri-component 
adducts.  Particularly important, a Pd-catalyzed cross-coupling reaction could be achieved 
when a catalytic amount of tetrakis(triphenylphosphine)palladium was employed with 
iodobenzene.  
Scheme 1-3. Access to Type II ARC via 1-Oxa-2-Silacyclopentane 
 
In a similar fashion, treatment of 1.16 with PhLi and capture of the resulting anion with 
4-iodobenzonitrile in the presence of a catalytic amount of Pd generated the expected tri-
component adduct 1.17 (Scheme 1-4). Interestingly, when the reaction solvent was 
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switched to a less polar solvent (i.e., from DMSO to THF) a completely different product 
(1.18) was obtained, as a result of intermolecular cross-coupling reaction between PhLi 
and 4-iodobenzonitrile. At the same time the silicon species 1.16 was regenerated 
following quenching of the reaction mixture.5a  
Scheme 1-4. Intramolecular vs. Intermolecular Cross-Coupling Processes 
 
Through further experimental investigation and reaction conditions optimization, the 
Smith Laboratory demonstrated siloxane 1.16 to be competent transfer agent for efficient 
palladium-catalyzed intermolecular cross-coupling reactions of aryl- and alkenyllithium 
reagents with aryl- and alkenyliodides at ambient temperature and pressure (Scheme 1-5). 
The siloxane transfer agent 1.16 was proposed and then subsequently supported by 
theoretical calculation5b to capture the organolithium reagents in an equilibrium between 
alkoxide 1.16b and pentavalent silicon-ate species 1.16a. Transmetalation from silicon to 
palladium then regenerated the transfer agent. Via this reaction manifold, a variety of aryl-
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aryl, aryl-alkenyl or alkenyl-alkenyl cross-coupled products was obtained in high yield 
exploiting the siloxane transfer agent 1.16. 
Scheme 1-5. Examples of Pd-CCRs Exploiting Siloxane Transfer Agent 
 
Organolithium reagents are cheap and either commercially available or readily 
accessible through lithium-halogen exchange or via direct metalation. Not surprisingly, 
organolithium reagents have been among the most commonly used reagents in organic 
synthesis and were one of the earliest organometallic reagents to be cross-coupled (i.e., the 
Murahashi cross-coupling reactions6). However, the use of organolithiums in the Pd-
catalyzed cross-coupling reactions (CCR) has remained limited, often hampered by low 
yields, narrow substrate scope due to the very high reactivity, and competitive formation 
of homo-coupled products. To overcome these issues, organolithium reagents are 
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frequently converted to other less reactive organometallic reagents (e.g., organozincs,7 
organoborons,8 organotins9 and organosilicons10) to be employed in CCR. Taking 
advantage of the direct use of organolithiums in CCR, the siloxane-based cross-coupling 
tactic holds the promise to eliminate the extra manipulation and purification steps required 
to generate other organometallic reagents as well as to avoid the stoichiometric generation 
of heavy metal or main group waste streams observed in traditional cross-coupling 
reactions (Scheme 1-6). Importantly, this strategy provides a solution to the intrinsic 
limitation of the Murahashi and recent Feringa slow addition cross-coupling protocols6,11 
of organolithiums, which are not compatible with substrates bearing sensitive functional 
groups such as nitriles or carbonyls (i.e., ketones, aldehyde and/or esters). 
Scheme 1-6. Solutions to the Metal Waste Problem in Traditional Palladium-
Catalyzed Cross-Coupling Reactions  
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1-2: Design, Synthesis and Validation of Recoverable and Readily 
Reusable Siloxane Transfer Agents 
(This work was conducted in collaboration with Drs. Dionicio Martinez-Solorio and Adam 
T. Hoye in the Smith Laboratory and published in Martinez-Solorio, D.; Hoye, A. T.; 
Nguyen M. H.; Smith, A. B., III. Org. Lett. 2013, 15, 2454.) 
Although siloxane 1.16 (Scheme 1-5) performed effectively in the reported cross-
coupling reactions, there are several drawbacks associated with 1.16 as a transfer agent. 
The most important one is the chromatographic behavior on silica gel (i.e., streaking), 
which significantly complicates purification and recovery. In such cases, the siloxane, 
which is regenerated during the course of the cross-coupling reactions, can be readily 
removed by chromatography following a Fleming-Tamao oxidation12 to furnish the 
corresponding phenol. Oxidation of 1.16 eliminates the possibility of recovering the 
siloxane for further use. Therefore, it is of great interest to improve the aforementioned 
cross-coupling reactions by developing a new class of compounds that not only are 
effective transfer agents, but also are readily purified and recovered. 
In addition to the problematic chromatographic behavior of siloxane 1.16, the reported 
synthesis of 1.16 requires four steps, including protection and deprotection,4 which 
challenge the likelihood of adoption by the chemical community. Thus we approached 
analog design and validation in modular sense, focusing initially on improving the 
synthesis of 1.16 compared to the previously reported route (Scheme 1-7, Eq 1). Inspired 
by the work of Akiba13 and Britton,14 treatment of benzaldehyde with 2.2 equiv of n-BuLi 
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generated benzylic alkoxide, which underwent directed ortho-lithiation to form dianion 
1.19 upon heating at reflux. Trapping of 1.19 with Me2SiHCl, followed by aqueous work-  
Scheme 1-7. Improved Siloxane Synthesis 
 
up, generated a mixture of siloxane 1.16 and benzylic alcohol 1.20 (4:1 by H NMR), which 
required only treatment with catalytic KOt-Bu to achieve ring closure to generate siloxane 
1.16 with concomitant evolution of H2 gas.
15 The siloxane could then be isolated via simple 
column chromatography followed by Kugelrohr distillation in 52% yield on 23 g scale. It 
should be noted that treatment with KOt-Bu is, in some cases, not required for analog 
synthesis as demonstrated in the one-pot synthesis of siloxane 1.21 (Scheme 1-7, Eq 2). 
Having developed an effective synthetic strategy, we explored structure modification 
to gain insight into the cross-coupling reactivity of different siloxane congeners, with 
particular emphasis on improving purification and recovery following cross-coupling 
reactions (Figure 1-1). While siloxane congeners possessing a single benzylic substituent 
(cf. 1.22-1.25) performed well in the cross-coupling reactions, the unsubstituted derivative 
1.26 did not participate in the cross-coupling reaction at room temperature, but required 
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heating to 50 °C with the observation of a minor amount of homocoupled product observed. 
Siloxane congener with geminal substitution at the benzylic position (cf. 1.27) also did not 
perform well in cross-coupling reactions, possibly due to increased steric hindrance. 
Interestingly, while the electron-deficent siloxane 1.29 proceeded smoothly in cross-
coupling reactions, electron-rich siloxane 1.28 proved less effective. The chromatographic 
behavior of the above siloxanes, also unfortunately, remained problematic, which might be 
attributed to the nucleophilic susceptibility of the dimethylsilyl group to the Lewis-basic 
oxygen atoms of SiO2. Accordingly, increasing the steric environment around the silicon 
atom eliminated the chromatographic challenges (cf. 1.21, 1.30-1.32). However, cross-
coupling conversion employing the diisopropyl siloxanes (1.31 and 1.32) was modest when 
PhLi was employed in cross-coupling reactions, with observation of significant 
homocoupling. Best results were obtained with diethyl siloxanes (1.21 and 1.30), providing 
excellent yield of cross-coupling product and near quantitative recovery of the transfer 
agents by flash chromatography.  
Figure 1-1. Siloxane Analog Development 
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Significant advancement in this series of analogs was envisioned to be achievable if we 
were able to recover the transfer agent by adjusting the pH of the cross-coupling product 
mixture. Toward this end, introduction of a Brønsted-base in the siloxane structure (cf. 
1.33-1.36, Figure 1-1) was accomplished, as we attempted to explore the possibility of 
recovering the transfer agents following cross-coupling reactions by an acid-base 
extraction protocol. Gratifyingly, exposure of these siloxanes to a biphasic mixture of 
aqueous HCl solution (1-3 M concentration) and Et2O (1:1), followed by separation of the 
acidic aqueous phase and treatment with aqueous NaOH solution (1 M concentration) 
permitted near quantitative recovery of the siloxane transfer agents. In this series, best 
results with regard to the integrity and recoverability of the transfer agents as well as cross-
coupling efficiency were achieved with siloxanes 1.34 and 1.36, possessing diethyl 
substituents on silicon.  
To illustrate the utility of the new transfer agent analogs, a series of cross-coupling 
reactions were performed employing electron-deficient and -rich coupling partners as 
illustrated in Table 1-1. In all cases, excellent reaction yields were achieved with the 
siloxane transfer agents recovered near-quantitatively via either flash chromatography or 
acid-base extraction protocol. Taken together, these newly developed transfer agents 
eliminated the drawbacks of the parent transfer agent (1.16) relating to facile recovery for 
potential recycling. 
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Table 1-1. Validation of Optimal Siloxanes 
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1-3: Design, Synthesis and Validation of First Generation Polymer-
Supported Siloxane Transfer Agents  
(Part of this work was published in Nguyen M. H.; Smith, A. B., III. Org. Lett. 2013, 15, 
4258.) 
Given that the siloxane-based transfer agents are fully regenerated following the cross-
coupling reactions, the siloxane-based method comprises an atom-economical approach 
for the construction of C-C bonds. The recovery of these transfer agents via either 
chromatographic separation or acid-base extraction, the latter by incorporation of a 
Brønsted base in the structure, in some cases however has proven less than optimal. The 
development of solid-supported transfer agents would significantly simplify product 
purification, and thereby would provide an attractive and practical method for recycling of 
transfer agents, further advancing the siloxane-based tactic (e.g., a polymer with attached 
siloxane transfer agents in flow reactors) and facilitating the use of the transfer agents by 
the chemical community. We therefore undertook incorporation of siloxane transfer agents 
onto readily recyclable polymer supports. 
From the outset, two goals were set for the development of an effective polymer-
supported siloxane transfer agent: (A) the synthesis of the polymer must be short, scalable, 
and inexpensive; and (B) the designed polymer should be soluble in THF, the reaction 
solvent for the cross-coupling reactions, and then should become insoluble upon addition 
of a more polar solvent following the cross-coupling reaction to permit facile removal of 
the polymer from the desired products. Based on these considerations, ring-opening 
metathesis polymerization (ROMP)16 was employed to construct a polymeric siloxane 
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transfer agent. One of the most common monomers employed in the ROMP protocol 
comprises norbornene and derivatives thereof, due to both their high ROMP activity and 
ease of incorporation of diverse functional groups.17 To this end, the ROMP monomer was 
constructed by treating a commercially available mixture of endo- and exo- isomers of 5-
norbornene-2-carboxaldehyde (1.37) with PhMgCl to furnish benzylic alcohol 1.38, which 
upon ortho-lithiation with n-BuLi, followed by capture of the resulting anion with 
Me2SiHCl and ring-closure catalyzed by KOtBu,
15 led to the siloxane 1.39 containing the 
desired norbornene moiety (Scheme 1-8). Ring-opening metathesis polymerization of 1.39 
was then achieved smoothly with the first generation Grubbs catalyst18 to furnish the 
polynorbornene-supported transfer agent PNTA-I200.  
Scheme 1-8. Synthesis of Polynorbornene-Supported Transfer Agent 
 
The resulting polymer proved soluble in most organic solvents and insoluble in H2O 
and MeCN, which we took advantage of in the purification process. Precipitation via 
dropwise addition of the concentrated reaction mixture into MeCN afforded the desired 
polymer as a white solid. Importantly, this short, efficient, and cost-effective route permits 
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preparation of the polymer on multi-gram scale. Given that the polymer was obtained in 
near quantitative yield, without use of cross-linking units or copolymerization agents, the 
siloxane loading of the polymer was reasoned to be nearly identical to the molarity of the 
monomer, namely 3.9 mmol/g, with each polymer chain having a relative length of 200-
mers, the latter based on the ratio of monomer 1.39 to the Grubbs catalyst (200:1). 
To evaluate PNTA-I200 as a viable cross-coupling transfer agent, conditions similar to 
those previously reported for the small molecule transfer agents were examined. As 
illustrated in Table 1-2 (entry 1), the use of 2.0 equiv of PNTA-I200 at a concentration of  
Table 1-2. Optimization of CCR Employing PNTA 
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15 mg/mL led to cross-coupling product 1.41 of PhLi and 4-iodoanisole (1.40). A 
significant amount of 1.40 however remained, in conjunction with formation of a small 
amount of homocoupled product 1.42. Increasing the equivalents of PhLi and PNTA-I200 
to 2.5 and 3.0, respectively, while keeping the polymer concentration at 15 mg/mL, greatly 
improved the efficiency of the process, providing 1.41 as the major product (entry 2). 
Lowering the polymer concentration to 10 mg/mL led to complete conversion of 1.40 
within 2 h, to furnish 1.41 in 98% isolated yield (entry 3). Attempts to reduce the amount 
of either PhLi or the siloxane polymer required to consume the starting aryl halide, without 
leading to homocoupled products, however, proved unsuccessful (entries 4-6). As expected, 
and consistent with Murahashi’s observation,6 a control experiment in the absence of 
siloxane polymer resulted in inefficient cross-coupling, in conjunction with significant 
formation of the undesired homocoupled product (entry 7). 
Having developed both an effective synthetic tactic and identified the optimal cross-
coupling conditions for the siloxane polymer PNTA-I200, we examined the effect of 
polymer structure on reactivity, vis-à-vis the ability to serve as a transfer agent. To this end, 
a series of polymer analogues was synthesized and employed in the cross-coupling reaction 
between PhLi and 4-iodoanisole (Table 1-3). Reducing the relative length of polymer chain 
to 20-mer by employing a higher Grubbs catalyst loading in the ROMP process led to 
competing homocoupled product formation in the cross-coupling process (entry 2). The 
polymer’s ability to serve as a transfer agent also proved sensitive to the steric environment 
around the silicon center, as a small increase in steric bulk by changing the substituents on 
the silicon atom from methyl to ethyl resulted in unproductive cross-coupling processes 
(entries 3 and 4). To explore the effect of the unsaturation in the polymer chain, a tandem 
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Table 1-3. Structure-Activity of Siloxane Polymer in Cross-Coupling Reactions 
 
ROMP-hydrogenation protocol19 was developed to access polymers with a saturated 
backbone (entries 5 and 6, Table 1-3). Interestingly, while the saturated 20-mer displays 
physical and cross-coupling properties similar to those of the unsaturated analogue (i.e., 
complete conversion with significant homocoupling, entry 6), the saturated 200-mer 
proved both insoluble in any organic solvent and yielded only trace amount of desired 
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product (entry 5). Best results in this series, with regard to polymer physical properties (i.e., 
solubility), ease of handling, and cross-coupling efficiency were obtained with the 
unsaturated 200-mer possessing dimethyl substituents on the silicon (i.e., PNTA-I200, entry 
1). 
To illustrate the utility and scope of the polynorbornene support, we carried out a series 
of cross-coupling reactions employing PNTA-I200 as the transfer agent (Table 1-4). 
Aryllithiums underwent effective coupling with various aryl- and alkenyliodides to provide 
the cross-coupling products in excellent yields (entries 1, 2, 3, and 6). Electron-rich and -
deficient substrates were well tolerated; even an azaheterocycle proceeded well (entry 3). 
While the cross-coupling reaction was also effective with the electron-deficient p-
cyanophenyl bromide, reaction employing the electron-rich p-methoxyphenyl bromide 
proved ineffective (entries 4 and 5). Alkenyllithiums were also well tolerated in the cross-
coupling reactions, proceeding in good yield with retention of the alkene geometry (entries 
7-9). In all cases, the reaction mixtures were quenched with saturated aqueous NH4Cl, 
followed by extraction with Et2O. The resultant organic solution was then concentrated, 
the siloxane polymer precipitated with CH3CN, and the polymer removed from the product 
by filtration. Importantly, cross-coupling reactions employing PNTA-I200 are as rapid and 
high-yielding as those employing the small molecule transfer agents (e.g., 1.16), with the 
added advantage of simple product isolation. 
Attention was next directed toward the possibility of repeated recycling of the 
polynorbornene-supported transfer agent. The ability of PNTA-I200 to retain cross-
coupling activity in multiple reactions employing the same coupling partners was first  
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Table 1-4. Validation of Polynorbornene Support in Cross-Coupling Reactions 
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examined. As illustrated in Table 1-5, PhLi and 4-iodoanisole were employed for each 
experiment. The reaction was quenched after a two-hour time period; and the siloxane 
polymer was removed from the reaction products via precipitation in MeCN and then 
employed in the subsequent cross-coupling run. Pleasingly, the polymer could be recovered 
in near quantitative yield and reused for three cycles, to furnish the desired cross-coupling 
product in good to excellent yields. However, a small decrease in cross-coupling efficiency 
was observed after each cycle, in conjunction with an increase in the number average 
molecular weight (Mn) and polydispersity index (PDI) of the recovered polymer, as 
determined by gel permeation chromatography (Figure 1-2).  
Table 1-5. Recyclability of Polynorbornene-Supported Transfer Agent in Cross-
Coupling Reactions Employing the Same Coupling Partnerts 
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Figure 1-2. Gel Permeation Chromatogram of Recovered PNTA-I200 after 
Successive Cross-Coupling Reactions 
 
We reason that the change in the polymer structure after successive cross-coupling 
reactions was likely due to cross-linking of the polymers. As depicted in Scheme 1-9, 
addition of PhLi into the polymer solution in the siloxane activation step is envisioned to 
generate alkoxide intermediates. During the course of the reaction, an oxyanion could 
attack a silicon atom of a nearby siloxane unit (either to remain intact after the activation 
step or to be regenerated after the cross-coupling step) residing on a different polymer chain, 
thereby resulting in cross-linking of the polymer. The higher degree of cross-linking, the 
less efficient the recovered polymer would be in mediating the cross-coupling process. The 
observation that the recovered polymer appeared to have an increase in hardness, in 
conjunction with a small decrease in solubility in organic solvents after each cycle, 
supports this hypothesis. An increase in the number average molecular weight (Mn) was 
also observed in repeated cross-coupling reactions employing the saturated polymer 
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(PNTA-I’20, Table 1-3), thus suggesting that the olefinic backbone is not responsible for 
the increase in molecular weight. 
Scheme 1-9. Polymer Cross-linking that Leads to Decrease in Reaction Efficiency 
after Repeated Cycles 
 
We next performed a series of experiments to explore repeated recycling of the 
polynorbornene support in cross-coupling reactions employing different coupling partners, 
with particular attention paid to cross-contamination of the nucleophile in the cross-
coupling products (Table 1-6). In the first experiment, two different nucleophilic coupling  
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Table 1-6. Recyclability of Polynorbornene-Supported Transfer Agent in Cross-
Coupling Reactions Employing Different Nucleophilic Coupling Partnerts 
 
partners were employed in two successive cross-coupling reactions using the same 
electrophilic coupling partner. Analysis of 1H-NMR of the product mixture revealed a 
small amount of the first cross-coupling product (4%) in the second cycle; this cross-over 
contaminant remained present in the third cycle, albeit in a minor amount (Table 1-6A). In 
the second experiment, the cross-over contamination of the nucleophile was also observed 
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in repeated cross-coupling reactions employing different nucleophiles and electrophiles 
(Table 1-6B). These results clearly demonstrate nucleophile scrambling due to the 
incomplete reform of the siloxane moiety following quenching of the reaction mixture, 
leading to nucleophile carryover when the cross-coupling partners are changed in 
subsequent reactions. 
In summary, we had successfully validated the use of ring-opening metathesis 
polymerization to incorporate an effective transfer agent onto a readily recoverable 
polynorbornene support that significantly simplifies product purification and transfer agent 
recycling. However, we observed a decrease in reaction efficiency in conjunction with 
nucleophile cross-contamination after repeated polymer reuse. 
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1-4: Design, Synthesis and Validation of Second Generation Polymer-
Supported Siloxane Transfer Agents  
(Part of this work was published in Nguyen M. H.; Smith, A. B., III. Org. Lett. 2014, 16, 
2070.) 
While the soluble linear polynorbornene support proved effective in mediating the 
palladium-catalyzed cross-coupling reactions of organolithiums, a number of concerns 
were associated with this polymer, including a decrease in reaction eﬃciency after repeated 
cycles in conjunction with reagent-induced increase in the polymer dispersity. Attention 
was thus directed toward the design of a more effective solid support with improved 
recycling properties. We began by addressing the issue of polymer cross-linking that we 
reasoned accounted for the drop in reaction efficiency (Scheme 1-9). We hypothesized that 
we could suppress this process by restricting the polymer chain mobility and thereby 
restrain the interaction of the reactive sites on the polymer chain via use of a more rigid, 
cross-linked, insoluble polymeric network. Toward this end, use of an inert co-monomer 
in the polymerization process would place the siloxane units further away from each other, 
therefore minimizing the undesired cross-linking behavior. Another factor considered in 
the design was removal of the unsaturation element in the polymer chain, given the possible 
vulnerability of the olefinic backbone to chemical and thermal degradation. Based on our 
previous observation that steric hindrance at the silicon atom leads to inefficient reactivity, 
use of a spacer between the siloxane moiety and the polymer matrix was also considered 
to reduce any steric effect induced by a bulky polymer backbone (Scheme 1-10). On the 
basic of this logic, cross-linked polystyrene polymers emerged as suitable solid supports 
for the transfer agent. 
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Scheme 1-10. Design of 2nd Generation Polymer-Supported Transfer Agent 
 
To test this hypothesis, we first directed our effort toward strategies to attach the 
transfer agent onto commercially available cross-linked polystyrene resin beads (Scheme 
1-11). However, all attempts to install the siloxane moiety onto a polystyrene resin via 
nucleophilic substitution reactions proved unsuccessful, presumably due to undesired  
Scheme 1-11. Unsuccessful Attempts to Immobilize Transfer Agent onto 
Commercially Available Resin Beads 
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reaction at the silicon atom. The use of a cross-coupling strategy employing 1.62 to 
functionalize the commercial resin beads also proved unsatisfactory as less than 10% of 
siloxane moiety was incorporated into the polystyrene resin 1.64. 
We next turned to polymeric immobilization of the transfer agent, in a “bottom up 
fashion” by first constructing a siloxane monomer (1.68, Scheme 1-12) possessing a 
styrene moiety which could then be subjected to co-polymerization with styrene and a 
suitable cross-linker to provide the desired cross-linked polystyrene-supported transfer 
agent. In this way, we would have excellent control of both the siloxane loading and the 
swelling properties of the polymer as these requirements would simply be a matter of 
mixing monomers and the cross-linker of choice in appropriate ratios. We began with the  
Scheme 1-12. Synthesis of Polystyrene-Supported Siloxane Transfer Agent 
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synthesis of the siloxane monomer 1.68 via treatment of commercially available 2-
bromobenzaldehyde 1.65 with allylmagnesium chloride to furnish benzylic alcohol 1.66, 
which was converted to siloxane 1.62, employed earlier (Scheme 1-11), by a one-pot, three 
step reaction sequence involving lithiation with n-BuLi, followed in turn by anion capture 
with Me2SiHCl and ring closure upon quenching with H2O. Hydroboration with 9-BBN, 
followed by a Suzuki Pd-catalyzed cross-coupling reaction20 with p-dibromobenzene 
smoothly provided aryl bromide 1.67 in 85% yield. In turn, 1.67 was converted to siloxane 
monomer 1.68 via second Suzuki cross-coupling reaction employing vinyltrifloroborate.21 
Suspension co-polymerization22 of 1.68, styrene, and the tetrahydrofuran-based cross-
linker 1.69 (in a molar ratio of 12:87:1, respectively) was then smoothly achieved with 
benzoyl peroxide to provide the 1% cross-linked polystyrene-supported transfer agent 
PSTA-I as well-defined beads. Selection of the highly flexible cross-linker 1.69 in the 
polymerization process led to a gel-type resin that exhibits excellent swelling properties in 
THF,23 the reaction solvent for many cross-coupling reactions. The siloxane loading of 
PSTA-I (1.5 mmol/g) was reasoned to be nearly identical to the silicon loading, the latter 
determined by elemental analysis. 
We next evaluated the PSTA-I polymer as a viable transfer agent employing the similar 
conditions developed for the polynorbornene-supported transfer agent (Scheme 1-13). 
Pleasingly, PSTA-I efficiently mediated the palladium-catalyzed cross-coupling reaction 
between PhLi and 4-iodoanisole to furnish the desired cross-coupling product 1.41 in 96% 
yield without observation of the homo-coupling product. Importantly, the cross-coupling 
efficiency remained the same after six cross-coupling iterations employing the same batch 
of polymer, thereby demonstrating a significant improvement of the designed polystyrene 
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Scheme 1-13. Recyclability of the Polystyrene Support in Cross-Coupling Reactions 
Employing the Same Nucleophile and Electrophile 
 
support compared to the polynorbornene support. Also noteworthy was the ease of transfer 
agent recovery, as the polymer could be readily removed from the product mixture via 
simple filtration, then washed with organic solvents and dried under vacuum before being 
employed in the next cross-coupling cycle. 
The use of the new polystyrene support in repeated cross-coupling reactions employing 
different nucleophiles and electrophiles was next explored. As shown in Table 1-7, a single 
batch of siloxane polymer efficiently mediated a total of ten cross-coupling reactions, 
furnishing the desired cross-coupling products with no evidence of homocoupled products. 
Importantly, cross-coupling reactions employing recycled PSTA-I proved as high yielding 
as those employing the freshly made PNTA-I200. Equally significant, no nucleophile cross-
contamination was detected across this series of reactions. Moreover, substrates containing 
highly sensitive functional groups such as nitriles and ketones were well tolerated in cross-
coupling reactions mediated by PSTA-I, demonstrating the unique advantage of this  
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Table 1-7. Recyclability of PSTA-I in Reactions Employing Multiple Cross-
Coupling Partnerts 
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protocol compared to other reported cross-coupling methods6,11 employing organolithium 
reagents as the nucleophilic coupling partnerts. 
A proposed reaction mechanism for the siloxane-mediated cross-coupling reaction of 
organolithium reagents under catalytic amounts of Pd0 and CuI is illustrated in Scheme 1-
14. Addition of organolithium to the transfer agent during the siloxane activation step 
generates an alkoxide intermediate, presumably in equilibrium with a pentavalent 
siliconate complex.10 Transmetalation from silicon to copper10,24 furnishes aryl-CuI species  
Scheme 1-14. Proposed Reaction Mechanism 
with simultaneous regeneration of the transfer agent. A second transmetalation step from 
copper to palladium results in the diarylpalladium(II) complex, which undergoes reductive 
elimination to provide the coupled products, in conjunction with Pd0 that re-enters the 
catalytic cycle. We also reason that a catalytic amount of CuI is required to serve as a 
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molecular transporter between two transmetalation processes (i.e., first accepting 
nucleophile from activated transfer agent then donating a nucleophile to the palladium 
center). 
In summary, we were able to achieve the rational design, synthesis, and validation of a 
significantly improved second-generation, insoluble, polymer-supported siloxane transfer 
agent for use in the palladium-catalyzed cross-coupling reactions of organolithiums with 
aryl and alkenyl iodides. Drawbacks of the previous polymer-supported siloxane transfer 
agent, relating to reaction eﬃciency and polymer stability after repeated cycles, were 
addressed. Importantly, the cross-linked polystyrene support signiﬁcantly simpliﬁes 
product puriﬁcation and permits excellent polymer reuse with diverse nucleophiles and 
electrophiles, rendering this tactic a powerful tool in organic synthesis that could provide 
both “greener” and more sustainable chemical processes, as well as the potential for 
performing the siloxane-based cross-coupling reactions in flow. 
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1-5: Copper-Catalyzed Electrophilic Amination of Organolithiums 
Mediated by Recoverable Siloxane Transfer Agents 
(Part of this work was published in Nguyen M. H.; Smith, A. B., III. Org. Lett. 2013, 15, 
4872.) 
A central feature of the siloxane transfer agent tactic entails the novel use of recyclable 
agents that can capture and convert highly reactive and nonselective organolithium 
reagents, without any purification or isolation, to nucleophilic silicon-ate intermediates for 
chemoselective transformations. Thus, it should be possible to access different product 
types by employing different classes of electrophilic coupling partners. Having established 
an efficient method for the construction of carbon-carbon bonds exploiting siloxane 
transfer agent, we next explored the possibility of employing this tactic in other bond-
forming processes. 
Based on the similarities between the reactive intermediate involved in our siloxane-
based cross-coupling reactions (alkoxide 1.16b, Scheme 1-5) and arylsilanes 1.75 
employed in electrophilic aminations with O-benzoyl hydroxylamines 1.76 reported by 
Miura and co-workers (Scheme 1-15),25 we reasoned that we could intersect this reaction  
Scheme 1-15. Electrophilic Amination of Arylsilanes 
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manifold via a siloxane transfer agent. Such success would provide a valuable and practical 
method for the direct amination of organolithium compounds. 
We began by subjecting alkoxide intermediate 1.78b, derived from reaction of PhLi 
and 1.21, to conditions similar to those reported by Miura and coworkers, employing N,N-
dibenzyl-O-benzoyl hydroxylamine (1.76a) as the electrophile (Scheme 1-16). Pleasingly, 
the desired product, dibenzyl aniline, was obtained in 63% yield. Although the majority of 
siloxane 1.21 could be recovered from the reaction mixture, the siloxane-derived benzoate 
1.79 and triphenylmethanol were also isolated. We envisioned that the reaction proceeded 
via two pathways under the employed conditions. The desired reaction involves 
transmetalation from silicon to copper, with subsequent electrophilic amination of the 
arylcopper intermediate to generate 1.77a. Alternatively, the lithium alkoxide (1.78a) can 
O-acylate 1.76a to generate silane 1.79 or transfer the phenyl group to 1.76a to generate 
triphenylmethanol 1.80. 
Scheme 1-16. Initial Attempt at the Electrophilic Amination of Phenyllithium 
Employing Siloxane Transfer Agent 
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With these preliminary results in hand, we turned our efforts to optimize the reaction, 
including both product yield and siloxane recovery (Table 1-8). Changing the solvent from 
1,4-dioxane to THF increased the yield of desired amination product (1.77a) (entry 1). 
Importantly, the reaction proceeded effectively at room temperature within a two-hour time 
period. An increase in both product yield and siloxane recovery was also realized when the 
catalyst loading was increased (entries 2 and 3); a further increase in the copper catalyst 
(40 mol %), however, proved ineffective (entry 4). Particularly pleasing, the efficiency of 
the process was significantly improved when dpca, the optimal ligand employed in the 
Table 1-8. Optimization of the Electrophilic Amination of Organolithiums 
Employing Siloxane Transfer Agent 
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Pd-catalyzed cross-coupling reactions, was employed (Scheme 1-4). The use of 10 mol % 
CuI and 10 mol % dpca proved optimal, leading to complete conversion of 1.76a within 
two hours at room temperature to furnish 1.77a in 98% isolated yield, along with full 
recovery of the siloxane transfer agent (entry 5). Attempts to reduce the amount of PhLi or 
the catalyst loading, while maintaining the efficiency of the process, provided no 
enhancement (entries 6 and 7). Importantly, as a control experiment, only 7% of 1.77a was 
obtained in the absence of the siloxane transfer agent (entry 8). Also as expected, reaction 
of PhLi with the electrophilic aminating reagent 1.76a provided triphenylmethanol as the 
major product; no amination product could be detected (entry 9). 
Having established the optimized reaction conditions, we next explored the scope of 
the Cu(I)-catalyzed electrophilic amination of organolithium compounds employing 
siloxane transfer agent 1.21 (Table 1-9). Various acyclic and cyclic amines underwent 
effective coupling with PhLi, furnishing the corresponding anilines in good to excellent 
yields (1.77a-i). The resultant N-allyl and N-benzyl moieties (1.77a-c) can serve as useful 
synthetic handles upon removal of the benzyl or allyl groups to access either unsubstituted 
or monosubstituted anilines (e.g., 1.77c).26 Notably, the reaction of PhLi and the sterically 
hindered electrophile N,N-diisopropyl-O-benzoyl hydroxylamine proceeds to form the 
corresponding aniline in good yield (1.77e). Electrophilic amination was also effective with 
a variety of organolithium agents. In particular, the electron-rich p-methoxyphenyllithium 
readily underwent electrophilic amination to provide the corresponding amination products 
in good yield (1.77j and 1.77k). On the other hand, electron-deficient organolithiums 
proceeded with somewhat lower efficiency (1.77l-n). Pleasingly however, the aryl-Cl 
moiety remained intact in the amination of p-chlorophenyllithium with piperidine-1-yl 
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benzoate to furnish 1.77n, providing an opportunity for additional transformations, such as 
palladium-catalyzed cross-coupling reactions. Sterically hindered organolithiums such as  
Table 1-9. Substrate-Scope Study of the Electrophilic Amination of Organolithiums 
Employing Siloxane Transfer Agent 
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o-methoxyphenyllithium and 1-naphthyllithium also proceeded, albeit in moderate yield 
(1.77o and 1.77q). Importantly, heteroaryllithiums such as 3-pyridyllithium and 2-
benzofuryllithium were also tolerated in the amination (1.77p and 1.77r), with the latter 
accessed via a direct ortho lithiation/amination sequence of benzofuran. Use of 3-
thienyllithium and the sterically hinderred mesityllithium however proved unsuccessful 
(1.77s and 1.77t). Gratifyingly, the amination protocol can be carried out on a gram scale 
to provide a very good yield of the desired product (1.77f, 94%), indicating both the 
scalability and reliability of the method. Equally important, in this case, the siloxane 
transfer agent was recovered in 92% yield via Kugelrohr distillation, with the amination 
product 1.77f conveniently isolated via acid-base extraction. 
We next explored the use of other siloxane transfer agents in the amination process, 
focusing on the ability to recycle the transfer agent via a simple protocol. As shown in 
Scheme 1-17, Brønsted base incorporated siloxane transfer agents 1.34 and 1.36 were  
Scheme 1-17. Performance of Brønsted Base-Siloxanes in Electrophilic Amination 
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found to be effective in the electrophilic amination between PhLi and N,N-dibenzyl-O-
benzoyl hydroxylamine, providing the amination product in moderate to good yields, with 
near quantitative recovery of the transfer agents via acid-base extraction, exploiting the 
differential basicity of the siloxanes and the amine products. 
We also examined the utility of the polynorbornene-supported siloxane transfer agent 
PNTA-I200 for electrophilic amination between PhLi and piperidine-1-ylbenzoate (Table 
1-10). Pleasingly, the polymer can be used for at least three cycles, providing good to 
excellent yields of the desired amination product 4g, abeit with a small decrease in 
efficiency after each cycle. In all cases, the amination product was purified via acid-base 
extraction and the polymer was recovered in near quantitative yield via precipitation in  
Table 1-10. Recyclability of Polymer-Supported Siloxane Transfer Agent in 
Electrophilic Amination 
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CH3CN, thus featuring a chromatography-free purification strategy. 
In summary, we have developed and validated the direct copper-catalyzed, 
electrophilic amination of aryl and heteroaryl organolithiums with N,N-dialkyl-O-benzoyl 
hydroxylamines. The mild, room temperature reaction conditions, in conjunction with the 
ease of product purification, make this approach a valuable addition to methods for C-N 
bond construction employing transition-metal catalysis27 (e.g., Buchwald-Hartwig 
palladium-catalyzed cross-coupling, Ullmann-type copper-catalyzed cross-coupling, and 
Chan-Lam copper-mediated oxidative coupling). Importantly, the use of siloxane transfer 
agents offers a solution for the direct application of organolithiums in electrophilic 
amination28 and, in turn, eliminates the need for multiple synthetic manipulation and/or 
isolation of the required organometallic reagents (e.g., organoborons29 and 
organosilicons25), as well as the requirement for a stoichiometric amount of toxic, heavy 
metals (e.g., Zn,30 Sn,31 and Ti32) in this amination tactic.  
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1-6: Conclusions 
We reported here the development of siloxane transfer agents for use in the cross-
coupling reactions of organolithium compounds. In addition to carbon-carbon bond 
formation, the transfer agent tactic was expanded for the construction for carbon-nitrogen 
bonds. Through rational design and synthesis, we have validated the possibility of 
incorporating the transfer agent onto a solid support to simplify product purification while 
maintaining the cross-coupling activity through multiple reaction cycles. While there are 
still limitations associated with the current transfer agents (e.g., the use of more than one 
equivalent of nucleophilic coupling partners), the mild reaction conditions, and an 
operationally convenient protocol provided by the polymer supports significantly advance 
the siloxane based tactic, holding promise for a variety of applications.  One possible 
application involves coating of siloxane polymer in flow microreactors, which will further 
facilitate the adoption of this cross-coupling strategy by the chemical industry. There is 
also a possibility of capturing and isolating the reactive intermediates generated via 
addition of organolithiums to polymer-supported transfer agents. For example, addition of 
PhLi to a solution of PNTA-I200 followed by removal of solvent via rotary evaporation 
generated a bench-stable, free-flowing powder. The exact structure of the resulting 
functional group embedded in the hydrophobic polymeric network remains unclear. 
Presumably the lithium salt of alkoxide or pentavalent siliconate complex is formed. 
Interestingly, this polymeric substance indeed participated in the Pd-catalyzed cross-
coupling reactions upon exposure to a solution containing the electrophile and catalyst 
system, without the need for external bases or additives (Scheme 1-18). This important, 
albeit preliminary, result demonstrates the promise of developing a new class of air-stable,  
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Scheme 1-18. Polymer-Supported Nucleophilic Silicon Reagents 
 
conveniently handled and re-generable polymer-supported nucleophilic silicon reagents 
for use in transition-metal-catalyzed C-C and C-heteroatom bonds formation. These 
reagents will not only expand the siloxane tactic, but also find good use in a variety of 
applications, such as in the field of combinatorial chemistry. 
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1-8: Experimental Section 
1-8-a: General 
All moisture-sensitive reactions were performed using syringe-septum cap techniques 
under an inert atmosphere of N2. All glassware was flame dried or dried in an oven (140 
C) for at least 4 h prior to use. Reactions were magnetically stirred unless otherwise 
stated.  Tetrahydrofuran (THF), dichloromethane (CH2Cl2) and diethyl ether (Et2O) were 
dried by passage through alumina in a Pure Solve™ PS-400 solvent purification system.  
Unless otherwise stated, solvents and reagents were used as received.  Analytical thin 
layer chromatography was performed on pre-coated silica gel 60 F-254 plates (particle 
size 40-55 micron, 230-400 mesh) and visualized by a uv lamp or by staining with PMA 
(2 g phosphomolybdic acid dissolved in 20 mL absolute ethanol), KMnO4 (1.5 g of 
KMnO4, 10 g of K2CO3 and 2.5 mL of 5% aq. NaOH in 150 mL H2O), or CAM (4.8 g of 
(NH4)6Mo7O24·4H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N H2SO4 solution). 
Column chromatography was performed using silica gel (Silacycle Silaflash®) P60, 40-63 
micron particle size, 230-300 mesh) and compressed air pressure with commercial grade 
solvents. Yields refer to chromatographically and spectroscopically pure compounds, 
unless otherwise stated.  NMR spectra were recorded at 500 MHz/125 MHz (1H NMR/ 13C 
NMR) on a Bruker Avance III 500 MHz spectrometer at 300 K. Chemical shifts are 
reported in parts per million with the residual solvent peak as an internal standard.  1H 
NMR spectra are tabulated   as follows:  chemical shift, multiplicity (s=singlet, d=doublet, 
t=triplet, q=quartet, dd=doublet of doublets, ddd= doublet of doublet of doublets, dddd= 
doublet of doublet of doublet of doublets, dt= doublet of triplets, m=multiplet, b=broad), 
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coupling constant and integration. 1 3 C NMR spectra are tabulated by observed peak. 
Melting points were determined using a Thomas-Hoover capillar melting point apparatus 
and are uncorrected.  Infrared spectra were measured on a Jasco FT/IR 480 plus 
spectrometer.  High-resolution mass spectra (HRMS) were obtained at the University of 
Pennsylvania on a Waters GCT Premier spectrometer. GPC analysis of the polymer 
samples were done on a Perkin-Elmer Series 10 high-performance liquid chromatography 
(HPLC), equipped with an LC-100 column oven (30 C), a Nelson Analytical 900 Series 
integration data station, a Perkin-Elmer 785 UV-vis detector (254 nm), a Varian star 4090 
refractive index detector, and three AM gel columns (500 Å, 5 µm; 1000 Å, 5 µm; and 104 
Å, 5 µm). THF (Fisher, HPLC grade) was used as eluent at a flow rate of 1 mL/min. The 
number-average (Mn) and weight-average (Mw) molecular weights of polymer samples 
were determined with poly(methyl methacrylate) (PMMA) standards purchased from 
American Polymer Standards. Elemental analysis of Si was determined by Robertson 
Microlit Laboratories Inc via inductively coupled plasma optical emission spectrometry 
(ICP-OES). 
Preparation of water-washed silica gel for column chromatography (where 
specified): Silica gel was suspended in deionized H2O and the slurry mixture was then 
packed into a prepared column. The obtained H2O-washed silica gel packed column was 
then rinsed with 2 column volumes of acetone, 1 column volume of EtOAc and 2 column 
volumes of hexanes, successively. The obtained column is then ready for use. 
1-8-b: Experimental Procedures 
1-8-b-1: Synthesis of Small Molecule Siloxane Transfer Agents 
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The synthesis of siloxanes 1.16, 1.21, 1.26, 1.27, 1.33-1.36 and cross-coupling studies 
of all small molecule siloxane transfer agents described in Section 1-2 were conducted by 
Drs. Dionicio Martinez-Solorio and Adam T. Hoye in the Smith Laboratory and reported 
in Martinez-Solorio, D.; Hoye, A. T.; Nguyen M. H.; Smith, A. B., III. Org. Lett. 2013, 
15, 2454. 
 
A solution of n-BuLi (2.45 M in hexanes, 14.65 mL, 35.9 mmol) was added dropwise 
to a stirred solution of (2-bromophenyl)(phenyl)methanol (4.29 g, 16.3 mmol) in 50 mL 
THF at –78 oC. The obtained solution was stirred for 1 h, followed by the addition of 
Me2SiHCl (3.90 mL, 35.9 mmol) at –78 oC. The resulting reaction mixture was allowed to 
warm to rt and was stirred overnight. After 17 h, the reaction mixture was quenched by 
addition of t-BuOH (20 mL) and stirred for 5 h, followed by the addition of deionized H2O 
(20 ml) and was stirred for another 2 h. The organic layer was collected and the aqueous 
layer was extracted with Et2O (2 x 25 mL). The combined organic layers were washed with 
brine, dried with MgSO4, and concentrated in vacuo. The crude product was purified by 
flash chromatography on wet silica gel (0 – 1% Et2O/Hexanes) to afford the desired 
siloxane 1.22 (1.82 g, 7.57 mmol, 46%) as a white crystalline solid (M.P. = 45.5 – 46.5 oC): 
IR (neat, cm–1) 3057 (m), 2964 (m), 2874 (m), 1447 (m), 1265 (s), 1181 (m), 1136 (m), 
1042 (s), 1016 (s), 862 (s), 822 (s), 793 (s), 740 (s), 702 (s), 656 (m); 1H NMR (500 MHz, 
CDCl3) δ = 7.63-7.59 (m, 1 H), 7.36-7.26 (m, 7 H), 7.05-7.01 (m, 1 H), 6.17 (s, 1 H), 0.53 
(s, 3 H), 0.45 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 152.6, 143.9, 135.3, 130.8, 129.9, 
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128.7, 127.9, 127.3, 127.3, 123.9, 84.2, 1.4, 0.7; HRMS (CI+) m/z (M+H)+: Calcd for 
C15H17SiO: 241.1049, found: 241.1034. 
 
 
To a stirred solution of 2-methyl-1-phenyl-1-propanol (2.76 g, 18.4 mmol) in hexanes 
(125 mL, dried over MgSO4) and Et2O (100 ml) at 0
 oC was added n-BuLi (1.77 M in 
hexanes, 22.9 mL, 40.5 mmol) dropwise. The solution was stirred at room temperature for 
30 minutes, at which time reflux condenser was attached and the solution was heated to 
reflux at 75 oC for 28 h. The solution was then cooled to –78 oC and Me2SiHCl (4.40 mL, 
40.5 mmol) was added dropwise. The solution was stirred and warmed up to room 
temperature. After 18 h, the reaction mixture was quenched by addition of t-BuOH (20 mL) 
and stirred for 6 h, followed by the addition of deionized H2O (20 mL) and was stirred for 
another 2 h. The organic layer was collected and the aqueous layer was extracted with Et2O 
(2 x 25 mL). The combined organic layers were washed with brine, dried with MgSO4, and 
concentrated in vacuo. The crude product was purified by flash chromatography on wet 
silica gel (0 – 1% Et2O/hexanes), followed by Kugelrohr distillation (75 – 80 oC, 0.025 
mmHg) to afford the desired siloxane 1.23 (1.48 g, 7.17 mmol, 39%) as a colorless oil: IR 
(neat, cm–1) 3060 (m), 2963 (s), 2873 (m), 1594 (m), 1469 (m), 1442 (m), 1383 (m), 1365 
(m), 1251 (s), 1198 (m), 1137 (m), 1120 (m), 1102 (m), 1067 (s), 1014 (s), 953 (s), 874 (s), 
830 (s), 788 (s), 744 (s), 704 (m), 651 (m);  1H NMR (500 MHz, CDCl3) δ = 7.54 (d, J = 
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7.1 Hz, 1 H), 7.39 (dt, J = 1.0, 7.5 Hz, 1 H), 7.29 (t, J = 7.2 Hz, 1 H), 7.20 (d, J = 7.7 Hz, 
1 H), 5.17 (d, J = 2.2 Hz, 1 H), 2.12 (dspt, J = 2.5, 6.8 Hz, 1 H), 1.17 (d, J = 6.9 Hz, 3 H), 
0.60 (d, J = 6.7 Hz, 3 H), 0.41 (s, 3 H), 0.36 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 
152.5, 136.4, 130.8, 129.7, 127.0, 122.4, 86.5, 34.6, 20.4, 15.0, 1.0, 0.8; HRMS (CI+) m/z 
(M-Me)+: Calcd for C11H15SiO: 191.0892, found: 191.0893. 
 
 
To a stirred solution of benzaldehyde (3.25 g, 30.6 mmol) in hexanes (125 mL, dried 
over MgSO4) and Et2O (100 mL) at 0
 oC was added sec-BuLi (1.4 M in cyclohexane, 26.2 
mL, 36.7 mmol) dropwise. The solution was stirred at room temperature for 5 h, at which 
time n-BuLi (1.77 M in hexanes, 20.7 mL, 36.7 mmol) was added dropwise. Reflux 
condenser was then attached and the solution was heated to reflux at 75 oC for 20 h. The 
solution was then cooled to –78 oC and Me2SiHCl (7.97 mL, 73.4 mmol) was added 
dropwise. The solution was stirred and warmed up to room temperature. After 23 h, the 
reaction mixture was quenched by addition of t-BuOH (20 mL) and stirred for 6 h, followed 
by the addition of deionized H2O (20 mL) and was stirred overnight. The organic layer was 
collected and the aqueous layer was extracted with Et2O (2 x 25 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on wet silica gel (0 – 1% 
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Et2O/hexanes), followed by Kugelrohr distillation (140 – 160 oC, 0.01 mmHg) to afford 
the desired siloxane 1.24 (2.02 g, 9.17 mmol, 30%) as a colorless oil. Mixture of 2 isomers 
with a ratio of 5:3 was obtained following purification: IR (neat, cm–1) 3060 (m), 2962 (s), 
2875 (s), 1594 (m), 1443 (s), 1375 (m), 1323 (m), 1250 (s), 1197 (m), 1137 (m), 1107 (s), 
1068 (s), 1040 (s), 1014 (s), 960 (s), 875 (s), 826 (s), 789 (s), 746 (s), 705 (m), 653 (m). 
HRMS (CI+) m/z (M-H)+: Calcd for C13H19SiO: 221.1362, found: 221.1368. Major isomer: 
1H NMR (500 MHz, CDCl3) δ = 7.54 (d, J = 7.1 Hz, 1 H), 7.39 (t, J = 7.5 Hz, 1 H), 7.29 
(t, J = 7.1 Hz, 1 H), 7.21 (d, J = 7.7 Hz, 1 H), 5.20 (d, J = 2.2 Hz, 1 H), 1.88-1.79 (m, 1 H), 
1.13 (d, J = 6.9 Hz, 3 H), 1.08-1.01 (m, 2 H), 0.79 (t, J = 7.4 Hz, 3 H), 0.40 (s, 3 H), 0.36 
(s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 152.3, 136.6, 130.9, 129.6, 126.9, 122.4, 86.7, 
41.8, 22.5, 16.9, 12.5, 1.0, 0.8. Minor isomer: 1H NMR (500 MHz, CDCl3) δ = 7.54 (d, J 
= 7.1 Hz, 1 H), 7.39 (t, J = 7.5 Hz, 1 H), 7.29 (t, J = 7.1 Hz, 1 H), 7.19 (d, J = 7.7 Hz, 1 H), 
5.20 (d, J = 1.2 Hz, 1 H), 1.88-1.79 (m, 1 H), 1.74-1.65 (m, 1 H), 1.53-1.43 (m, 1 H), 1.04 
(t, J = 7.7 Hz, 3 H), 0.55 (d, J = 6.7 Hz, 3 H), 0.40 (s, 3 H), 0.36 (s, 3 H); 13C NMR (125 
MHz, CDCl3) δ = 152.7, 136.4, 130.8, 129.7, 126.9, 122.2, 84.62, 41.5, 31.9, 27.5, 12.5, 
1.0, 0.7.  
 
 
To a stirred solution of benzaldehyde (2.63 g, 24.8 mmol) in hexanes (125 mL, dried 
over MgSO4) and Et2O (100 mL) at 0
 oC was added MeLi (1.36 M in Et2O, 21.9 mL, 29.7 
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mmol) dropwise. The solution was stirred at room temperature for 5 h, at which time n-
BuLi (2.45 M in hexanes, 12.1 mL, 29.7 mmol) was added dropwise. Reflux condenser 
was then attached and the solution was heated to reflux at 75 oC for 24 h. The solution was 
then cooled to –78 oC and Me2SiHCl (6.46 mL, 59.4 mmol) was added dropwise. The 
solution was stirred and warmed up to room temperature. After 23 h, the reaction mixture 
was quenched by addition of t-BuOH (20 mL) and stirred for 6 h, followed by the addition 
of deionized H2O (20 mL) and was stirred for another 2 h. The organic layer was collected 
and the aqueous layer was extracted with Et2O (2 x 25 mL). The combined organic layers 
were washed with brine, dried with MgSO4, and concentrated in vacuo. The crude product 
was purified by flash chromatography on wet silica gel (0 – 1% Et2O/hexanes), followed 
by Kugelrohr distillation (55 oC, 0.01 mmHg) to afford the desired siloxane 1.25 (1.55 g, 
8.69 mmol, 35%) as a colorless oil: IR (neat, cm–1) 3060 (m), 2968 (s), 2924 (m), 2867 
(m), 1595 (m), 1444 (s), 1368 (m), 1318 (s), 1251 (s), 1199 (m), 1137 (m), 1086 (s), 1028 
(s), 929 (s), 855 (s), 828 (s), 793 (s), 759 (s), 742 (s), 696 (m), 653 (m); 1H NMR (500 
MHz, CDCl3) δ = 7.56 (d, J = 7.1 Hz, 1 H), 7.40 (dt, J = 0.8, 7.5 Hz, 1 H), 7.30 (t, J = 7.3 
Hz, 1 H), 7.22 (d, J = 7.7 Hz, 1 H), 5.34 (q, J = 6.5 Hz, 1 H), 1.51 (d, J = 6.5 Hz, 3 H), 0.41 
(s, 3 H), 0.37 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 154.5, 135.2, 131.0, 129.8, 127.0, 
122.3, 78.0, 25.4, 1.7, 0.6; HRMS (CI+) m/z (M-Me)+: Calcd for C9H11SiO: 163.0579, 
found: 163.0578. 
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A solution of n-BuLi (2.45 M in hexanes, 9.84 mL, 24.1 mmol) was added dropwise to 
a stirred solution of (2-bromo-5-methoxyphenyl)(phenyl)methanol (3.211 g, 10.96 mmol) 
in 50 mL THF at –78 oC. The obtained solution was stirred for 1 h, followed by the addition 
of Me2SiHCl (2.62 mL, 24.1 mmol) at –78 oC. The resulting reaction mixture was allowed 
to warm to room temperature and was stirred overnight. After 18 h, the reaction mixture 
was quenched by addition of H2O (20 mL) and stirred for 40 min. The organic layer was 
collected and the aqueous layer was extracted with Et2O (2 x 25 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on wet silica gel (1% Et2O/hexanes) 
to afford the desired siloxane 1.28 (0.89 g, 3.29 mmol, 30%) as a white crystalline solid 
(M.P. = 89.0 – 90.0 oC): IR (neat, cm–1) 3062, 3030, 2955, 2917, 2849, 1596 (s), 1561, 
1475, 1455, 1302, 1277, 1251, 1237 (s), 1073, 1064, 1046, 1023, 861 (s), 840 (s), 783 (s), 
737, 699, 668; 1H NMR (500 MHz, CDCl3) δ = 7.53-7.50 (d, J = 7.9 Hz, 1 H), 7.36-7.31 
(m, 2 H), 7.30-7.27 (m, 3 H), 6.88 (dd, J = 8.1, 2.0 Hz, 1 H), 6.52 (d, J = 1.8 Hz, 1 H), 6.11 
(s, 1 H), 3.72 (s, 3 H), 0.51 (s, 3 H), 0.43 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 161.5, 
154.9, 143.8, 131.9, 128.7, 128.0, 127.3, 126.3, 114.4, 108.7, 84.0, 55.3, 1.6, 0.9; HRMS 
(CI+) m/z (M+H)+: Calcd for C16H19SiO2: 271.1154, found: 271.1157. 
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A solution of n-BuLi (2.65 M in hexanes, 20.6 mL, 54.5 mmol) was added dropwise to 
a stirred solution of (2-bromo-5-fluorophenyl)(phenyl)methanol (6.966 g, 24.79 mmol) in 
180 mL THF at –78 oC. The obtained solution was stirred for 1 h, followed by the addition 
of Me2SiHCl (5.90 mL, 54.5 mmol) at –78 oC. The resulting reaction mixture was allowed 
to warm to room temperature and was stirred overnight. After 14 h, the reaction mixture 
was quenched by addition of H2O (50 mL) and stirred for 24 h. The organic layer was 
collected and the aqueous layer was extracted with Et2O (2 x 50 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on wet silica gel (1% Et2O/hexanes) 
to afford the desired siloxane 1.29 (0.64 g, 2.48 mmol, 10%) as a colorless oil: IR (neat, 
cm–1) 3063, 3030, 2960, 2922, 1599, 1574, 1467, 1255 (s), 1227, 1043 (s), 1025 (s), 945, 
864, 843, 786, 738, 698, 665; 1H NMR (500 MHz, CDCl3) δ = 7.56 (dd, J = 7.9, 5.9, 1 H), 
7.38-7.24 (m, 5 H), 7.04-6.97 (m, 1 H), 6.70 (dd, J = 9.7, 2.0 Hz, 1 H), 6.11 (s, 1 H), 0.53 
(s, 3 H), 0.44 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ = 164.6 (d, J = 247.5 Hz), 155.5 (d, 
J = 7.5 Hz), 143.3, 132.5 (d, J = 8.8 Hz), 130.5 (d, J = 2.5 Hz), 128.8, 128.2, 127.2, 115.2 
(d, J = 20 Hz), 110.9 (d, J = 21.3 Hz), 83.8, 1.44, 0.74; HRMS (CI+) m/z (M)+: Calcd for 
C15H15SiOF: 258.0876, found: 258.0884. 
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A solution of n-BuLi (2.39 M in hexanes, 14.6 mL, 34.8 mmol) was added dropwise to 
a stirred solution of (2-bromophenyl)(phenyl)methanol (4.16 g, 15.8 mmol) in 120 mL 
THF at –78 oC. The obtained solution was stirred for 1 h, followed by the addition of 
Et2SiHCl (34.76 mmol) at –78 oC. The resulting reaction mixture was allowed to warm to 
rt and was stirred overnight. After 28 h, the reaction mixture was quenched by addition of 
deionized H2O (50 mL) and stirred for 18 h at room temperature. The organic layer was 
collected and the aqueous layer was extracted with hexanes (2 x 50 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel (0 - 5% Et2O/hexanes) 
to afford the desired siloxane 1.30 (1.74 g, 6.48 mmol, 41%) as a colorless oil: IR (neat, 
cm–1) 3059 (m), 2999 (m), 2956 (s), 2878 (s), 1595 (m), 1486 (m), 1451 (s), 1412 (m), 
1343 (w), 1265 (m), 1236 (m), 1182 (m), 1133 (m), 1012 (bs), 964 (m), 926 (m), 871 (m), 
817 (s), 739 (bs), 661 (m), 629 (m); 1H NMR (500 MHz, CDCl3) δ = 7.63 - 7.60 (m, 1 H), 
7.36 - 7.27 (m, 7 H), 7.02 (d, J = 7.1 Hz, 1 H), 6.16 (s, 1 H), 1.08 (t, J = 7.9 Hz, 3 H), 1.02 
- 0.95 (m, 5 H), 0.95 - 0.82 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ = 153.2, 143.9, 133.6, 
131.4, 129.9, 128.6, 128.0, 127.5, 127.1, 123.9, 84.4, 7.4, 7.1, 7.0, 6.7; HRMS (CI+) m/z 
(M+H)+: Calcd for C17H21SiO: 269.1362, found: 269.1366. 
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To a stirred solution of benzaldehyde (3.08 g, 29.0 mmol) in hexanes (125 mL, dried 
over MgSO4) and Et2O (100 mL) at 0
 oC was added n-BuLi (2.3 M in hexanes, 27.8 mL, 
63.9 mmol) dropwise. The solution was stirred at room temperature for 2 h, at which time 
reflux condenser was then attached and the solution was heated to reflux at 75 oC for 17 h. 
The solution was then cooled to –78 oC and i-Pr2SiHCl (10.9 mL, 63.9 mmol) was added 
dropwise. The solution was stirred and warmed to room temperature. After 23 h, the 
reaction mixture was quenched by addition of 3 M HCl in MeOH (40 mL) at 0 oC and 
stirred for 21 h at room temperature. The reaction mixture was then added deionized H2O 
(100 mL) and stirred for another 2 h. The organic layer was collected and the aqueous layer 
was extracted with hexanes (2 x 50 mL). The combined organic layers were washed with 
brine, dried with MgSO4, and concentrated in vacuo. The crude product was purified by 
flash chromatography on silica gel (1% Et2O/hexanes) to afford the desired siloxane 1.31 
(5.94 g, 21.5 mmol, 74%) as a colorless oil: IR (neat, cm–1) 3059 (m), 3000 (m), 2941 (s), 
2864 (s), 1595 (m), 1464 (s), 1443 (m), 1381 (m), 1261 (m), 1111 (m), 1080 (s), 1054 (m), 
1012 (m), 988 (m), 973 (m), 917 (s), 880 (s), 846 (m), 831 (m), 816 (m), 749 (s), 716 (s), 
668 (s), 648 (m), 612 (m); 1H NMR (500 MHz, CDCl3) δ = 7.53 (d, J = 7.1 Hz, 1 H), 7.38 
(t, J = 7.5 Hz, 1 H), 7.27 (t, J = 7.1 Hz, 1 H), 7.20 (d, J = 7.7 Hz, 1 H), 5.18 - 5.14 (m, 1 
H), 1.94 - 1.86 (m, 1 H), 1.60 - 1.48 (m, 3 H), 1.45 - 1.30 (m, 2 H), 1.25 - 1.16 (m, 2 H), 
1.06 (d, J = 6.7 Hz, 2 H), 1.05 (d, J = 7.1 Hz, 2 H), 1.00 (d, J = 7.5 Hz, 2 H), 0.93 (d, J = 
7.3 Hz, 2 H), 0.92 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ = 154.7, 132.4, 
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132.2, 129.5, 126.7, 122.2, 82.3, 39.1, 28.1, 23.0, 17.6, 17.5, 17.2, 17.1, 14.2, 13.4, 12.9; 
HRMS (CI+) m/z (M-C3H7)
+: Calcd for C14H21SiO: 233.1726, found: 233.1726. 
 
 
A solution of n-BuLi (2.28 M in hexanes, 19.0 mL, 43.3 mmol) was added dropwise to 
a stirred solution of (2-bromophenyl)(phenyl)methanol (5.18 g, 19.7 mmol) in 50 mL THF 
at –78 oC. The obtained solution was stirred for 1 h, followed by the addition of i-Pr2SiHCl 
(7.39 mL, 43.30 mmol) at –78 oC. The resulting reaction mixture was allowed to warm to 
room temperature and was stirred overnight. After 17 h, the reaction mixture was quenched 
by addition of 3 M HCl in MeOH (40 mL) at 0 oC and stirred for 4 h at room temperature. 
The reaction mixture was then added deionized H2O (100 mL). The organic layer was 
collected and the aqueous layer was extracted with hexanes (2 x 50 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel (1% Et2O/hexanes) to 
afford the desired siloxane 1.32 (4.12 g, 13.9 mmol, 71%) as a colorless oil: IR (neat, cm–
1) 3061 (m), 3031 (m), 3000 (m), 2942 (s), 2891 (m), 2864 (s), 1592 (m), 1494 (m), 1463 
(s), 1442 (s), 1383 (m), 1263 (m), 1182 (m), 1133 (m), 1077 (m), 1065 (s), 1038 (s), 1014 
(s), 988 (s), 919 (m), 881 (m), 815 (s), 747 (s), 732 (s), 713 (s), 698 (s), 669 (s), 633 (m); 
1H NMR (500 MHz, CDCl3) δ = 7.63 - 7.59 (m, 1 H), 7.37 - 7.27 (m, 7 H), 6.99 (d, J = 6.9 
Hz, 1 H), 6.12 (s, 1 H), 1.39 - 1.24 (m, 2 H), 1.16 (d, J = 7.5 Hz, 2 H), 1.13 (d, J = 7.5 Hz, 
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2 H), 1.06 (d, J = 5.7 Hz, 2 H), 1.04 (d, J = 5.7 Hz, 2 H); 13C NMR (125 MHz, CDCl3) δ 
= 153.4, 143.8, 132.7, 131.9, 129.8, 128.6, 128.0, 127.8, 127.0, 123.9, 84.6, 17.7, 17.2, 
13.6, 13.3; HRMS (CI+) m/z (M-C3H7)
+: Calcd for C16H17SiO: 253.1049, found: 253.1056. 
 
1-8-b-2: Synthesis and Cross-Coupling Reactions of Polynorbornene-supported 
Transfer Agents 
 
PhMgBr (3.0 M in Et2O, 17.55 mL, 52.64 mmol) was added slowly to a vigorously 
stirred solution of aldehyde 1.37 (95% purity, mixture of endo- and exo-isomers) (5.36 g, 
41.7 mmol) in 200 mL Et2O at 0
 oC. The obtained solution was stirred at rt for 15 h, and 
was quenched with saturated aqueous NH4Cl (50 mL). The organic layer was collected and 
the aqueous layer was extracted with Et2O (2 x 50 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel (5 – 30% Et2O/Hexanes) to afford the 
desired alcohol 1.38 as a mixture of diastereomers in a 1 : 1 : 3.7 : 3.7 ratio by 1H NMR 
spectroscopy (7.87 g, 39.3 mmol, 94%): colorless solid (M.P. = 50 – 53 oC); Rf 0.2 (20% 
Et2O in hexanes); IR (neat, cm
–1) 3376 (s), 3060 (s), 3029 (s), 2967 (s), 2939 (s), 2908 (s), 
2869 (s), 1603 (m), 1494 (s), 1454 (s), 1392 (m), 1335 (s), 1277 (m), 1253 (m), 1225 (m), 
1144 (m), 1068 (s), 1015 (s), 980 (m), 910 (m), 833 (m), 758 (s), 719 (s), 700 (s), 622 (s); 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.23 (m, 4 H), 6.27 – 6.22 (m, 0.77 H, vinyl proton), 
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6.20 – 6.14 (m, 0.51 H, vinyl proton), 6.10 – 6.04 (m, 0.22 H, vinyl proton), 6.00 – 5.94 
(m, 0.50 H, vinyl proton), 4.41 (d, J = 9.5 Hz, 0.11 H, benzylic proton), 4.36 (d, J = 10.1 
Hz, 0.11 H, benzylic proton), 4.03 (d, J = 10.1 Hz, 0.39 H, benzylic proton), 3.98 (d, J = 
10.1 Hz, 0.39 H, benzylic proton), 3.16 (bs, 0.39 H, allylic proton), 3.10 (bs, 0.11 H, allylic 
proton), 2.92 (bs, 0.11 H, allylic proton), 2.88 (bs, 0.39 H, allylic proton), 2.77 (bs, 0.11 H, 
allylic proton), 2.75 (bs, 0.39 H, allylic proton), 2.52 – 2.42 (m, 0.80 H), 2.31 (bs, 0.39 H, 
allylic proton), 2.26 (bs, 0.11 H, allylic proton), 2.05 – 1.98 (m, 0.43 H), 1.87 – 0.88 (m, 
4.37 H), 0.52 – 0.45 (m, 0.40 H); 13C NMR (125 MHz, CDCl3) δ 144.6, 144.5, 144.3, 
144.2, 138.1, 138.1, 137.3, 137.1, 136.8, 136.8, 132.8, 132.4, 128.7, 128.6, 128.6, 128.3, 
127.9, 127.9, 127.8, 127.0, 126.8, 126.5, 126.0, 80.0, 79.5, 79.3, 78.6, 49.9, 49.5, 48.1, 
47.2, 46.9, 46.9, 45.7, 45.3, 44.9, 44.5, 44.4, 43.7, 43.0, 42.5, 42.3, 42.0, 30.9, 30.3, 30.1, 
29.5; HRMS (CI+) m/z (M+H)+: Calcd for C14H17O: 201.1279, found: 201.1277. 
 
 
To a stirred solution of alcohol 1.38 (7.71 g, 38.6 mmol) in hexanes (125 mL, dried 
over MgSO4) and Et2O (100 mL) at 0
 oC was added n-BuLi (2.3 M in hexanes, 36.9 mL, 
84.9 mmol) dropwise. The solution was stirred at room temperature for 1 h, at which time 
reflux condenser was attached and the solution was heated to reflux at 70 oC for 21 h. The 
solution was then cooled to –78 oC and Me2SiHCl (9.22 ml, 84.9 mmol) was added 
dropwise. The solution was stirred and warmed up to room temperature. After 29 h, the 
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reaction mixture was quenched by addition of deionized H2O (100 mL) and stirred for 16 
h. The organic layer was collected and the aqueous layer was extracted with hexanes (2 x 
50 mL). The combined organic layers were washed with brine, dried with MgSO4, and 
concentrated in vacuo. The crude product was then taken up in THF (150 mL), and KOtBu 
(0.65 g, 5.79 mmol) was divided into 3 portions and added to the stirred solution 
sequentially, each portion after 1 h. The mixture was stirred for a total of 4 h, followed by 
addition of deionized H2O (50 mL), and the resulting mixture was stirred for another 30 
min. The organic layer was collected and the aqueous layer was extracted with hexanes (2 
x 50 mL). The combined organic layers were washed with brine, dried with MgSO4, and 
concentrated in vacuo. Kugelrohr distillation (110 – 160 oC, 0.025 mmHg), followed by 
flash chromatography on water-washed silica gel (0 – 0.5% Et2O/hexanes) afforded the 
desired siloxane 1.39 as a mixture of diastereomers in a 1 : 1.5 : 3.4 : 4.9 ratio by 1H NMR 
spectroscopy (3.97 g, 15.51 mmol, 40%): colorless oil; Rf 0.5 (5% Et2O in hexanes); IR 
(neat, cm–1) 3058 (m), 2962 (s), 2902 (m), 2870 (m), 1594 (m), 1445 (m), 1330 (m), 1254 
(s), 1134 (m), 1072 (m), 1028 (s), 873 (s), 823 (s), 787 (s), 748 (s), 712 (m), 646 (m); 1H 
NMR (500 MHz, CDCl3) δ 7.59 – 7.52 (m, 0.88 H), 7.44 – 7.20 (m, 3.12 H), 6.30 – 6.14 
(m, 1.70 H, vinyl proton), 6.08 – 6.03 (m, 0.30 H, vinyl proton), 5.41 (d, J = 4.0 Hz, 0.14 
H, benzylic proton), 5.25 (d, J = 5.5 Hz, 0.09 H, benzylic proton), 4.65 (d, J = 9.7 Hz, 0.46 
H, benzylic proton), 4.55 (d, J = 10.3 Hz, 0.31 H, benzylic proton), 3.18 (bs, 0.32 H, allylic 
proton), 2.97 (bs, 0.45 H, allylic proton), 2.90 (bs, 0.19 H, allylic proton), 2.87 – 2.80 (m, 
0.74 H, allylic proton), 2.76 (bs, 0.18 H, allylic proton), 2.58 (bs, 0.12 H, allylic proton), 
2.15 – 2.06 (m, 0.80 H), 1.95 – 1.67 (m, 1.43 H), 1.48 – 1.12 (m, 2.77 H), 0.45 – 0.31 (m, 
6 H); 13C NMR (125 MHz, CDCl3) δ 154.2, 153.5, 153.3, 138.1, 138.0, 137.8, 137.5, 137.5, 
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137.0, 136.1, 136.0, 135.9, 135.8, 133.5, 132.5, 131.2, 131.0, 130.9, 130.0, 129.7, 129.3, 
129.2, 127.1, 127.0, 127.0, 126.9, 123.2, 122.8, 122.7, 122.5, 85.9, 85.3, 84.3, 84.0, 49.8, 
49.3, 49.0, 48.3, 47.1, 46.3, 46.2, 46.2, 46.0, 45.6, 44.7, 43.1, 42.6, 42.3, 42.2, 41.6, 30.0, 
29.8, 29.8, 27.0, 1.8, 1.8, 1.6, 1.2, 1.0, 1.0, 0.8, 0.7; HRMS (CI+) m/z (M+H)+: Calcd for 
C16H21OSi: 257.1362, found: 257.1357. 
 
 
To a stirred solution alcohol 1.38 (7.78 g, 38.9 mmol) in hexanes (125 mL, dried over 
MgSO4) and Et2O (100 mL) at 0
 oC was added n-BuLi (2.3 M in hexanes, 37.2 mL, 85.6 
mmol) dropwise. The solution was stirred at room temperature for 1 h, at which time reflux 
condenser was attached and the solution was heated to reflux at 70 oC for 21 h. The solution 
was then cooled to –78 oC and Et2SiCl2 (7.56 ml, 50.6 mmol) was added dropwise. The 
solution was stirred and warmed up to room temperature. After 21 h, the reaction mixture 
was quenched by addition of deionized H2O (50 mL) and stirred for 15 min. The organic 
layer was collected and the aqueous layer was extracted with hexanes (2 x 50 mL). The 
combined organic layers were washed with brine, dried with MgSO4, and concentrated in 
vacuo. Kugelrohr distillation (120 – 150 oC, 0.025 mmHg), followed by flash 
chromatography on silica gel (0 – 1% Et2O/hexanes) afforded the desired siloxane 1.39b 
as a mixture of diastereomers in a 1 : 1 : 1.8 : 4.8 ratio by 1H NMR spectroscopy (1.49 g, 
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5.25 mmol, 13%): colorless oil; Rf 0.55 (5% Et2O in hexanes); IR (neat, cm
–1) 3056 (m), 
2957 (s), 2911 (m), 2874 (m), 1460 (m), 1443 (m), 1335 (m), 1232 (m), 1137 (m), 1071 
(m), 1038 (m), 1019 (s), 962 (m), 853 (m), 804 (m), 741 s), 715 (s), 651 (m); 1H NMR 
(500 MHz, CDCl3) δ 7.59 – 7.51 (m, 0.93 H), 7.44 – 7.34 (m, 1.36 H), 7.34 – 7.23 (m, 1.71 
H), 6.31 – 6.15 (m, 1.67 H, vinyl proton), 6.09 – 6.03 (m, 0.33 H, vinyl proton), 5.37 (d, J 
= 4.4 Hz, 0.12 H, benzylic proton), 5.20 (d, J = 6.5 Hz, 0.12 H, benzylic proton), 4.63 (d, 
J = 10.1 Hz, 0.55 H, benzylic proton), 4.55 (d, J = 10.5 Hz, 0.21 H, benzylic proton), 3.20 
(bs, 0.21 H, allylic proton), 3.00 (bs, 0.56 H, allylic proton), 2.92 (bs, 0.21 H, allylic proton), 
2.87 – 2.81 (m, 0.77 H, allylic proton), 2.78 – 2.72 (m, 0.25 H, allylic proton), 2.15 – 2.05 
(m, 0.79 H), 1.94 – 1.79 (m, 1.17 H), 1.52 – 0.71 (m, 13.04 H); 13C NMR (125 MHz, 
CDCl3) δ 154.9, 154.3, 153.9, 138.15, 137.8, 137.7, 137.5, 137.4, 136.9, 134.1, 134.1, 
134.0, 133.9, 133.6, 132.5, 131.8, 131.8, 131.6, 131.5, 129.6, 129.3, 129.2, 126.9, 126.8, 
126.8, 126.7, 123.1, 122.8, 122.7, 122.4, 86.1, 85.5, 84.7, 84.2, 49.7, 49.4, 48.9, 48.2, 47.4, 
46.2, 46.1, 46.1, 46.0, 45.6, 44.6, 43.3, 42.6, 42.4, 42.1, 41.6, 30.1, 30.0, 30.0, 29.8, 27.0, 
7.6, 7.4, 7.1, 7.1, 7.0, 6.9, 6.6, 6.5; HRMS (CI+) m/z (M+H)+: Calcd for C18H25OSi: 
285.1675, found: 285.1664. 
 
General procedure A: ring opening metathesis polymerization (ROMP)  
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Grubbs catalyst (1st generation) was dissolved in 0.5 mL CH2Cl2 and stirred for 30 min. 
The catalyst solution was then cannulated into another flask containing siloxane monomer 
in 1 mL CH2Cl2 (rinsed with 2 x 0.5 mL CH2Cl2). Under a flowing stream of N2, the 
obtained solution was stirred at room temperature for 16 h, at which time reflux condenser 
was attached, another 1 mL CH2Cl2 was added and the solution was heated to reflux at 50
 
oC for 19 h. The obtained mixture was cooled to room temperature, diluted with 1 mL 
CH2Cl2, followed by addition of ethyl vinyl ether (2 mL). The solution was then heated to 
reflux for another 2 h. The solution was then cooled to room temperature, diluted with 1 
mL CH2Cl2, followed by addition of a solution of tris(hydroxymethyl)phosphine in 
deionized H2O (2 mL) and Et3N (freshly distilled, 0.1 mL). The obtained mixture was 
stirred vigorously for 30 min. The resultant organic layer was collected and the aqueous 
layer was extracted with CH2Cl2 (2 x 5 mL). The combined organic layers were washed 
with brine, dried with MgSO4, and concentrated in vacuo. The obtained solid was then 
dissolved in 1 mL CH2Cl2 and precipitated via dropwise addition into a vigorously stirred 
solution of CH3CN (250 mL). The precipitate was filtered and concentrated in vacuo to 
afford the desired polymer.  
Following general procedure A, ROMP of siloxane monomer 1.39 (0.256 
g, 1.0 mmol) using first generation Grubbs catalyst (4.1 mg, 5.0 µmol, 0.5 mol %) and  
tris(hydroxymethyl)phosphine (120 mg, 1.0 mmol) afforded siloxane polymer PNTA-I200 
(0.245 g, 96%) as a white solid: IR (CDCl3, cm
–1) 3057 (m), 2998 (m), 2947 (s), 2862 (m), 
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1593 (m), 1442 (m), 1309 (m), 1252 (s), 1194 (m), 1136 (m), 1070 (m), 1013 (s), 943 (m), 
910 (s), 870 (s), 823 (s), 789 (s), 740 (s), 653 (m); 1H NMR (500 MHz, CDCl3) δ 7.60 – 
7.41 (bs, 1H), 7.41 – 6.98 (bm, 3 H), 6.10 – 4.60 (bm, 3 H), 3.41 – 0.71 (bm, 7 H), 0.64 – 
0.00 (bm, 6 H); Mn = 63500, PDI = 1.2. The transformation was successfully carried out 
on a multigram-scale.  
Following general procedure A, ROMP of siloxane monomer 1.39 (0.267 
g, 1.0 mmol) using first generation Grubbs catalyst (42.9 mg, 0.052 mmol, 5.0 mol %) and 
tris(hydroxymethyl)phosphine (1.95 g, 15.7 mmol) afforded siloxane polymer PNTA-I20 
(0.227 g, 85%) as a white solid: IR and 1H NMR identical to PNTA-I200; Mn = 7000, PDI 
= 1.5. 
 Following general procedure A, ROMP of siloxane monomer 1.39b 
(0.270 g, 0.95 mmol) using first generation Grubbs catalyst (3.9 mg, 4.8 µmol, 0.5 mol %) 
and tris(hydroxymethyl)phosphine (46.2 mg, 0.37 mmol) afforded siloxane polymer 
PNTA-II200 (0.234 g, 87%) as a white solid: IR (CDCl3, cm
–1) 3057 (m), 2997 (m), 2953 
(s), 2874 (s), 1445 (m), 1235 (m), 1134 (m), 1069 (m), 1039 (m), 1012 (s), 942 (m), 910 
(m), 854 (m), 809 (m), 737 (s), 652 (m); 1H NMR (500 MHz, CDCl3) δ 7.63 – 7.39 (bs, 
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1H), 7.39 – 6.97 (bm, 3 H), 6.06 – 4.85 (bm, 3 H), 3.39 – 0.30 (bm, 17 H); Mn = 48600, 
PDI = 1.4. 
 Following general procedure A, ROMP of siloxane monomer 1.39b 
(0.223 g, 0.78 mmol) using first generation Grubbs catalyst (32.3 mg, 0.039 mmol, 5.0 
mol %) and tris(hydroxymethyl)phosphine (415 mg, 3.35 mmol) afforded siloxane 
polymer PNTA-II20 (0.220 g, 99%) as a pale yellow solid: IR and 1H NMR identical to 
PNTA-II200; Mn = 6500, PDI = 1.7.  
 
 
First generation Grubbs catalyst (4.1 mg, 5.0 µmol) was dissolved in 0.5 mL CH2Cl2 
and stirred for 30 min. The catalyst solution was then cannulated into another flask 
containing siloxane monomer (0.255 g, 1.0 mmol) in 1 mL CH2Cl2 (rinsed with 2 x 0.5 mL 
CH2Cl2). Under a flowing stream of N2, the obtained solution was stirred at room 
temperature for 16 h, at which time reflux condenser was attached, another 1 mL CH2Cl2 
was added and the solution was heated to reflux at 50 oC for 19 h. The obtained mixture 
was cooled to room temperature, diluted with 10 mL CH2Cl2, followed by addition of 
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MeOH (5 mL) and Et3N (freshly distilled, 50 µL). The solution was then stirred and heated 
to 50 oC under an atmosphere of hydrogen (250 psi) in a Parr bomb for 19 h. The reaction 
mixture was then cooled to room temperature, removed from the Parr bomb, and the 
solvent was removed in vacuo. The obtained solid was washed with excess CH3CN and 
MeOH to afford the desired polymer PNTA-I’200 (0.247 g, 97%) as a brown solid. 
 
 
First generation Grubbs catalyst (31.2 mg, 0.038 mmol) was dissolved in 1.5 mL 
CH2Cl2 and stirred for 30 min. The catalyst solution was then cannulated into another flask 
containing siloxane monomer (0.194 g, 0.759 mmol) in 1 mL CH2Cl2 (rinsed with 2 x 0.5 
mL CH2Cl2). Under a flowing stream of N2, the obtained solution was stirred at room 
temperature for 16 h, at which time reflux condenser was attached, another 1 mL CH2Cl2 
was added and the solution was heated to reflux at 50 oC for 19 h. The obtained mixture 
was cooled to room temperature, diluted with 5 mL CH2Cl2, followed by addition of MeOH 
(2 mL) and Et3N (freshly distilled, 50 µL). The solution was then stirred and heated to 50
 
oC under an atmosphere of hydrogen (250 psi) in a Parr bomb for 48 h. The solution was 
then cooled to room temperature, removed from the Parr bomb, followed by addition of a 
solution of tris(hydroxymethyl)phosphine (1.37 g, 11.1 mmol) in deionized H2O (10 mL) 
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and Et3N (freshly distilled, 1.0 mL). The obtained mixture was stirred vigorously for 30 
min. The resultant organic layer was collected and the aqueous layer was extracted with 
CH2Cl2 (2 x 5 mL). The combined organic layers were washed with brine, dried with 
MgSO4, and concentrated in vacuo. The obtained solid was then dissolved in 1 mL CH2Cl2 
and precipitated via dropwise addition into a vigorously stirred solution of CH3CN (250 
mL). The precipitate was filtered and concentrated in vacuo to afford the desired polymer 
PNTA-I’20 (0.186 g, 95%) as a gray solid: IR (CDCl3, cm–1) 3058 (m), 2999 (m), 2927 (s), 
2855 (s), 1592 (m), 1442 (m), 1252 (s), 1136 (m), 1074 (m), 1038 (m), 1012 (m), 908 (s), 
869 (s), 822 (s), 789 (s), 741 (s), 652 (m); 1H NMR (500 MHz, CDCl3) δ 7.60 – 7.43 (bs, 
1H), 7.41 – 7.05 (bm, 3 H), 5.49 – 5.00 (bm, 1 H), 2.59 – 0.55 (bm, 11 H), 0.50 – 0.13 (bm, 
6 H); Mn = 7200, PDI = 1.6. 
General procedure B: To a cooled solution of siloxane polymer in THF (3.0 equiv, 
10 mg/mL) at –78 oC was added PhLi in Bu2O (2.5 equiv) dropwise. The reaction mixture 
was allowed to warm to room temperature and was stirred for 3 h, and a white, cloudy 
solution developed. A solid mixture of PdCl2 (0.03 equiv), CuI (0.1 equiv), and dpca (0.04 
equiv) was combined and added to the reaction flask, followed by addition of the arylhalide 
(1.0 equiv). The obtained reaction mixture was stirred vigorously at room temperature. 
Care should be taken so that all reactants are submerged in THF and no solid is deposited 
on the side of the flask. After 2 h, the reaction mixture was quenched with sat. aq. NH4Cl 
(5 mL), followed by addition of deionized H2O (5 mL). The organic layer was collected 
and the aqueous layer was extracted with Et2O (2 x 10 mL). The combined organic layers 
were washed with brine, dried with MgSO4, and concentrated in vacuo to 1-2 mL in volume. 
The obtained concentrated solution was added dropwise into a vigorously stirred solution 
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of CH3CN (250 mL). The precipitated polymer was filtered and the supernatant was 
concentrated in vacuo to provide the crude product. Following removal from the 
supernatant, the polymer was re-dissolved in CH2Cl2 (20 mL) and filter through a glass 
fritted funnel to remove insoluble particles, if there is any. The obtained solution was then 
concentrated in vacuo to provide the recovered polymer.  
General procedure C: To a solution of alkenyl or aryliodide in THF (2.5 equiv, 0.1 
M) at –78 oC was added t-BuLi in pentane (5.2 equiv), and a bright, yellow slurry developed. 
The reaction mixture was allowed to stirred at –78 oC for 1 h to ensure complete formation 
of the corresponding alkenyl or aryllithium. A solution of siloxane polymer in THF (3.0 
equiv) was prepared and added into the reaction flask dropwise via syringe at –78 oC. Note 
that the final concentration of the siloxane polymer in the reaction flask should be 10 
mg/mL. The reaction mixture was allowed to warm to room temperature and was stirred 
for 3 h, and a white, cloudy solution developed. A solid mixture of PdCl2 (0.03 equiv), CuI 
(0.1 equiv), and dpca (0.04 equiv) was combined and added to the reaction flask, followed 
by addition of the aryl halide (1.0 equiv). The obtained reaction mixture was stirred 
vigorously at rt. Care should be taken so that all reactants are submerged in THF and no 
solid is deposited on the side of the flask. After 2 h, the reaction mixture was quenched 
with sat. aq. NH4Cl (5 mL), followed by addition of deionized H2O (5 mL). The organic 
layer was collected and the aqueous layer was extracted with Et2O (2 x 10 mL). The 
combined organic layers were washed with brine, dried with MgSO4, and concentrated in 
vacuo to 1-2 mL in volume. The obtained concentrated solution was added dropwise into 
a vigorously stirred solution of CH3CN (250 mL). The precipitated polymer was filtered 
and the supernatant was concentrated in vacuo to provide the crude product. Following 
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removal from the supernatant, the polymer was re-dissolved in CH2Cl2 (20 mL) and filter 
through a glass fritted funnel to remove insoluble particles, if there is any. The obtained 
solution was then concentrated in vacuo to provide the recovered polymer.  
4-Phenylanisole: Following general procedure B, using PSTA-I200 
(0.213 g, 0.832 mmol), PhLi (384 µL, 1.8 M, 0.692 mmol), PdCl2 (1.5 mg, 8.3 µmol), dpca 
(4.1 mg, 0.011 mmol), CuI (5.3 mg, 0.028 mmol) and 1.40 (0.065 g, 0.28 mmol). The 
product was purified by chromatography on SiO2 (1 % Et2O/ hexanes) to afford 1.41 (50.2 
mg, 0.273 mmol, 98%) as a colorless solid. Analytical data matches that which has been 
previously reported for 1.41:1 1H NMR (500 MHz, CDCl3) δ 7.57-7.53 (m, 4 H), 7.42 (t, 
J = 7.6 Hz, 2 H), 7.31 (t, J = 7.4 Hz, 1 H), 6.99 (d, J = 8.7 Hz, 2 H), 3.86 (s, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 159.3, 141.0, 133.9, 128.9, 128.3, 126.9, 126.8, 114.3, 55.5; 
HRMS (CI+) m/z (M+H)+: Calcd for C13H13O: 185.0966, found: 185.0963. Preparation of 
1.41 from 1.46 was carried out in a similar fashion.  
4-Cyanobiphenyl: Following general procedure B, using PSTA-I200 
(0.193 g, 0.752 mmol), PhLi (348 µL, 1.8 M, 0.627 mmol), PdCl2 (1.3 mg, 7.5 µmol), dpca 
(3.7 mg, 0.01 mmol), CuI (4.8 mg, 0.025 mmol) and 1.43 (56.8 g, 0.248 mmol). The 
product was purified by chromatography on SiO2 (2 % Et2O/ hexanes) to afford 1.18 (40.3 
mg, 0.225 mmol, 91%) as a colorless solid. Analytical data matches that which has been 
previously reported for 1.18:2 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 2 H), 7.69 
(d, J = 8.4 Hz, 2 H), 7.59 (d, J = 7.4 Hz, 2 H), 7.49 (t, J = 7.2 Hz, 2 H), 7.43 (t, J = 7.3 Hz, 
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1 H); 13C NMR (125 MHz, CDCl3) δ 145.8, 139.3, 132.8, 129.3, 128.8, 127.9, 127.4, 119.1, 
111.1; HRMS (CI+) m/z (M+H)+: Calcd for C13H10N: 180.1813, found: 180.0813.
 
Preparation of 1.18 from 1.47 was carried out in a similar fashion.  
4-(5-Phenylpyridin-2-yl)morpholine: Following general 
procedure B, using PSTA-I200 (0.238 g, 0.930 mmol), PhLi (431 µL, 1.8 M, 0.775 mmol), 
PdCl2 (1.7 mg, 9.3 µmol), dpca (4.6 mg, 0.012 mmol), CuI (5.9 mg, 0.031 mmol) and 1.44 
(88.8 g, 0.306 mmol). The product was purified by chromatography on SiO2 (2 % Et2O/ 
hexanes) to afford 1.45 (68.4 mg, 0.285 mmol, 93%) as a colorless solid. Analytical data 
matches that which has been previously reported for 1.45:3 1H NMR (500 MHz, CDCl3) δ 
8.47 (d, J = 2.2 Hz, 1 H), 7.75 (dd, J = 2.5, 8.8 Hz, 1 H), 7.53 (d, J = 7.4 Hz, 2 H), 7.43 (t, 
J = 7.5 Hz, 2 H), 7.32 (t, J = 7.4 Hz, 1 H), 6.71 (d, J = 8.8 Hz, 1 H), 3.85 (app t, J = 4.9 Hz, 
4 H), 3.56 (app t, J = 4.9 Hz, 4 H); 13C NMR (125 MHz, CDCl3) δ 158.9, 146.3, 138.4, 
136.3, 129.1, 127.0, 126.9, 126.4, 106.8, 66.9, 45.8; HRMS (CI+) m/z (M+H)+: Calcd for 
C15H17N2O: 241.1341, found: 241.1344.
 
(E)-1-Methoxy-4-(4-phenylbut-1-en-1-yl)benzene: Following 
general procedure C, using PSTA-I200 (0.227 g, 0.887 mmol), 1.40 (0.173 g, 0.739 mmol), 
t-BuLi (1.06 mL µL, 1.45 M, 1.54 mmol), PdCl2 (1.6 mg, 8.9 µmol), dpca (4.4 mg, 0.012 
mmol), CuI (5.6 mg, 0.030 mmol) and 1.49 (76.9 mg, 0.298 mmol, in 1 mL THF). The 
product was purified by chromatography on SiO2 (0.5 % Et2O/ hexanes) to afford 1.50 
(69.5 mg, 0.292 mmol, 98%) as a colorless solid. Analytical data matches that which has 
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been previously reported for 1.50:4 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.18 (m, 7 H), 
6.85 (d, J = 8.5 Hz, 2 H), 6.38 (d, J = 15.9 Hz, 1 H), 6.13 (td, J = 6.9, 15.7 Hz, 1 H), 3.82 
(s, 3 H), 2.79 (t, J = 7.8 Hz, 2 H), 2.52 (q, J = 7.2 Hz, 2 H); 13C NMR (125 MHz, CDCl3) 
δ 158.9, 142.3, 130.7, 129.9, 128.6, 128.5, 127.96, 127.21, 126.0, 114.1, 55.4, 36.2, 35.0; 
HRMS (CI+) m/z (M+H)+: Calcd for C17H19O: 239.1346, found: 239.1432.
 
(E)-1-(Hept-1-en-1-yl)-4-methoxybenzene: Following general 
procedure C, using PSTA-I200 (0.214 g, 0.836 mmol), (E)-1-iodohept-1-ene (the 
corresponding vinyl iodide of 1.51) (0.156 g, 0.697 mmol), t-BuLi (1.01 mL, 1.43 M, 1.45 
mmol), PdCl2 (1.5 mg, 8.4 µmol), dpca (4.1 mg, 0.011 mmol), CuI (5.3 mg, 0.028 mmol) 
and 1.40 (64.0 mg, 0.273 mmol). The product was purified by chromatography on SiO2 (0 
- 0.5 % Et2O/ hexanes) to afford 1.52 (39.4 mg, 0.193 mmol, 71%) as a colorless oil. 
Analytical data matches that which has been previously reported for 1.52:5 1H NMR (500 
MHz, CDCl3) δ 7.28 (dd, J = 2.0, 6.5 Hz, 2 H), 6.84 (dd, J = 2.1, 6.6 Hz, 2 H), 6.32 (d, J = 
15.7 Hz, 1 H), 6.09 (dt, J = 7.2, 15.8 Hz, 1 H), 3.80 (s, 3 H), 2.18 (m, 2 H), 1.46 (m, 2 H), 
1.40-1.37 (m, 4 H), 0.90 (t, J = 7.1 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 158.6, 131.2, 
129.6, 129.5, 127.1, 114.2, 55.7, 33.5, 31.4, 29.5, 22.7, 14.1; HRMS (CI+) m/z (M+H)+: 
Calcd for C14H21O: 205.1592, found: 205.1621. 
(E)-4-(4-Phenylbut-1-en-1-yl)benzonitrile: Following general 
procedure C, using PSTA-I200 (0.241 g, 0.942 mmol), (E)-(4-iodobut-3-en-1-yl)benzene 
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(the corresponding vinyl iodide of 1.53) (0.203 g, 0.785 mmol), t-BuLi (1.17 mL, 1.40 M, 
1.63 mmol), PdCl2 (1.7 mg, 9.4 µmol), dpca (4.7 mg, 0.013 mmol), CuI (6.0 mg, 0.031 
mmol) and 1.43 (71.6 mg, 0.313 mmol). The product was purified by chromatography on 
SiO2 (5 % Et2O/ hexanes) to afford 1.54 (51.3 mg, 0.220 mmol, 70%) as a colorless solid. 
Analytical data matches that which has been previously reported for 1.54:6 1H NMR (500 
MHz, CDCl3) δ 7.57 (d, J = 8.3 Hz, 2 H), 7.39 (d, J = 8.3 Hz, 2 H), 7.31 (t, J = 7.5 Hz, 2 
H), 7.25 - 7.18 (m, 3 H), 6.46 - 6.35 (m, 2 H), 2.81 (t, J = 7.7 Hz, 2 H), 2.64 - 2.52 (m, 2 
H); 13C NMR (125 MHz, CDCl3) δ 142.3, 141.4, 134.4, 132.5, 129.2, 128.6, 128.6, 126.6, 
126.2, 119.2, 110.3, 35.6, 35.0; HRMS (CI+) m/z (M)+: Calcd for C17H15N: 233.1204, 
found: 233.1200. 
(2E, 4E)-7-Phenylhepta-2,4-dien-1-ol: Following general 
procedure C, using PSTA-I200 (0.223 g, 0.871 mmol), (E)-tert-butyl((3-
iodoallyl)oxy)dimethylsilane (the corresponding vinyl iodide of 1.55) (0.216 g, 0.726 
mmol), t-BuLi (1.04 mL, 1.45 M, 1.51 mmol), PdCl2 (1.5 mg, 8.7 µmol), dpca (4.3 mg, 
0.012 mmol), CuI (5.5 mg, 0.029 mmol) and 1.49 (74.8 mg, 0.290 mmol). The crude was 
taken up in THF (3 mL) and treated with TBAF (1.16 mmol, 4.0 equiv, 1.0 M in THF). 
The reaction mixture was stirred at room temperature for 4 h, quenched with sat. aq. NH4Cl 
(5 mL), followed by addition of deionized H2O (5 mL). The organic layer was collected 
and the aqueous layer was extracted with Et2O (2 x 10 mL). The combined organic layers 
were washed with brine, dried with MgSO4, and concentrated in vacuo. The product was 
purified by chromatography on SiO2 (20 % Et2O/ hexanes) to afford 1.56 (39.0 mg, 0.207 
mmol, 72%) as a colorless oil. Analytical data matches that which has been previously 
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reported for 1.56:7 1H NMR (500 MHz, CDCl3) δ 7.31 - 7.26 (m, 2 H), 7.22 - 7.16 (m, 3 
H), 6.22 (dd, J = 10.5, 15.1 Hz, 1 H), 6.09 (dd, J = 10.5, 15.1 Hz, 1 H), 5.79 - 5.70 (m, 2 
H), 4.17 (d, J = 3.8 Hz, 2 H), 2.71 (t, J = 7.8 Hz, 2 H), 2.42 (q, J = 7.4 Hz, 2 H), 1.30 (bs, 
1 H); 13C NMR (125 MHz, CDCl3) δ 141.8, 134.6, 132.0, 130.1, 130.0, 128.6, 128.5, 126.0, 
63.7, 35.8, 34.6; HRMS (CI+) m/z (M-OH)+: Calcd for C13H15: 171.1174, found: 171.1182. 
 
1-8-b-3: Synthesis and Cross-Coupling Reactions of Polystyrene-supported 
Transfer Agents 
 
 
A solution of n-BuLi (2.55 M in hexanes, 62.10 mL, 158.3 mmol) was added dropwise 
to a stirred solution of benzyl alcohol 1.66 (16.33 g, 71.95 mmol) in 250 mL THF at –78 
oC. The obtained solution was stirred for 1 h, followed by addition of Me2SiHCl (17.20 
mL, 158.3 mmol) in one portion at –78 oC. The resulting reaction mixture was allowed to 
warm to room temperature and was stirred overnight. After 14 h, the reaction mixture was 
quenched by addition of deionized H2O (100 mL) and stirred for 4 h. The organic layer 
was collected and the aqueous layer was extracted with hexanes (2 x 50 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. 
Kugelrohr distillation (50 – 140 oC, 0.025 mmHg), followed by flash chromatography on 
water-washed silica gel (1% Et2O/hexanes) afforded the desired siloxane 1.62 as a colorless 
oil (6.60 g, 32.4 mmol, 45%): IR (neat, cm–1) 3072 (s), 3001 (s), 2966 (s), 2931 (s), 2899 
(s), 2868 (s), 1642 (m), 1595 (m), 1443 (s), 1329 (s), 1251 (s), 1137 (s), 1076 (s), 1049 (s), 
76 
 
988 (s), 897 (s), 825 (s), 790 (s), 744 (s), 653 (s); 1H NMR (500 MHz, CDCl3) δ 7.56 (d, 
J = 7.1 Hz, 1 H), 7.42-7.37 (m, 1 H), 7.31 (t, J = 7.1 Hz, 1 H), 7.24 (d, J = 7.7 Hz, 1 H), 
5.87-5.76 (m, 1 H), 5.30 (dd, J = 3.9, 7.0 Hz, 1 H), 5.14-5.04 (m, 2 H), 2.73-2.65 (m, 1 H), 
2.47-2.39 (m, 1 H), 0.38 (d, J = 15.5 Hz, 6 H); 13C NMR (125 MHz, CDCl3) δ 152.5, 135.9, 
134.7, 131.0, 129.7, 127.2, 122.5, 117.7, 81.2, 43.5, 1.5, 0.7; HRMS (CI+) m/z (M-CH3)
+: 
Calcd for C11H13OSi: 189.0736, found: 189.0733. 
 
 
 
 
A solution of 9-BBN (0.5 M in THF, 12.15 mL, 6.1 mmol) was added dropwise to a 
flask containing siloxane 1.62 (826.3 mg, 4.05 mmol) while stirring at room temperature. 
The obtained solution was stirred for 3 h, at which time TLC analysis indicated 
consumption of the starting material 1.62. A screw-cap vial was charged with 1,4-
dibromobenzene (2.87 g, 12.2 mmol), Pd(dppf)Cl2.CH2Cl2 (165.4 mg, 0.203 mmol), 
K3PO4 (1.72 g, 8.10 mmol), and the mixture was suspended in 10 mL DMF. The obtained 
mixture was stirred for 15 min at room temperature, followed by addition of the above 
solution containing siloxane 1.62/9-BBN adduct via cannula (rinsed with 0.5 mL DMF). 
The obtained vial was capped and heated to 50 oC for 16 h. The reaction mixture was then 
cooled to room temperature and quenched with deionized H2O (10 mL). The resulting 
mixture was extracted with Et2O (2 x 25 mL). The combined organic layers were washed 
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with brine, dried with MgSO4, and concentrated in vacuo. The crude oil was then taken up 
in THF (10 mL), followed by addition of solid NaBO3.4H2O (3.12 g, 20.3 mmol), and 
deionized H2O (10 mL) for oxidation of borane byproducts to facilitate purification. The 
mixture was then stirred vigorously at room temperature, open to air, for 2 h. The aqueous 
layer was then extracted with hexanes (2 x 25 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo. Kugelrohr distillation 
(180 oC, 0.025 mmHg) afforded the desired aryl bromide 1.67 as pale yellow oil (1.25 g, 
3.46 mmol, 85%): IR (neat, cm–1) 3058 (m), 2999 (m), 2942 (s), 2860 (s), 1593 (m), 1487 
(s), 1442 (m), 1252 (s), 1077 (s), 1012 (m), 949 (m), 876 (s), 818 (s), 790 (s), 749 (s); 1H 
NMR (500 MHz, CDCl3) δ 7.54 (d, J = 7.1 Hz, 1 H), 7.41-7.35 (m, 3 H), 7.29 (t, J = 7.1 
Hz, 1 H), 7.15 (d, J = 7.7 Hz, 1 H), 7.03 (d, J = 8.3 Hz, 2 H), 5.25 (dd, J = 3.3, 7.4 Hz, 1 
H), 2.68-2.53 (m, 2 H), 1.98-1.90 (m, 1 H), 1.82-1.59 (m, 3 H), 0.37 (d, J = 4.8 Hz, 6 H); 
13C NMR (125 MHz, CDCl3) δ 153.0, 141.5, 135.7, 131.4, 131.0, 130.3, 129.8, 127.1, 
122.3, 119.5, 81.5, 38.3, 35.3, 26.5, 1.5, 0.7; HRMS (CI+) m/z (M)+: Calcd for 
C18H21OBrSi: 360.0545, found: 360.0529. 
 
A solution of potassium vinyltrifluoroborate (336.6 mg, 2.51 mmol), PdCl2 (6.9 mg, 
0.039 mmol), PPh3 (30.4 mg, 0.116 mmol), Cs2CO3 (1.89 g, 5.80 mmol), and aryl bromide 
1.67 (698.5 mg, 1.93 mmol) in THF/H2O (9:1, 4.1 mL) was heated at 85 
oC in a screw-cap 
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vial. The reaction mixture was stirred at 85 oC for 19 h, then cooled to room temperature 
and diluted with H2O (5 mL), followed by extraction with dichloromethane (2 x 10 mL). 
The combined organic layers were washed with brine, dried with MgSO4, and concentrated 
in vacuo. Purification via flash chromatography on water-washed silica gel (1% 
Et2O/hexanes) afforded the desired styrene 1.68 as a colorless oil (536.7 mg, 1.74 mmol, 
90%): IR (neat, cm–1) 3055 (m), 3001 (m), 2941 (s), 2858 (s), 1629 (m), 1511 (m), 1442 
(m), 1406 (m), 1330 (m), 1252 (s), 1137 (m), 1085 (s), 1023 (m), 989 (m), 947 (m), 876 
(s), 823 (s), 790 (s), 748 (s); 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 7.1 Hz, 1 H), 7.40-
7.35 (m, 1 H), 7.33-7.26 (m, 3 H), 7.16 (d, J = 7.7 Hz, 1 H), 7.12 (d, J = 7.9 Hz, 2 H), 6.69 
(dd, J = 10.9, 17.6 Hz, 1 H), 5.70 (d, J = 17.6 Hz, 1 H), 5.26 (dd, J = 3.2, 7.3 Hz, 1 H), 
5.18 (d, J = 10.9 Hz, 1 H), 2.72-2.57 (m, 2 H), 2.01-1.90 (m, 1 H), 1.84-1.59 (m, 3 H), 0.38 
(d, J = 7.1 Hz, 6 H); 13C NMR (125 MHz, CDCl3) δ 153.1, 142.3, 136.9, 135.7, 135.2, 
131.0, 129.7, 128.7, 127.0, 126.3, 122.3, 113.0, 81.6, 38.4, 35.6, 26.5, 1.5, 0.7; HRMS 
(CI+) m/z (M)+: Calcd for C20H24OSi: 308.1596, found: 308.1581. 
 
A solution of acacia gum (3.2 g) and NaCl (2.0 g) in H2O (85 mL) was placed in a 100 
mL- reaction flask equipped with a mechanical stirrer and deoxygenated by purging with 
N2 for 30 min. A solution of monomer 1.68 (433 mg, 1.40 mmol), styrene (1.20 mL, 10.5 
mmol), cross-linker 1.69 (34.9 mg, 0.119 mmol), and benzoyl peroxide (20.0 mg, 0.083 
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mmol) in chlorobenzene (2.0 mL) was injected to the rapidly stirred aqueous solution. This 
mixture was heated at 85 oC for 17 h. The crude polymer was collected by filtration and 
washed sequentially with MeOH/H2O (3:1, 4 x 50 mL), MeOH (2 x 50 mL), THF (2 x 25 
mL), Et2O (2 x 25 mL), hexanes (2 x 25 mL), followed by drying in vacuo to provide the 
desired polymer PSTA-I as white beads (724 mg) and a Si loading of 1.49 mmol/g was 
determined by inductively coupled plasma optical emission spectrometry (ICP-OES). The 
yield was 77% based on Si incorporation. IR (KBr, cm–1) 3026 (s), 2914 (s), 1943 (m), 
1872 (m), 1803 (m), 1721 (s), 1492 (s), 1448 (s), 1372 (s), 1329 (s), 1249 (s), 1179 (m), 
1082 (s), 1026 (s), 945 (m), 875 (m), 819 (m), 789 (m), 743 (s), 698 (s). 
Procedure for recyclability of PSTA-I using the same nucleophile and electrophile: 
To a cooled suspension of siloxane polymer PSTA-I (1.49 mmol/g, 500 mg, 0.745 mmol) 
swelling in THF (20 mL) at –78 oC was added PhLi in Bu2O (1.8 M, 345 µL, 0.621 mmol) 
dropwise. The reaction mixture was allowed to warm to room temperature and was stirred 
for 3 h. A solid mixture of PdCl2 (1.3 mg, 7.4 µmol), CuI (4.7 mg, 25 µmol), and dpca (3.7 
mg, 9.9 µmol) was combined and added to the reaction flask, followed by addition of 4-
iodoanisole (58.0 mg, 0.248 mmol). The obtained reaction mixture was stirred vigorously 
at room temperature for 18 h. The reaction mixture was then quenched with sat. aq. NH4Cl 
(5 mL), followed by addition of deionized H2O (5 mL), and stirred for an hour at room 
temperature. The obtained mixture was filtered through a fritted filter to remove polymer. 
The filtered polymer was then washed with Et2O (4 x 50 mL). The combined filtrate was 
washed with brine, dried with MgSO4, and concentrated in vacuo, followed by purification 
via flash chromatography (1% Et2O/ hexanes) to provide the desired cross-coupling 
product 4-phenylanisole 6 as a white solid (43.8 mg, 0.238 mmol, 96%). Following 
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filtration, the polymer was further washed sequentially with MeOH/H2O solution (1:1, 2 x 
50 mL), MeOH (2 x 25 mL), CH2Cl2 (2 x 25 mL), Et2O (2 x 25 mL), hexanes (2 x 25 mL), 
and dried in vacuo to provide near quantitative recovery of siloxane polymer. The obtained 
polymer was re-used 5 more times employing the same procedure above and showed no 
loss in cross-coupling efficiency.  
General procedure for preparation of organolithium reagents for cross-coupling 
reactions: In a dried flask was added the corresponding aryl or vinyl iodide (2.0 mmol) in 
1 mL THF and the solution was cooled to –78 oC. t-BuLi (2.0 equiv) was added dropwise 
and the obtained solution was stirred at –78 oC for 30 mins and then at room temperature 
for another 30 mins. The resulting organolithium solution was then titrated with 
diphenylacetic acid before use. 
General procedure for recyclability of PSTA-I using multiple nucleophiles and 
electrophiles: To a cooled suspension of siloxane polymer PSTA-I (0.74 mmol/g, 3.0 
equiv) swelling in THF (25 mL) at –78 oC was added the organolithium solution (2.5 equiv) 
dropwise. The reaction mixture was allowed to warm to room temperature and was stirred 
for 3 h. A solid mixture of PdCl2 (3 mol %), CuI (10 mol %), and dpca (4 mol %) was 
combined and added to the reaction flask, followed by addition of the aryl or alkenyl halide 
(1.0 equiv). The obtained reaction mixture was stirred vigorously at room temperature for 
18 h. The reaction mixture was then quenched with sat. aq. NH4Cl (5 mL), followed by 
addition of deionized H2O (5 mL), and stirred for an hour at room temperature. The 
obtained mixture was filtered through a fritted filter to remove polymer. The filtered 
polymer was then washed with Et2O (4 x 50 mL). The combined filtrate was washed with 
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brine, dried with MgSO4, and concentrated in vacuo, followed by purification via flash 
chromatography to provide the desired cross-coupling product. Following filtration, the 
polymer was further washed sequentially with MeOH/H2O solution (1:1, 2 x 50 mL), 
MeOH (2 x 25 mL), CH2Cl2 (2 x 25 mL), Et2O (2 x 25 mL), hexanes (2 x 25 mL), and 
dried in vacuo to provide near quantitative recovery of siloxane polymer, which was 
employed in the next cross-coupling cycle.  
4-(tert-Butyl)-4'-methoxy-1,1'-biphenyl: Following general 
procedure, using PSTA-I (750 mg, 0.555 mmol), 1.70 (926 µL, 0.50 M, 0.463 mmol), 
PdCl2 (1.0 mg,  5.6 µmol), dpca (2.7 mg, 7.4 µmol), CuI (3.5 mg, 19 µmol) and 1.40 (42.0 
mg, 0.180 mmol). The product was purified by chromatography on SiO2 (1% Et2O/ 
hexanes) to afford 1.71 (41.2 mg, 0.172 mmol, 95%) as a colorless solid. Analytical data 
matches that which has been previously reported for 1.71:8 1H NMR (500 MHz, CDCl3) δ 
7.57-7.49 (m, 4 H), 7.48-7.44 (m, 2 H), 6.98 (d, J = 8.7 Hz, 2 H), 3.86 (s, 3 H), 1.38 (s, 9 
H); 13C NMR (125 MHz, CDCl3) δ 159.1, 149.8, 138.1, 133.8, 128.1, 126.5, 125.8, 114.3, 
55.5, 34.6, 31.5; HRMS (CI+) m/z (M+H)+: Calcd for C17H21O: 241.1592, found: 241.1603. 
4-Phenylanisole: Following general procedure, using PSTA-I (720 
mg, 0.533 mmol), PhLi (234 µL, 1.9 M, 0.444 mmol), PdCl2 (0.9 mg, 5.3 µmol), dpca (2.6 
mg, 7.1 µmol), CuI (3.4 mg, 18 µmol) and 1.40 (41.6 mg, 0.178 mmol). The product was 
purified by chromatography on SiO2 (1% Et2O/ hexanes) to afford 1.41 (31.8 mg, 0.173 
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mmol, 97%) as a colorless solid. Analytical data matches that which has been previously 
reported in section 1-8-b-2.  
(E)-1-Methoxy-4-(4-phenylbut-1-en-1-yl)benzene: Following 
general procedure, using PSTA-I (702 mg, 0.519 mmol), 1.48 (1.2 mL, 0.36 M, 0.43 
mmol), PdCl2 (0.9 mg, 5.2 µmol), dpca (2.6 mg, 7.0 µmol), CuI (3.3 mg, 17 µmol) and 
1.49 (44.7 mg, 0.173 mmol). The product was purified by chromatography on SiO2 (0.5 % 
Et2O/ hexanes) to afford 1.50 (37 mg, 0.16 mmol, 90%) as a colorless solid. Analytical 
data matches that which has been previously reported in section 1-8-b-2.  
(E)-1-(Hept-1-en-1-yl)-4-methoxybenzene: Following general 
procedure, using PSTA-I (686 mg, 0.508 mmol), 1.51 (1.14 mL, 0.37 M, 0.42 mmol), 
PdCl2 (0.9 mg, 5.1 µmol), dpca (2.5 mg, 6.8 µmol), CuI (3.2 mg, 17 µmol) and 1.40 (39.6 
mg, 0.169 mmol). The product was purified by chromatography on SiO2 (0-0.5 % Et2O/ 
hexanes) to afford 1.52 (25.5 mg, 0.125 mmol, 74%) as a colorless oil. Analytical data 
matches that which has been previously reported in section 1-8-b-2.  
(2E, 4E)-7-Phenylhepta-2,4-dien-1-ol: Following general 
procedure, using PSTA-I (662 mg, 0.490 mmol), 1.55 (1.4 mL, 0.30 M, 0.41 mmol), PdCl2 
(0.9 mg, 5 µmol), dpca (2.4 mg, 6.5 µmol), CuI (3.1 mg, 16 µmol) and 1.49 (42.1 mg, 
0.163 mmol). The crude was taken up in THF (3 mL) and treated with TBAF (0.65 mmol, 
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4.0 equiv, 1.0 M in THF). The reaction mixture was stirred at room temperature for 4 h, 
quenched with sat. aq. NH4Cl (5 mL), followed by addition of deionized H2O (5 mL). The 
organic layer was collected and the aqueous layer was extracted with Et2O (2 x 10 mL). 
The combined organic layers were washed with brine, dried with MgSO4, and concentrated 
in vacuo. The product was purified by chromatography on SiO2 (20 % Et2O/ hexanes) to 
afford 1.56 (22.0 mg, 0.117 mmol, 72%) as a colorless oil. Analytical data matches that 
which has been previously reported in section 1-8-b-2.  
4-Cyanobiphenyl: Following general procedure, using PSTA-I (660 
mg, 0.488 mmol), PhLi (214 µL, 1.9 M, 0.41 mmol), PdCl2 (0.9 mg, 5 µmol), dpca (2.4 
mg, 6.5 µmol), CuI (3.1 mg, 16 µmol) and 1.43 (37.3 mg, 0.163 mmol). The product was 
purified by chromatography on SiO2 (2% Et2O/ hexanes) to afford 1.18 (26.8 mg, 0.150 
mmol, 92%) as a colorless solid. Analytical data matches that which has been previously 
reported in section 1-8-b-2. Preparation of 1.18 from 1.47 was carried out in a similar 
fashion. 
4-(5-Phenylpyridin-2-yl)morpholine: Following general 
procedure, using PSTA-I (650 mg, 0.481 mmol), PhLi (211 µL, 1.9 M, 0.40 mmol), PdCl2 
(0.9 mg, 5 µmol), dpca (2.4 mg, 6.4 µmol), CuI (3.0 mg, 16 µmol) and 1.44 (46.4 mg, 
0.160 mmol). The product was purified by chromatography on SiO2 (20% Et2O/ hexanes) 
to afford 1.45 (34.9 mg, 0.145 mmol, 91%) as a colorless solid. Analytical data matches 
that which has been previously reported in section 1-8-b-2.  
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4-Acetylbiphenyl: Following general procedure, using PSTA-I (620 
mg, 0.459 mmol), PhLi (201 µL, 1.9 M, 0.38 mmol), PdCl2 (0.8 mg, 4.6 µmol), dpca (2.3 
mg, 6.1 µmol), CuI (2.9 mg, 15 µmol) and 1.72 (36.5 mg, 0.148 mmol). The product was 
purified by chromatography on SiO2 (5% Et2O/ hexanes) to afford 1.73 (23.8 mg, 0.121 
mmol, 82%) as a colorless solid. Analytical data matches that which has been previously 
reported for 1.73:9 1H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.3 Hz, 2 H), 7.69 (d, J = 
8.1 Hz, 2 H), 7.63 (d, J = 7.3 Hz, 2 H), 7.48 (t, J = 7.5 Hz, 2 H), 7.41 (t, J = 7.3 Hz, 1 H), 
2.64 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 197.9, 145.9, 140.0, 136.0, 129.1, 129.0, 
128.4, 127.4, 127.4, 26.8; HRMS (CI+) m/z (M)+: Calcd for C14H12O: 196.0888, found: 
196.0888. Preparation of 1.73 from 1.74 was carried out in a similar fashion. 
 
1-8-b-4: Copper-Catalyzed Electrophilic Amination of Organolithiums 
Mediated by Recoverable Siloxane Transfer Agents 
General procedure A: To a cooled solution of siloxane transfer agent in THF (1.8 
equiv, 4 mL) at –78 oC was added PhLi in Bu2O (1.5 equiv) dropwise. The reaction mixture 
was allowed to warm to room temperature and was stirred for 2 h. A solid mixture of CuI 
(0.1 equiv) and dpca (0.1 equiv) was combined and added to the reaction flask, followed 
by addition of the N, N-dialkyl-O-benzoylhydroxylamine (1.0 equiv, if solid added directly, 
if oil added via cannulation in 1 mL solution of THF). The obtained reaction mixture was 
stirred at room temperature. After 2 h, the reaction mixture was quenched with sat. aq. 
NH4Cl (5 mL), followed by addition of deionized H2O (5 mL). The organic layer was 
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collected and the aqueous layer was extracted with Et2O (2 x 10 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo to 
provide the crude product.  
General procedure B: To a solution of aryl halide (1.5 equiv) in 2 mL THF at –78 oC 
was added t-BuLi in pentane (3.6 equiv). The reaction mixture was allowed to stirred at –
78 oC for 1 h to ensure complete formation of the corresponding aryllithium. A solution of 
siloxane transfer agent in THF (1.8 equiv, 1 mL) was prepared and cannulated into the 
reaction flask at –78 oC (rinsed with 2 x 0.5 mL THF). The reaction mixture was allowed 
to warm to room temperature and was stirred for 2 h. A solid mixture of CuI (0.1 equiv) 
and dpca (0.1 equiv) was combined and added to the reaction flask, followed by addition 
of the N, N-dialkyl-O-benzoylhydroxylamine (1.0 equiv). The obtained reaction mixture 
was stirred at room temperature. After 2 h, the reaction mixture was quenched with sat. aq. 
NH4Cl (5 mL), followed by addition of deionized H2O (5 mL). The organic layer was 
collected and the aqueous layer was extracted with Et2O (2 x 10 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo to 
provide the crude product.  
Acid-base extraction purification protocol (where specified): The crude reaction 
mixture was dissolved in 10 mL Et2O and extracted with aq. HCl (1 M, 2 x 10 mL). The 
remaining organic layer containing siloxane transfer agent was dried with MgSO4, 
concentrated, followed by purification via chromatography on SiO2 (1 % Et2O/ hexanes) 
to afford the recovered siloxane transfer agent. To the combined acidic aqueous layers was 
added aq. NaOH (1 M, 30 mL) and extracted with Et2O (2 x 20 mL). The combined organic 
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layer was then washed with brine, dried with MgSO4, and concentrated in vacuo to provide 
the desired amination product. 
Oxidative work-up (where specified): To the crude reaction mixture in 3 mL THF 
was added aq. NaOH (1 M, 2 mL) and H2O2 (30% in H2O, 1 mL). The obtained mixture 
was stirred vigorously at rt for 2 h. The reaction mixture was quenched with sat. aq. NH4Cl 
(5 mL), followed by extraction with Et2O (2 x 10 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo. 
Gram-Scale Synthesis of 1-phenylazepane via siloxane transfer agent 1.21: To a 
cooled solution of siloxane transfer agent 1.21 (1.34 g, 5.40 mmol, 1.8 equiv) in 40 mL 
THF at –78 oC was added PhLi in Bu2O (2.50 mL, 1.8 M, 4.5 mmol, 1.5 equiv) dropwise. 
The reaction mixture was allowed to warm to room temperature and was stirred for 2 h. A 
solid mixture of CuI (57.1 mg, 0.300 mmol, 0.1 equiv) and dpca (111.2 mg, 0.300 mmol, 
0.1 equiv) was combined and added to the reaction flask, followed by addition of azepan-
1-yl benzoate (0.658 g, 3.00 mmol, 1.0 equiv). The obtained reaction mixture was stirred 
at room temperature. After 2 h, the reaction mixture was quenched with sat. aq. NH4Cl (50 
mL), followed by addition of deionized H2O (50 mL). The organic layer was collected and 
the aqueous layer was extracted with Et2O (2 x 100 mL). The combined organic layers 
were washed with brine, dried with MgSO4, and concentrated in vacuo to provide the crude 
product. The crude was taken up in 50 mL Et2O and extracted with aq. HCl (1 M, 3 x 50 
mL). The remaining organic layer was dried with MgSO4 and concentrated in vacuo, 
followed by Kugelrohr distillation (120-140 oC, 0.025 torr) to afford recovered siloxane 
transfer agent 1.21 as colorless oil (1.22 g, 91% recovery).  On the other hand, the 
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combined aqueous extract was treated with aq. NaOH (1 M, 200 mL), followed by 
extraction with Et2O (2 x 50 mL). The combined organic layers was then washed with brine, 
dried with MgSO4, and concentrated in vacuo to provide the desired amination product 1-
phenylazepane (1.77f) (0.494 g, 2.82 mmol, 94%) as a pale yellow oil.  
Synthesis of N, N-dibenzyl aniline via siloxane transfer agent 1.36: To a cooled 
solution of siloxane transfer agent 1.36 (104.0 mg, 0.334 mmol, 1.8 equiv) in 4 mL THF 
at –78 oC was added PhLi in Bu2O (155 µL, 1.8 M, 0.278 mmol, 1.5 equiv) dropwise. The 
reaction mixture was allowed to warm to room temperature and was stirred for 2 h. A solid 
mixture of CuI (3.5 mg, 0.019 mmol, 0.1 equiv) and dpca (6.9 mg, 0.019 mmol, 0.1 equiv) 
was combined and added to the reaction flask, followed by addition of N, N-dibenzyl-O-
benzoyl hydroxylamine (58.7 mg, 0.185 mmol, 1.0 equiv). The obtained reaction mixture 
was stirred at room tempereature. After 2 h, the reaction mixture was quenched with sat. 
aq. NH4Cl (5 mL), followed by addition of deionized H2O (5 mL). The organic layer was 
collected and the aqueous layer was extracted with Et2O (2 x 10 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo to 
provide the crude product. The crude was taken up in 20 mL Et2O and extracted with aq. 
HCl (1 M, 3 x 50 mL). The remaining organic layer was dried with MgSO4 and 
concentrated in vacuo, followed by purification via chromatography on SiO2 (1 % Et2O/ 
hexanes) to afford the desired amination product N, N-dibenzyl aniline (41.4 mg, 0.151 
mmol, 82%) as a colorless solid.  On the other hand, the combined acidic aqueous extract 
was treated with aq. NaOH (1 M, 170 mL), followed by extraction with Et2O (2 x 20 mL). 
The combined organic layers was then washed with brine, dried with MgSO4, and 
concentrated in vacuo to provide the recovered siloxane transfer agent 1.36 (101.7 mg, 98% 
88 
 
recovery) as a pale yellow oil. The synthesis and purification of N, N-dibenzyl aniline via 
siloxane transfer agent 1.34 was carried out in a similar fashion.  
Synthesis of 1-phenylpiperidine via polymer-supported siloxane transfer agent 
PSTA-I200: To a cooled solution of siloxane polymer in 23 mL THF (233 mg, 0.910 mmol, 
3.0 equiv, 10 mg/mL) at –78 oC was added PhLi in Bu2O (421 µL, 0.758 mmol, 2.5 equiv) 
dropwise. The reaction mixture was allowed to warm to room temperature and was stirred 
for 3 h, and a white, cloudy solution developed. A solid mixture of CuI (5.8 mg, 0.030 
mmol, 0.1 equiv), and dpca (11.2 mg, 0.030 mmol, 0.1 equiv) was combined and added to 
the reaction flask, followed by addition of piperidine-1-yl benzoate (62.2 mg, 0.303 mmol, 
1.0 equiv). The obtained reaction mixture was stirred vigorously at room tempereature. 
Care should be taken so that all reactants are submerged in THF and no solid is deposited 
on the side of the flask. After 2 h, the reaction mixture was quenched with sat. aq. NH4Cl 
(5 mL), followed by addition of deionized H2O (5 mL). The organic layer was extracted 
with aq. HCl (1 M, 2 x 20 mL). The remaining organic layer was washed with brine, dried 
with MgSO4 and concentrated to about 1 mL in volume, which was then dropwise added 
into a vigorously stirred solution of CH3CN (250 mL). The precipitate was filtered and 
dried in vacuo to afford recovered polymer (220.6 mg, 95% recovery).  On the other hand, 
the combined aqueous extract was treated with aq. NaOH (1 M, 50 mL), followed by 
extraction with Et2O (2 x 20 mL). The combined organic layers was then washed with brine, 
dried with MgSO4, and concentrated in vacuo to provide the desired amination product 1-
phenylpiperidine (1.77g) (44.9 mg, 0.279 mmol, 92%) as a pale yellow oil. 
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Compound 1.79 was isolated as a side product during the initial study of 
the electrophilic amination of phenyllithium with N,N-dibenzyl-O-benzoyl hydroxylamine 
mediated by siloxane transfer agent 1.21. Purification via chromatography on SiO2 (1 % 
Et2O/ hexanes) afforded 1.79 as a colorless oil: IR (neat, cm
–1) 3063, 2956, 2931, 2873, 
1719 (s), 1454, 1429, 1268 (s), 1109 (s), 711 (s); 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J 
= 7.3 Hz, 2 H), 7.59 – 7.51 (m, 5 H), 7.42 (t, J = 7.7 Hz, 3 H), 7.35 – 7.27 (m, 4 H), 6.02 
(dd, J = 9.3, 3.6 Hz, 1 H), 1.67 – 1.59 (m, 1 H), 1.51 – 1.42 (m, 1 H), 1.31 – 1.16 (m, 4 H), 
1.09 – 0.87 (m, 10, H), 0.69 (t, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 165.7, 
148.0, 137.4, 135.9, 134.9, 134.0, 132.8, 130.9, 129.9, 129.8, 129.2, 128.4, 128.0, 127.0, 
126.3, 76.8, 37.9, 28.2, 22.7, 14.0, 7.6, 7.5, 4.5, 3.5; HRMS (ES+) m/z (M+Na)+: Calcd for 
C28H34O2NaSi: 453.2226, found: 453.2224. 
N,N-Dibenzylaniline: Following general procedure A, using siloxane 
transfer agent 1.21 (106 mg, 0.427 mmol), PhLi (198 µL, 1.8 M, 0.36 mmol), CuI (4.5 mg, 
0.024 mmol), dpca (8.8 mg, 0.024 mmol), and N, N-dibenzyl-O-benzoyl hydroxylamine 
(75.2 mg, 0.237 mmol). Oxidative work-up, followed by purification via chromatography 
on SiO2 (1 % Et2O/ hexanes) afforded 1.77a (63.5 mg, 0.232 mmol, 98 %) as a colorless 
solid. Analytical data matches that which has been previously reported for 1.77a:10 1H 
NMR (500 MHz, CDCl3) δ 7.33 (t, J = 7.3 Hz, 4 H), 7.24 - 7.26 (m, 6 H), 7.17 (t, J = 8.2 
Hz, 2 H), 6.74 (d, J = 8.2 Hz, 2 H), 6.70 (t, J = 8.2 Hz, 1 H), 4.66 (s, 4 H); 13C NMR (125 
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MHz, CDCl3) δ 149.3, 138.7, 129.4, 128.8, 127.0, 126.8, 116.8, 112.6, 54.3; HRMS (ES+) 
m/z (M+H)+: Calcd for C20H20N: 274.1596, found: 274.1596. 
N,N-Diallylaniline: Following general procedure A, using siloxane transfer 
agent 1.21 (114.8 mg, 0.462 mmol), PhLi (214 µL, 1.8 M, 0.38 mmol), CuI (4.9 mg, 0.026 
mmol), dpca (9.5 mg, 0.026 mmol), and N,N-diallyl-O-benzoyl hydroxylamine (55.8 mg, 
0.257 mmol). Purification via acid-base extraction protocol afforded recovered 1.21 (99.9 
mg, 87%) and 1.77b (40.0 mg, 0.231 mmol, 90%) as a pale yellow oil. Analytical data 
matches that which has been previously reported for 1.77b:11 1H NMR (500 MHz, CDCl3) 
δ 7.24 – 7.17 (m, 2 H), 6.74 – 6.65 (m, 3 H), 5.93 – 5.82 (m, 2 H), 5.24 – 5.11 (m, 4 H), 
3.98 – 3.88 (m, 4 H); 13C NMR (125 MHz, CDCl3) δ 148.9, 134.2, 129.2, 116.4, 116.1, 
112.5, 52.9; HRMS (ES+) m/z (M+H)+: Calcd for C12H16N: 174.1283, found: 174.1285. 
N-Allyl-N-methylaniline: Following general procedure A, using siloxane 
transfer agent 1.21 (119.2 mg, 0.480 mmol), PhLi (222 µL, 1.8 M, 0.40 mmol), CuI (5.1 
mg, 0.027 mmol), dpca (9.9 mg, 0.026 mmol), and N-allyl-N-methyl-O-benzoyl 
hydroxylamine (51.1 mg, 0.267 mmol). Purification via acid-base extraction protocol 
afforded recovered 1.21 (104.9 mg, 88%) and 1.77c (33.4 mg, 0.227 mmol, 85%) as a pale 
yellow oil. Analytical data matches that which has been previously reported for 1.77c:12 
1H NMR (500 MHz, CDCl3) δ 7.23 (t, J = 7.9 Hz, 2 H), 6.77 – 6.67 (m, 3 H), 5.91 – 5.81 
(m, 1 H), 5.21 – 5.12 (m, 2 H), 3.92 (d, J = 5 Hz, 2 H), 2.94 (s, 3 H); 13C NMR (125 MHz, 
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CDCl3) δ 149.7, 134.0, 129.2, 116.5, 116.3, 112.6, 55.4, 38.12; HRMS (ES+) m/z (M+H)+: 
Calcd for C10H14N: 148.1126, found: 148.1122. 
N,N-Diethylaniline: Following general procedure A, using siloxane transfer 
agent 1.21 (115.5 mg, 0.465 mmol), PhLi (215 µL, 1.8 M, 0.39 mmol), CuI (4.9 mg, 0.026 
mmol), dpca (9.6 mg, 0.026 mmol), and N,N-diethyl-O-benzoyl hydroxylamine (49.8 mg, 
0.258 mmol). Purification via acid-base extraction protocol afforded recovered 1 (98.2 mg, 
85%) and 1.77d (35.0 mg, 0.235 mmol, 91%) as a pale yellow oil. Analytical data matches 
that which has been previously reported for 1.77d:11 1H NMR (500 MHz, CDCl3) δ 7.24 - 
7.20 (m, 2 H), 6.69 (d, J = 8.1 Hz, 2 H), 6.64 (t, J = 7.2 Hz, 1 H), 3.35 (q, J = 7.0 Hz, 4 H), 
1.16 (t, J = 7.0 Hz, 6 H); 13C NMR (125 MHz, CDCl3) δ 148.0, 129.4, 115.5, 112.0, 44.5, 
12.7; HRMS (ES+) m/z (M+H)+: Calcd for C10H16N: 150.1283, found: 150.1277. 
N,N-Diisopropylaniline: Following general procedure A, using siloxane 
transfer agent 1 (128.0 mg, 0.515 mmol), PhLi (239 µL, 1.8 M, 0.43 mmol), CuI (5.4 mg, 
0.029 mmol), dpca (10.6 mg, 0.029 mmol), and N,N-diisopropyl-O-benzoyl 
hydroxylamine (63.3 mg, 0.286 mmol). Purification via acid-base extraction protocol 
afforded recovered 1.21 (113.0 mg, 88%) and 1.77e (41.6 mg, 0.235 mmol, 82%) as a pale 
yellow oil. Analytical data matches that which has been previously reported for 1.77e:11 1H 
NMR (500 MHz, CDCl3) δ 7.19 (t, J = 7.9 Hz, 2 H), 6.90 (d, J = 8.1 Hz, 2 H), 6.77 (t, J = 
7.2 Hz, 1 H), 3.77 (spt, J = 6.5 Hz, 2 H), 1.21 (d, J = 6.7 Hz, 12 H); 13C NMR (125 MHz, 
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CDCl3) δ 148.2, 128.6, 119.6, 118.4, 47.7, 21.5; HRMS (ES+) m/z (M+H)+: Calcd for 
C12H20N: 178.1596, found: 178.1594. 
1-pPhenylazepane: Following general procedure A, using siloxane transfer 
agent 1.21 (112.5 mg, 0.453 mmol), PhLi (210 µL, 1.8 M, 0.38 mmol), CuI (4.8 mg, 0.025 
mmol), dpca (9.3 mg, 0.025 mmol), and azepan-1-yl benzoate (55.3 mg, 0.252 mmol). 
Purification via acid-base extraction protocol afforded recovered 1.21 (101.3 mg, 90%) and 
1.77f (42.8 mg, 0.244 mmol, 97%) as a pale yellow oil. Analytical data matches that which 
has been previously reported for 1.77f:13 1H NMR (500 MHz, CDCl3) δ 7.23 – 7.18 (m, 2 
H), 6.69 (d, J = 8.1 Hz, 2 H), 6.63 (t, J = 7.2 Hz, 1 H), 3.45 (t, J = 5.9 Hz, 4 H), 1.79 (bs, 
4 H), 1.60 – 1.52 (m, 4 H); 13C NMR (125 MHz, CDCl3) δ 149.0, 129.4, 115.2, 111.3, 
49.2, 27.9, 27.3; HRMS (ES+) m/z (M+H)+: Calcd for C12H18N: 176.1439, found: 176.1436. 
1-Phenylpiperidine: Following general procedure A, using siloxane 
transfer agent 1.21 (112.5 mg, 0.453 mmol), PhLi (210 µL, 1.8 M, 0.38 mmol), CuI (4.8 
mg, 0.025 mmol), dpca (9.3 mg, 0.025 mmol), and piperidine-1-yl benzoate (51.7 mg, 
0.252 mmol). Purification via acid-base extraction protocol afforded recovered 1 (97.9 mg, 
87%) and 1.77g (37.7 mg, 0.234 mmol, 93%) as a pale yellow oil. Analytical data matches 
that which has been previously reported for 1.77g:14 1H NMR (500 MHz, CDCl3) δ 7.28 – 
7.22 (m,  2H), 6.95 (d, J = 7.9 Hz, 2 H), 6.82 (t, J = 7.2 Hz, 1 H), 3.16 (t, J = 5.5 Hz, 4 H), 
1.76 – 1.68 (m, 4 H), 1.62 – 1.55 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 152.4, 129.1, 
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119.3, 116.7, 50.8, 26.0, 24.5; HRMS (ES+) m/z (M+H)+: Calcd for C11H16N: 162.1283, 
found: 162.1283. 
4-Phenylmorpholine: Following general procedure A, using siloxane 
transfer agent 1.21 (106.3 mg, 0.428 mmol), PhLi (198 µL, 1.8 M, 0.36 mmol), CuI (9.1 
mg, 0.048 mmol), dpca (8.8 mg, 0.024 mmol), and morpholino benzoate (49.3 mg, 0.238 
mmol). Purification via acid-base extraction protocol afforded recovered 1.21 (91.4 mg, 
86%) and 1.77h (32.2 mg, 0.197 mmol, 83%) as a colorless solid. Analytical data matches 
that which has been previously reported for 1.77h:14 1H NMR (500 MHz, CDCl3) δ 7.31 – 
7.26 (m, 2 H), 6.95 -6.86 (m, 3 H), 3.87 (t, J = 4.6 Hz, 4 H), 3.16 (t, J = 4.6 Hz, 4 H); 13C 
NMR (125 MHz, CDCl3) δ 151.5, 129.4, 120.2, 115.9, 67.1, 49.5; HRMS (CI+) m/z (M)+: 
Calcd for C10H13NO: 163.0997, found: 163.0991. 
1-Phenylpyrrolidine: Following general procedure A, using siloxane 
transfer agent 1.21 (112.2 mg, 0.452 mmol), PhLi (209 µL, 1.8 M, 0.38 mmol), CuI (4.8 
mg, 0.025 mmol), dpca (9.3 mg, 0.025 mmol), and pyrrolidin-1-yl benzoate (48.0 mg, 
0.251 mmol). Purification via acid-base extraction protocol afforded recovered 1.21 (99.9 
mg, 89%) and 1.77i (25.1 mg, 0.171 mmol, 68%) as a pale yellow oil. Analytical data 
matches that which has been previously reported for 1.77i:14 1H NMR (500 MHz, CDCl3) 
δ 7.27 – 7.20 (m, 2 H), 6.67 (t, J = 7.2 Hz, 1 H), 6.58 (d, J = 8.1 Hz, 2 H), 3.33 – 3.25 (m, 
4H), 2.05 – 1.97 (m, 4 H); 13C NMR (125 MHz, CDCl3) δ 148.1, 129.3, 115.5, 111.8, 47.7, 
25.6; HRMS (ES+) m/z (M+H)+: Calcd for C10H14N: 148.1126, found: 148.1124. 
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N,N-Dibenzyl-4-methoxyaniline: Following general procedure B, 
using siloxane transfer agent 1.21 (98.8 mg, 0.398 mmol), 4-iodoanisole (77.6 mg, 0.331 
mmol), t-BuLi (570 µL, 1.4 M, 0.80 mmol), CuI (4.2 mg, 0.022 mmol), dpca (8.2 mg, 
0.022 mmol), and N,N-dibenzyl-O-benzoyl hydroxylamine (70.1 mg, 0.221 mmol). 
Purification via chromatography on SiO2 (1 % Et2O/ hexanes) afforded recovered 1.21 
(79.0 mg, 80%) and 1.77j (48.9 mg, 0.161 mmol, 73%) as a colorless solid. Analytical data 
matches that which has been previously reported for 1.77j:11 1H NMR (500 MHz, CDCl3) 
δ 7.37 – 7.30 (m, 4 H), 7.30 – 7.24 (m, 6 H), 6.81 – 6.75 (m, 2 H), 6.75 – 6.69 (m, 2 H), 
4.59 (s, 4 H), 3.75 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 151.8, 144.0, 139.1, 128.7, 
127.0, 127.0, 114.9, 114.6, 55.9, 55.3. 
1-(4-Methoxyphenyl)piperidine: Following general procedure B, 
using siloxane transfer agent 1.21 (120.0 mg, 0.483 mmol), 4-iodoanisole (94.2 mg, 0.403 
mmol), t-BuLi (690 µL, 1.4 M, 0.97 mmol), CuI (5.1 mg, 0.027 mmol), dpca (9.9 mg, 
0.027 mmol), and piperidine-1-yl benzoate (55.0 mg, 0.27 mmol). Purification via acid-
base extraction protocol afforded recovered 1.21 (97.2 mg, 81%) and 1.77k (42.0 mg, 
0.220 mmol, 82%) as a pale yellow oil. Analytical data matches that which has been 
previously reported for 1.77k:15 1H NMR (500 MHz, CDCl3) δ 6.94 – 6.89 (m, 2 H), 6.86 
– 6.81 (m, 2 H), 3.77 (s, 3 H), 3.02 (t, J = 5.4 Hz, 4 H), 1.76 – 1.70 (m, 4 H), 1.59 – 1.52 
(m, 2 H); 13C NMR (125 MHz, CDCl3) δ 153.7, 147.1, 118.9, 114.4, 55.7, 52.4, 26.3, 24.3; 
HRMS (CI+) m/z (M)+: Calcd for C12H17NO: 191.1310, found: 191.1317. 
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N,N-Dibenzyl-4-fluoroaniline: Following general procedure B, using 
siloxane transfer agent 1.21 (108.9 mg, 0.438 mmol), 1-bromo-4-fluorobenzene (63.9 mg, 
0.365 mmol), t-BuLi (626 µL, 1.4 M, 0.88 mmol), CuI (4.6 mg, 0.024 mmol), dpca (9.1 
mg, 0.024 mmol), and N,N-dibenzyl-O-benzoyl hydroxylamine (77.3 mg, 0.244 mmol). 
Oxidative work-up, followed by purification via chromatography on SiO2 (1 % Et2O/ 
hexanes) afforded 1.77l (31.9 mg, 0.109 mmol, 45 %) as a colorless oil. Analytical data 
matches that which has been previously reported for 1.77l:16 1H NMR (500 MHz, CDCl3) 
δ 7.39 – 7.32 (m, 4 H), 7.30 – 7.24 (m, 6 H), 6.92 – 6.86 (m, 2 H), 6.71 – 6.64 (m, 2 H), 
4.63 (s, 4 H); 13C NMR (125 MHz, CDCl3) δ 155.7 (d, J = 234 Hz), 145.9, 138.6, 128.8, 
127.11, 126.9, 115.7 (d, J = 23 Hz), 114.0 (d, J = 8 Hz), 55.2; HRMS (ES+) m/z (M+H)+: 
Calcd for C20H19NF: 292.1502, found: 292.1500. 
1-(4-(Trifluoromethyl)phenyl)piperidine: Following general 
procedure B, using siloxane transfer agent 1.21 (122.0 mg, 0.491 mmol), 1-iodo-4-
(trifluoromethyl)benzene (111.5 mg, 0.410 mmol), t-BuLi (703 µL, 1.4 M, 0.98 mmol), 
CuI (5.2 mg, 0.027 mmol), dpca (10.1 mg, 0.027 mmol), and piperidine-1-yl benzoate (56.0 
mg, 0.273 mmol). Purification via acid-base extraction protocol afforded recovered 1.21 
(100.0 mg, 82%) and 1.77m (26.3 mg, 0.115 mmol, 42%) as a colorless oil. Analytical data 
matches that which has been previously reported for 1.77m:17 1H NMR (500 MHz, CDCl3) 
δ 7.45 (d, J = 8.7 Hz, 2 H), 6.91 (d, J = 8.7 Hz, 2 H), 3.26 (t, J = 5 Hz, 4 H), 1.74 – 1.59 
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(m, 6 H); 13C NMR (125 MHz, CDCl3) δ 153.9, 126.5 (q, J = 4 Hz), 114.7, 49.5, 25.6, 
24.4; HRMS (CI+) m/z (M)+: Calcd for C12H14NF3: 229.1078, found: 229.1077. 
1-(4-Chlorophenyl)piperidine: Following general procedure B, using 
siloxane transfer agent 1.21 (134.8 mg, 0.543 mmol), 1-chloro-4-iodobenzene (107.8 mg, 
0.452 mmol), t-BuLi (732 µL, 1.4 M, 1.0 mmol), CuI (5.7 mg, 0.030 mmol), dpca (11.2 
mg, 0.030 mmol), and piperidine-1-yl benzoate (61.8 mg, 0.301 mmol). Purification via 
acid-base extraction protocol afforded recovered 1.21 (111.0 mg, 82%) and 1.77n (38.3 
mg, 0.196 mmol, 65%) as a colorless solid. Analytical data matches that which has been 
previously reported for 1.77n:15 1H NMR (500 MHz, CDCl3) δ 7.20 – 7.16 (m, 2 H), 6.87 
– 6.82 (m, 2 H), 3.12 (t, J = 5.4 Hz, 4 H), 1.74 – 1.66 (m, 4 H), 1.60 – 1.55 (m, 2 H); 13C 
NMR (125 MHz, CDCl3) δ 151.0, 129.0, 124.0, 117.8, 50.8, 25.9, 24.3; HRMS (ES+) m/z 
(M+H)+: Calcd for C11H15NCl: 196.0893, found: 196.0891. 
1-(2-Methoxyphenyl)piperidine: Following general procedure B, using 
siloxane transfer agent 1.21 (134.0 mg, 0.539 mmol), 1-iodo-2-methoxybenzene (105.2 mg, 
0.449 mmol), t-BuLi (730 µL, 1.4 M, 1.0 mmol), CuI (5.7 mg, 0.030 mmol), dpca (11.1 
mg, 0.030 mmol), and piperidine-1-yl benzoate (61.6 mg, 0.300 mmol). Purification via 
acid-base extraction protocol afforded recovered 1.21 (107.0 mg, 80%) and 1.77o (29.3 
mg, 0.153 mmol, 51%) as a pale yellow oil. Analytical data matches that which has been 
previously reported for 1.77o:15 1H NMR (500 MHz, CDCl3) δ 7.00 – 6.94 (m, 2 H), 6.93 
– 6.88 (m, 1 H), 6.86 – 6.83 (m, 1 H), 3.86 (s, 3 H), 2.98 (t, J = 4.8 Hz, 4 H), 1.80 – 1.72 
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(m, 4 H), 1.62 – 1.55 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 152.5, 142.9, 122.6, 121.0, 
118.5, 111.2, 55.5, 52.5, 26.5, 24.6; HRMS (ES+) m/z (M+H)+: Calcd for C12H18NO: 
192.1388, found: 192.1383. 
3-(Piperidine-1-yl)pyridine: To a solution of n-BuLi (0.466 mmol, 1.6 
equiv) in 1 mL THF at –78 oC was added a solution of 3-bromopyridine (69.1 mg, 0.437 
mmol, 1.5 equiv) in 1 mL THF. The reaction mixture was stirred at –78 oC for 30 min, at 
which time a solution of the siloxane transfer agent 1.21 (130.4 mg, 0.525 mmol, 1.8 equiv) 
in 2 mL THF was prepared and cannulated into the reaction flask. The reaction mixture 
was stirred for 2 h at room temperature. A solid mixture of CuI (5.6 mg, 0.029 mmol, 0.1 
equiv) and dpca (10.8 mg, 0.029 mmol, 0.1 equiv) was combined and added to the reaction 
flask, followed by addition of piperidine-1-yl benzoate (59.9 mg, 0.292 mmol, 1.0 equiv). 
The obtained reaction mixture was stirred at room temperature. After 2 h, the reaction 
mixture was quenched with aq. HCl (1 M, 10 mL), followed by acid-base extraction 
purification protocol to obtain recovered 1.21 (117.0 mg, 90%) and contaminated 
amination product, which was further purified via chromatography on SiO2 (0.2 % Et3N, 
1 % MeOH/ CH2Cl2) to afford clean 1.77p (29.8 mg, 0.184 mmol, 63%) as a colorless oil. 
Analytical data matches that which has been previously reported for 1.77p:18 1H NMR 
(500 MHz, CDCl3) δ 8.31 (bs, 1 H), 8.05 (bs, 1 H), 7.20 – 7.12 (m, 2H), 3.18 (t, J = 5.4 Hz, 
4 H), 1.75 – 1.68 (m, 4 H), 1.63 – 1.56 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 147.9, 
140.1, 139.0, 123.6, 122.8, 50.0, 25.7, 24.2; HRMS (ES+) m/z (M+H)+: Calcd for C10H15N2: 
163.1235, found: 163.1233. 
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1-(Naphthalene-1-yl)piperidine: Following general procedure B, using 
siloxane transfer agent 1.21 (119.0 mg, 0.539 mmol), 1-iodonaphthalene (101.4 mg, 0.400 
mmol), t-BuLi (646 µL, 1.4 M, 0.91 mmol), CuI (5.1 mg, 0.027 mmol), dpca (9.9 mg, 
0.027 mmol), and piperidine-1-yl benzoate (54.6 mg, 0.266 mmol). Purification via acid-
base extraction protocol afforded recovered 1.21 (102.0 mg, 86%) and 1.77q (30.9 mg, 
0.146 mmol, 55%) as a pale yellow oil. Analytical data matches that which has been 
previously reported for 1.77q:19 1H NMR (500 MHz, CDCl3) δ 8.21 (d, J = 7.7 Hz, 1 H), 
7.84 – 7.79 (m, 1 H), 7.52 (d, J = 8.1 Hz, 1 H), 7.50 – 7.43 (m, 2 H), 7.39 (t, J = 7.7 Hz, 1 
H), 7.07 (d, J = 7.3 Hz, 1 H), 3.07 (bs, 4 H), 1.93 – 1.80 (m, 4 H), 1.68 (bs, 2 H); 13C NMR 
(125 MHz, CDCl3) δ 151.3, 134.9, 129.3, 128.4, 126.0, 125.8, 125.3, 124.0, 123.0, 114.6, 
54.8, 26.8, 24.8; HRMS (ES+) m/z (M+H)+: Calcd for C15H18N: 212.1439, found: 212.1435. 
1-(Benzofuran-2-yl)piperidine: To a solution of benzofuran (66.4 mg, 
0.562 mmol, 1.5 equiv) in 2 mL THF at 0 oC was added n-BuLi in hexane (245 µL, 2.45 
M, 0.600 mmol, 1.6 equiv). The reaction mixture was allowed to warm to room temperature 
and was stirred for 1 h. A solution of siloxane transfer agent 1.21 (167.7 mg, 0.675 mmol, 
1.8 equiv) in 1 mL THF was prepared and cannulated into the reaction flask at room 
temperature. The reaction mixture was stirred for 2 h at room temperature. A solid mixture 
of CuI (14.3 mg, 0.075 mmol, 0.2 equiv) and dpca (13.9 mg, 0.0375 mmol, 0.1 equiv) was 
combined and added to the reaction flask, followed by addition of piperidine-1-yl benzoate 
(77.0 mg, 0.375 mmol, 1.0 equiv). The obtained reaction mixture was stirred at room 
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temperature. After 2 h, the reaction mixture was quenched with sat. aq. NH4Cl (5 mL), 
followed by addition of deionized H2O (5 mL). The organic layer was collected and the 
aqueous layer was extracted with Et2O (2 x 10 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo to provide the crude 
product. Purification via acid-base extraction protocol afforded recovered 1.21 (148.0 mg, 
88%) and 1.77r (45.2 mg, 0.225 mmol, 60%) as a pale yellow solid (non-crystalline). 
Analytical data matches that which has been previously reported for 1.77r:20 1H NMR (500 
MHz, CDCl3) δ 7.28 – 7.21 (m, 2 H), 7.11 – 7.06 (m, 1 H), 7.01 – 6.96 (m, 1 H), 5.4 (s, 1 
H), 3.27 (t, J = 5.2 Hz, 4 H), 1.76 – 1.67 (m, 4 H), 1.66 – 1.59 (m, 2 H); 13C NMR (125 
MHz, CDCl3) δ 162.0, 150.8, 131.2, 122.7, 120.1, 117.9, 109.6, 78.9, 48.4, 25.1, 24.4; 
HRMS (ES+) m/z (M+H)+: Calcd for C13H16NO: 202.1232, found: 202.1235. 
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Part 2  
TOTAL SYNTHESIS OF   
()-MANDELALIDE A EXPLOITING ANION RELAY 
CHEMISTRY 
 
2-1: Background 
2-1-a: Introduction of the Mandelalide Family  
The mandelalides constitute a family of unusual, variously glycosylated polyketide 
macrolides isolated by McPhail and coworkers via bioassay guided fractionation of the 
cytotoxic extracts of a rare species of Lissoclinum ascidian collected from Algoa Bay in 
South Africa. Mandelalides A-D, the first four members of the mandelalide family to be 
isolated, were reported in 2012 and their structures were proposed based on extensive NMR, 
mass spectral, and GC studies (Figure 2-1).1 Among this family, mandelalides A and B 
were reported by McPhail to exhibit potent biological activity, with nanomolar 
cytotoxicities against both human NCI-H460 lung cancer cells (IC50, 12 and 44 nM, 
respectively) and mouse Neuro-2A neuroblastoma cells (IC50, 29 and 84 nM, respectively), 
thus rendering the mandelalide family and analogs attractive as lead structures for cancer 
chemotherapeutics. The low quantities of the isolated material (< 1 mg) and the 
inaccessibility of the source organism, however, precluded further biological investigation.  
This architecturally interesting family of natural products has become of considerable  
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Figure 2-1. Originally Proposed Structures of Mandelalides A-D (2.1-2.4) 
 
interest to the synthetic community.2-6 The Fürstner group was the first to report synthetic 
work toward the mandelalide family in which they synthesized the originally reported 
structure of (–)-mandelalide A (2.1) as proposed by the isolation group. By comparing 
spectral data of the natural product with those of the synthetic material obtained through 
synthesis, Fürstner reported structural misassignment in the originally proposed structure 
of (–)-mandelalide A.2a The Ye group later disclosed the reassignment of the structure of 
(–)-mandelalide A as 2.5 by total synthesis, wherein all five stereocenters in the northern 
hemisphere were inverted (Figure 2-2).4 Subsequently, Fürstner confirmed this revision by 
total synthesis of 2.5 and predicted similar revisions for mandelalides B−D (2.6-2.8, Figure 
2-2).2b Since then, the total synthesis of the revised (–)-mandelalide A (2.5) has also been 
reported by the research groups of Altmann5 and Carter.6  
Interestingly, initial evaluations of synthetic (–)-mandelalide A against a small panel 
of cancer cell lines by several investigators yielded contradictory cell toxicity data. Ye’s 
biological assay on (–)-mandelalide A (2.5) revealed no significant cytotoxicities.4 Fürstner  
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Figure 2-2. Revised Structures of Mandelalide A-D and new mandelalide E (2.5-2.9) 
 
reported that 2.5 displayed selective and appreciable activity against human breast 
carcinoma cell line MDA-MB-361 with modest activity against human stomach cancer cell 
line N87.2b Altmann later suggested that 2.5 exerts a profound growth inhibitory effect on 
A549 and H460 lung carcinoma cells without being ultimately cytotoxic.5 McPhail, 
standing by her original biological data of the isolated natural product, has confirmed 
synthetic 2.5, from Carter’s synthetic material, as a fully efficacious cytotoxin against 
H460 lung cancer cells.6 More recently, recollection of the rare tunicate source by McPhail 
and co-workers has provided related mandelalide analogs (e.g., mandelalide E, 2.9, Figure 
2-2) and facilitated expanded, albeit limited, cytotoxicity study of the mandelalide family. 
In particular, the cytotoxicity of the mandelalides was demonstrated to be strongly 
influenced by compound glycosylation and assay cell density, in which the glycosylated 
mandelalides reduced the viability of human cancer cells cultured at a high starting density, 
yet displayed dramatically reduced cytotoxic efficacy against low density cultures.7 
Among all the mandelalide members isolated to date, (–)-mandelalide A (2.5) exhibited 
the most potent biological activity. The dramatic nanomolar cytotoxicity/anti-proliferating 
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activity of this natural product and the intriguing cell density dependence of biological 
activity demanded a preparative, modular synthesis of (–)-2.5 for detailed biological 
evaluation and future analog development. Chapter 2 will describe efforts to this end. 
2-1-b: The Ye Synthesis of ()-Mandelalide A  
The Ye synthetic approach toward ()-mandelalide A (2.5) is outlined in Scheme 2-1, 
in which the macrocyclic aglycon was assembled via union of two hemispheres, 2.10 and 
2.11, employing a Suzuki cross-coupling reaction and a Horner-Wadsworth-Emmons 
(HWE) macrocyclization. Late-stage Kahne glycosylation with thio-glycosyl donor 2.12 
produced the natural product.  
Scheme 2-1. The Ye Synthesis: Retrosynthetic Analysis 
 
The synthesis of the northern hemisphere 2.10 began with the enantioselective 
crotylation of aldehyde 2.13 to yield homoallylic alcohol 2.14, which was then converted 
to 2,5-dichlorobenzyl ether 2.16 in 5 steps (Scheme 2-2). Rychnovsky-Bartlett cyclization 
with I2 in MeCN was next employed to construct the 2,5-cis-tetrahydrofuran ring, which 
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was then converted to allylic alcohol 2.17 via base-promoted epoxide formation followed 
by ring opening with vinylmagnesium bromide promoted with copper iodide. Functional 
group manipulation, including a selective Sharpless dihydroxylation provided advanced 
intermediate 2.19. Final condensation with dimethylphosphonoacetic acid via Yamaguchi 
esterification protocol furnished the desired northern hemisphere 2.10. 
Scheme 2-2. The Ye Synthesis: Construction of Northern Hemisphere 
 
The southern hemisphere was constructed employing a key Prins cyclization reaction 
between aldehyde 2.20 and homoallylic alcohol 2.21 (Scheme 2-3). Trifluoroacetic acid 
was next used to induce cyclization; the corresponding tetrahydropyranyl trifluoroacetate 
was then immediately treated with K2CO3 in MeOH to afford tetrahydropyran 2.22 in 54% 
yield, with a diastereomeric ratio of 7:1. Functional group interconversions (7 steps) 
provided the desired southern hemisphere 2.11. 
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Scheme 2-3. The Ye Synthesis: Construction of Southern Hemisphere 
 
Fragments assembly was initiated with an intermolecular Suzuki cross-coupling 
reaction between the northern and southern hemispheres (2.10 and 2.11, respectively, 
Scheme 2-4). Selective oxidation of the primary alcohol, followed by an intramolecular 
Horner-Wadsworth-Emmons (HWE) reaction next provided the macrocyclic aglycon 2.25. 
Kahne glycosylation followed by global deprotection with TASF completed the total 
synthesis of ()-mandelalide A, identical to the natural product. The Ye total synthesis was 
achieved with a longest linear reaction sequence of 21 steps from known aldehyde 2.13 in 
ca. 4.1% overall yield. 
Scheme 2-4. The Ye Synthesis: Fragments Union 
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2-1-c: The Fürstner Synthesis of ()-Mandelalide A  
The Fürstner synthetic approach toward ()-mandelalide A (2.5) is outlined in Scheme 
2-5 in which the macrocyclic aglycon was assembled via union of two hemispheres, 2.26 
and 2.37, employing a key ring-closing alkyne metathesis (RCAM) tactic.  
Scheme 2-5. The Fürstner Synthesis: Retrosynthetic Analysis 
 
The northern hemisphere 2.26 was prepared as shown in Scheme 2-6. Silylation of 
commercially available epoxide 2.29 followed by a cobalt-catalyzed carbonylative epoxide 
opening and nucleophilic addition of 1-propenylmagnesium bromide generated enone 2.30 
in 58% yield. Cross-metathesis of 2.30 with terminal alkene 2.32, prepared in three steps 
from alcohol 2.31, furnished advanced intermediate 2.33. A SmI2-catalyzed Evans-
Tishchenko reaction followed by protecting group manipulations then provided 2.34, 
which underwent a selenoetherification under acidic condition in the presence of a Lewis 
base activator (Ph3PS) to provide 2.35 in good yield. Deselenation under free-radical 
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conditions and further functional group manipulation (4 steps) yielded the required 
northern hemisphere 2.26 possessing a terminal alkyne. 
Scheme 2-6. The Fürstner Synthesis: Construction of Northern Hemisphere 
 
The southern hemisphere was prepared from 1,3-diol, as shown in Scheme 2-7. An 
iridium-catalyzed Krische allylation followed by iodoetherification and TBS protection 
Scheme 2-7. The Fürstner Synthesis: Construction of Southern Hemisphere 
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afforded alkyl iodide 2.39. Conversion to 2.40 via use of Myers auxiliary and cross-
metathesis with methyl acrylate generated advanced intermediate 2.41. Installation of the 
enyne motif and ester saponification then furnished the desired southern hemisphere 2.27. 
Esterification of 2.26 and 2.27 was achieved with N, N'-dicyclohexylcarbodiimide 
(DCC), although the reaction was accompanied by significant isomerization of the enoate 
double bond to out of conjugation and required subsequent treatment with DBU to furnish 
2.42 in 44% yield (Scheme 2-8). Macrocyclization of diyne 2.42 proceeded smoothly in 
the presence of Fürstner catalyst 2.43. Semi-reduction of the enyne moiety followed by 
TESOTf-catalyzed rhamnosylation with glycosyl donor 2.28 then provided 2.46. Final 
global deprotection (2 steps) furnished the natural product ()-mandelalide A. The Fürstner  
Scheme 2-8. The Fürstner Synthesis: Fragments Union 
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total synthesis was achieved with a longest linear reaction sequence of 21 steps from known 
epoxide 2.29 in ca. 2.4% overall yield. 
2-1-d: The Altmann Synthesis of ()-Mandelalide A  
The Altmann synthetic approach toward ()-mandelalide A (2.5) is outlined in Scheme 
2-9 in which the macrocyclic aglycon was assembled via union of two hemispheres, 2.47 
and 2.48, employing a Sonogashira cross-coupling reaction followed by macro-
lactonization. Glycosylation with sugar donor 2.49 and global deprotection produced the 
natural product. 
Scheme 2-9. The Altmann Synthesis: Retrosynthetic Analysis 
 
The synthesis of the northern hemisphere 2.47 began with known ester 2.50 as depicted 
in Scheme 2-10. Reduction of 2.50, followed by Still-Gennari olefination afforded ester 
2.51, which was subjected to DIBALH reduction, asymmetric Sharpless epoxidation, and 
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TBS protection to furnish epoxide 2.52. Treatment of 2.52 with FeCl3. 6 H2O triggered 
acetonide cleavage and the simultaneous epoxide opening to generate the desired 
tetrahydrofuran 2.53 in good yield. Conversion of the primary alcohol to the alkyl iodide, 
followed by irradiation with 300 nm UV light in the presence of hexabutylditin and triflon 
2.54 furnished advanced intermediate 2.55 in moderate yield. Functional groups 
interconversion (5 steps) provided 2.57, which was subjected to asymmetric Sharpless 
dihydroxylation followed by primary alcohol protection to afford the desired northern 
hemisphere 2.47. 
Scheme 2-10. The Altmann Synthesis: Construction of Northern Hemisphere 
 
The Altmann southern hemisphere was constructed as outlined in Scheme 2-11. 
Rhodium-catalyzed enantioselective 1,4-addition of TIPS-acetylene to crotonaldehyde, 
followed by Keck allylation furnished homoallylic alcohol 2.60. Prins cyclization reaction 
between 2.60 and acetal 2.61 then led to tetrahydropyran 2.62, which was immediately 
treated with TBAF to generate advanced intermediate 2.63 as an 8:1 mixture of diastereo- 
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Scheme 2-11. The Altmann Synthesis: Construction of Southern Hemisphere 
 
isomers. Alkyne 2.63 was then converted in two steps to the desired southern hemisphere 
2.48. 
Fragment assembly began with an intermolecular Sonogashira cross-coupling reaction 
between the northern and southern hemispheres (2.47 and 2.48, respectively, Scheme 2-
12). Macrolactonization employing Shiina conditions of 2.47 and 2.48 afforded a mixture 
of macrolactones in which significant isomerization of the enoate double bond to out of 
conjugation took place and required treatment with DBU, as with the Fürstner synthesis, 
to furnish the desired isomer 2.64. Selective cleavage of the acetate ester and semi-
reduction of the enyne moiety then afforded aglycon 2.25. Glycosylation of 2.25 with the 
rhamnosyl donor 2.49 and global deprotection with HF.Pyridine complex completed the 
total synthesis of ()-mandelalide A (2.5). The Altmann total synthesis was achieved with 
a longest linear reaction sequence of 21 steps from known methyl ester 2.50 in ca. 2.3% 
overall yield. 
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Scheme 2-12. The Altmann Synthesis: Fragments Union 
 
2-1-e: The Carter Synthesis of ()-Mandelalide A  
The Carter synthetic approach toward ()-mandelalide A (2.5) is outlined in Scheme 
2-13 in which 2.5 was assembled via a key Wittig reaction followed by macrolactonization. 
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Scheme 2-13. The Carter Synthesis: Retrosynthetic Analysis 
 
Synthesis of the northern hemisphere 2.66 began with a Sonogashira union between 
known alkyne 2.69 and alkenyl iodide 2.70 (Scheme 2-14). Sharpless asymmetric 
dihyroxylation, followed by bis-esterification with benzoyl chloride furnished 2.72, which  
Scheme 2-14. The Carter Synthesis: Construction of Northern Hemisphere 
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underwent a key Ag-catalyzed cyclization to provide unstable enol benzoate 2.73. 
Subsequent in situ treatment with MeLi.LiBr and TBSOTf furnished ketone 2.74 in 68% 
yield. Olefination with the Petasis reagent followed by diastereoselective hydrogenation 
employing Rh/Al2O3 provided advanced intermediate 2.76. Functional group 
interconversions (4 steps) then furnished the desired northern hemisphere 2.66. 
The southern hemisphere was next constructed as outlined in Scheme 2-15. Union of 
epoxide 2.79 and alkyne 2.81, each prepared in 3 steps from known alcohol 2.78 and 
aldehyde 2.80, respectively, generated homopropargylic alcohol 2.82 in good yield. This 
Scheme 2-15. The Carter Synthesis: Construction of Glycosylated Southern 
Hemisphere 
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compound underwent AgBF4-catalyzed cyclization to yield 2.83, which was immediately 
submitted to hydrolysis to generate ketone 2.84. Functional group interconversion in four 
steps led to alcohol 2.86, which was then subjected to glycosylation with the rhamnosyl 
donor 2.68 to provide advanced intermediate 2.87. Further functional group manipulations 
(3 steps) yielded the glycosylated southern hemisphere 2.88. 
Wittig reaction between the phosphonium salt 2.66 and the aldehyde 2.88, followed by 
selective acetonide deprotection resulted in advanced fragment 2.89 (Scheme 2-16). A 
series of protecting group manipulations and functional group interconversions were then 
performed to generate the desired seco acid, which underwent Yamaguchi 
macrolactonization and final global deprotection to provide ()-mandelalide A (2.5). The 
Carter total synthesis was achieved with a longest linear reaction sequence of 22 steps from 
known aldehyde 2.80 in ca. 2.9% overall yield. 
Scheme 2-16. The Carter Synthesis: Fragments Union 
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2-2: Total Synthesis of ()-Mandelalide A Exploiting Anion Relay 
Chemistry Tactics 
(Part of this work was published in Nguyen, M. H.; Imanishi, M.; Kurogi, T.; Smith, A. 
B., III. J. Am. Chem. Soc. 2016, 138, 3675.) 
2-2-a: Retrosynthetic Analysis  
Immediately after we initiated a synthetic program targeting the proposed structure of  
mandelalide A (2.1, Figure 2-3), Fürstner reported the synthesis of 2.1 and a number of 
related stereoisomers.2a The spectroscopic data of Fürstner’s synthetic material, however, 
did not match those reported for the natural product, thus revealing a structural 
misassignment of mandelalide A by the isolation group. Based on the similarity in structure 
between the originally proposed structure of mandelalide A (2.1) and madeirolides A and 
B, two macrolides isolated from a lithistid Leiodermatium sponge (2.90 and 2.91, Figure  
Figure 2-3. Similarity in Structure between Mandelalide A and Madeirolides A & B 
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2-3),8,9 we decided to target structure 2.5, in which the relative configurations of five 
stereocenters in the northern hemisphere are inverted, as most likely the correct structure 
of mandelalide A.10 Indeed, our proposed structure for ()-mandelalide A was later 
validated by Ye and co-workers.4 
From the retrosynthetic perspective, the macrocyclic aglycon of ()-mandelalide A (2.5) 
was envisioned to arise from advanced intermediates 2.19 and 2.90, which would be united 
via esterification followed by a ring closing Heck cross-coupling reaction tactic  (Scheme 
2-17). Final glycosylation with the corresponding 2-O-methyl-α-L-rhamnose-based 
fragment ()-2.124 would then yield the structure of the natural product. The 
tetrahydrofuran and tetrahydropyran structural motifs embedded in the northern and  
Scheme 2-17. Retrosynthetic Analysis of ()-Mandelalide A 
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southern hemispheres in turn would be derived from advanced intermediates 2.91 and 2.92, 
respectively. Anion Relay Chemistry (ARC) was envisioned to provide access to both key 
fragments 2.91 and 2.92 importantly with great stereochemical flexibility for analog 
development and structural elucidation. Fragment 2.91 in turn would emerge from a Type 
II ARC/Cross-Coupling tactic employing 2-lithio-1,3-dithiane (2.93), bifunctional linchpin 
2.94,  and cis-alkenyl iodide 2.70. On the other hand, a Type I ARC reaction employing 
TBS-dithiane 2.95 and epoxides 2.96 and 2.97 would give rise to fragment 2.92. 
Importantly, the proposed strategy toward 2.91 would feature a novel and first-time Type 
II tactic in complex molecule synthesis, in which a negative charge is migrated to a sp2-
hybridized carbon center capable of undergoing cross-coupling reaction with an 
electrophilic partner.11 
2-2-b: Construction of the Northern Hemisphere 
The synthesis of the mandelalide A northern hemisphere 2.19 began with the 
preparation of epoxide linchpin ()-2.94, which was readily obtained in multi-gram 
quantity via Rh-catalyzed silylformylation of propyne,12 followed by epoxide formation13 
and then Jacobsen hydrolytic kinetic resolution (Scheme 2-18).14 Selective nucleophilic 
attack of ()-2.94  with 2-lithio-1,3-dithiane (2.93) at the least hindered site generated 
alkoxide 2.98. In the same flask, addition of CuI triggered a 1,4-Brook rearrangement to 
form what we envisioned to be a sp2-hybridized carbon nucleophile 2.99, which readily 
underwent Pd-catalyzed cross-coupling reaction with the cis-alkenyl iodide ()-2.706 to 
furnish the desired tri-component adduct ()-2.91 in 81% yield. Particularly significant, 
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this is the first successful example of ARC/Pd-Catalyzed Cross-Coupling in complex 
molecule synthesis. 
Scheme 2-18. Synthesis of linchpin 2.94 (A) and Application in Type II ARC/Pd 
Cross-Coupling (B) 
 
Adduct ()-2.91 was then subjected to what we anticipated would be a chemoselective 
Jacobsen asymmetric epoxidation with the anticipation that the disubstituted Z-olefin 
would react selectively; subsequent alcohol deprotection and epoxide opening would 
deliver 2.101, possessing the furan ring system (Scheme 2-19). This approach, however,  
Scheme 2-19. Initial Strategy at Constructing the Furan Ring System 
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proved unproductive as diene ()-2.91 quickly decomposes under the epoxidation 
condition. Attempts to force the five-member ring formation via selenoetherification also 
proved unsuccessful. 
After initial failure at constructing the furan ring system, we decided to revise our 
synthetic strategy (Scheme 2-20). Toward this end, application of the Type II ARC/Pd 
cross-coupling tactic employing lithiated dithiane 2.93, epoxide linchpin ()-2.94 and 
trans-vinyl iodide ()-2.104 furnished tri-component adduct ()-2.105 in good yield (81%).  
Scheme 2-20. Revised Strategy at Constructing the Furan Ring System 
 
Adduct ()-2.105 in turn was subjected to alcohol deprotection, dithiane removal and 
carbonyl reduction to provide diol (+)-2.106 in 76% yield over the three steps. Here we 
envisioned exploiting the 1,3-diol to chelate to a metal catalyst, facilitating a selective, syn-
specific oxidative cyclization on the disubstituted olefin of the diene system to generate 
2,5-cis-dihydrofuran 2.109 in a stereocontrolled fashion, possessing the requisite hydroxyl 
group at C21. A series of catalytic systems employing various metals such as osmium,
15 
ruthenium,16 and chromium17 that were reported to mediate oxidative cyclization of 1,2-
diols onto adjacent alkenes to generate cis-tetrahydrofurans was screened. All attempts 
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toward this end, however, proved unsuccessful, leading either to decomposition or to very 
sluggish reactions despite using excess metal catalysts. Several factors presumably hinder 
the oxidative cyclization of diol (+)-2.106, including: (a) the less favorable chelate ring 
size of 1,3-diol, compared to the 1,2-diol systems reported in the literature; (b) the presence 
of an acetonide functional group not compatible with the acidic conditions often required 
for oxidative cyclizations; and (c) the susceptibility of the allylic alcohol system to undergo 
undesired side reactions (e.g., oxidation, racemization). The major reason for this 
unproductive transformation, we believe, could be attributed to the inherent planar 
conformation of the conjugated diene system, which inhibits formation of the requisite 
transition state 2.108.  
One possible solution to the above problem would be to hydrogenate selectively the 
trisubstituted alkene of the conjugated diene, potentially by exploiting the adjacent 
hydroxyl group as a directing group. Alcohol 2.106 and several related substrates (2.110-
2.112, Scheme 2-21) were each subjected to hydrogenation conditions employing several    
Scheme 2-21. Attempts at Selective Hydrogenation of Conjugated Diene 
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asymmetric ruthenium and rhodium catalysts18 that are known to facilitate selective 
hydrogenation of alkenes under the influence of directing groups. All attempts toward this 
approach, however, proved unproductive as the conjugated diene system remained inert to 
the mild conditions employed. Forcing hydrogenation conditions, on the other hand, led to 
undesired hydrogenation of the disubstituted olefin. 
Another possible solution to the now recognized difficult cyclization would be to move 
the two double bonds in (+)-2.106 to out of conjugation. This approach demands a 
structural modification of the tri-component adduct ()-2.105, which, given the great 
flexibility of the ARC protocol, pleasingly only required a simple modification of the 
epoxide linchpin ()-2.94 (Scheme 2-22). To test this hypothesis, epoxide 2.115a19 
(Scheme 2-23A) possessing a terminal olefin was constructed from known aldehyde  
Scheme 2-22. Structural Modification of Linchpin 
 
2.115b20 via treatment with chloromethyllihium13 and then subjected to Jacobsen 
hydrolytic kinetic resolution to furnish the desired enantiomer ()-2.115. Importantly, the 
diol 2.115c byproduct from the Jacobsen resolution could be converted to the desired 
epoxide 2.115 in 65% yield via a three-step reaction sequence. Thus all of 2.115a could be 
converted to 2.115. Application of the Type II ARC/cross-coupling tactic now employing 
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1,3-dithiane, linchpin ()-2.115, and trans-alkenyl iodide ()-2.104 yielded tri-component 
adduct ()-2.118 in 89% yield on gram scale, exploiting an unprecedented CuCN-mediated 
cross-coupling reaction (Scheme 2-23B, see Section 2-3 for detailed discussion). 
Importantly, attempts to use palladium catalysis to carry out the same ARC/cross-coupling 
protocol failed to provide the desired adduct, demonstrating the unique utility of this 
CuCN-mediated cross-coupling reaction in a multicomponent union protocol (e.g., ARC). 
Scheme 2-23. Synthesis of Epoxide Linchpin 2.115 and Revision of the ARC tactic 
 
Adduct ()-2.118 was then subjected to dithiane removal and reduction to provide 1,3-
diol (+)-2.119 (Scheme 2-24), now possessing a skipped diene system which, as proposed, 
successfully underwent an osmium-mediated oxidative cyclization15 to provide the desired 
intermediate ()-2.120. The reaction conditions for this conversion were optimized by 
screening for solvents, acid catalysts, oxidants, temperatures, substrate concentrations as 
well as additives. The conditions that provided the best results are highlighted in Table 2-
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1. Under the optimal conditions, ()-2.119 was converted efficiently, albeit slowly,21 to 
()-2.120 in good yield with excellent stereoselectivity (88% brsm, >15:1 dr). Particularly 
significant, this is the first reported example of a transition-metal-mediated oxidative 
cyclization of an allylic 1,3-diol, a difficult substrate due both to the unfavorable chelate 
ring size and to a variety of possible side reactions (e.g., allylic alcohol oxidation, 
racemization, and product instability).  Diol ()-2.120 was then subjected to bis-hydroxy 
protection with TBSCl, followed by stereoselective hydrogenation with Wilkinson’s 
catalyst to install the desired stereocenter at C18 in 81% yield for the two steps. Advanced 
intermediate ()-2.121 was then subjected to selective desilylation of primary alcohol,  
Scheme 2-24. Completion of the Northern Hemisphere 
 
Table 2-1. Conditions Screened for Osmium-Mediated Oxidative Cyclization 
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Dess-Martin periodinane oxidation, and Stork-Zhao olefination22 to furnish ()-2.122 in 
74% yield for the three steps. Final selective acetonide removal with CeCl3-oxalic acid
23 
and protection of the primary alcohol as a TBS ether then afforded the desired northern 
hemisphere ()-2.19. 
2-2-c: Construction of the Southern Hemisphere 
(This work was conducted in collaboration with Dr. Masashi Imanishi and Taichi 
Kurogi in the Smith Laboratory) 
The synthesis of the mandelalide A southern hemisphere 2.92 began with preparation 
of the known epoxide ()-2.96,24 which was readily obtained in multi-gram quantities from 
known alcohol ()-2.7825 via m-CPBA-mediated epoxidation of the corresponding trityl 
ether, followed by Jacobsen hydrolytic kinetic resolution (HKR) (Scheme 2-25A). The diol 
byproduct 2.96c could again be converted to the desired epoxide 2.96 in 73% yield via a 
Scheme 2-25. Synthesis of Epoxide Linchpin 2.96 (A) and Application in Three-
Component Type I Anion Relay Chemistry (B) 
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three-step reaction sequence. Nucleophilic attack of ()-2.96 with 2-lithio-2-TBS-1,3-
dithiane (2.95), followed by a HMPA-triggered Brook rearrangement generated what we 
envision to be a carbon nucleophile at the 2-position of the dithiane (2.124), which was 
trapped in the same flask with epoxide ()-2.9726 to furnish desired tri-component adduct 
()-2.92 in 68% yield (Scheme 2-25B). A significant amount of side-product 2.125 was 
generated in this process, presumably due to partial quenching of the highly basic anion 
2.124 by the allylic proton in epoxide ()-2.97. This problem was circumvented when we 
revised the Type I ARC tactic into a four-component process.27 That is, as demonstrated in 
Scheme 2-26, application of Type I ARC strategy employing TBS dithiane 2.95a, epoxide 
()-2.96 and commercially available (S)-epichlorohydrin as the second electrophile 
generated chlorohydrin anion 2.126, which in turn formed a new electrophilic terminal 
epoxide (2.127) upon warming the reaction mixture to room temperature. Addition of 
vinylmagnesium bromide and copper iodide to the same flask completed construction of 
the requisite advanced homoallylic alcohol ()-2.92, with only trace amount of the 
Scheme 2-26. Four-Component Type I Anion Relay Chemistry 
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undesired 2.125 detected. Pleasingly, this four-component ARC adduct could be prepared 
in a single flask in 87% yield on half-gram scale, with an average yield of over 95% for 
each of the three carbon-carbon bond-forming steps. 
Treatment of homoallylic alcohol ()-2.92 with mesyl chloride then set the stage for 
ring formation upon TBS removal with TBAF, resulting in tetrahydropyran ()-2.128 
(Scheme 2-27). Dithiane removal followed by diastereoselective reduction with NaBH4 
Scheme 2-27. Completion of the Southern Hemisphere 
 
then furnished alcohol ()-2.129 in 82% yield. Protecting group manipulation and alkene 
cross-metathesis with methyl acrylate employing 2nd generation Hoveyda-Grubbs catalyst 
next led to advanced intermediate ()-2.130 in 76% yield over the three steps. Subsequent 
oxidation of the primary alcohol led to the corresponding aldehyde (2.131). Methylenation 
of this rather sensitive aldehyde at first proved problematic as treatment with methyl-
triphenylphosphonium bromide and NaHMDS under the standard Wittig conditions led to 
the desired product in low yield with substantial epimerization at C11. Attempts at this 
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transformation with mild and nonbasic protocols employing transition metal catalysis 
failed to provide the desired product.28 Gratifyingly, this problem could be addressed by 
employing the Julia-Kocienski olefination with known sulfone 2.132,29 to furnish the 
terminal alkene ()-2.133 in good yield, importantly with no loss in stereochemical 
integrity. Finally, ester saponification with aqueous LiOH provided the desired southern 
hemisphere ()-2.90. 
2-2-d: Fragment Union and Completion of the Total Synthesis of ()-
Mandelalide A 
Following construction of the northern and southern hemispheres, the glycosyl donor 
()-2.12 was readily constructed in multi-gram quantity from commercially available L-
rhamnose employing previously reported procedures4,30 (Scheme 2-28).  
Scheme 2-28. Synthesis of the Glycosyl Donor 
 
Having all fragments in hand, attention was next directed toward fragment assembly 
(Scheme 2-29). To this end, the northern and southern hemispheres ()-2.19 and ()-2.90 
were smoothly united via Yamaguchi esterification, furnishing ()-2.134 in 85% yield.  
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Scheme 2-29. Fragments Union 
 
Under our reaction conditions, the desired product was readily obtained without 
isomerization of the enoate double bond, an issue previously observed by both Fürstner2 
and Altmann.5 Advanced intermediate ()-2.134 was then subjected to macrocyclization 
employing an intramolecular Heck reaction31 to provide the PMB-protected aglycon 2.135 
in good yield. Attempts to remove the PMB protecting group in 2.135 with DDQ, however, 
led to decomposition because of competing oxidation of the conjugated diene moiety. This 
complication was resolved by exploiting the flexibility of our synthetic strategy. 
Specifically, the PMB group was removed prior to macrocyclization, to furnish alcohol 
()-2.137 in near quantitative yield. Kahne glycosylation employing sulfoxide ()-2.12 
then provided glycoside ()-2.138 in excellent yield as a single diastereomer. 
Macrocyclization employing Heck reaction and global desilylation with HF/pyridine then 
completed the total synthesis of ()-mandelalide A (2.5), in a total of 17 steps and 9% 
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overall yield, which displayed spectral properties identical in all respects to those reported 
for the natural product. Importantly, our synthetic ()-mandelalide A (2.5) displayed potent 
cytotoxicity against HeLa cervical cancer cells (IC50, 0.6 nM, Figure 2-4) in a biological 
assay performed by McPhail and coworkers using assay conditions comparable to those 
used in the original bioassay-guided drug discovery screen.1 
Figure 2-4. Concentration-Response Relationships for Synthetic ()-mandelalide A 
against Human HeLa Cervical Cancer Cells 
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2-3: Discovery of New CuCN-Mediated Cross-Coupling Reactions 
During the synthetic study toward the mandelalide A northern hemisphere, we 
developed a Type II ARC/Pd Cross-Coupling tactic comprising the migration of negative 
charge to a sp2-hybridized carbon center capable of undergoing Pd-catalyzed cross-
coupling with an alkenyl iodide (Schemes 2-18B and 2-20). While this synthetic strategy 
proved very effective for the union of epoxide linchpin ()-2.94, which features negative 
charge migration to a vinyl anion (2.99, Scheme 2-18B), application of the same protocol 
employing epoxide linchpin ()-2.115 proved ineffective (Scheme 2-30). Here, the 
presumed allyl anion generated during the anion relay failed to undergo the desired Pd- 
Scheme 2-30. Unexpected Failure in Constructing 2.118 Employing Type II 
ARC/Pd Cross-Coupling Tactic 
 
catalyzed cross-coupling with alkenyl iodide ()-2.104. As a result, the Brook-rearranged 
product, allylic alcohol 2.139, was obtained following treatment of the reaction mixture 
with TBAF to remove the TBS group from the hydroxyl group. This dramatic difference 
in the cross-coupling reactivity between the vinyl and allyl anions, both possessing sp2-
hybridized carbon centers, was unexpected. Attention was thus focused on seeking an 
effective cross-coupling protocol for the construction of advanced intermediate 2.118. 
Toward this end, allylsilane 2.116a, readily obtained via nucleophilic addition of 2-lithio-
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1,3-dithiane to epoxide ()-2.115, was treated with n-BuLi and HMPA to mimic the 
reaction conditions of the ARC process. The obtained alkoxide 2.116, presumably in 
equilibrium with the pentavalent silicon-ate complex 2.117, was subjected to cross-
coupling reactions with alkenyl iodide ()-2.104  employing various palladium catalytic 
systems (Table 2-2, entry 1). In all cases, no desired cross-coupling product, 2.118, was 
observed. Addition of copper halides or zinc halides to the reaction mixture in an attempt 
to trigger transmetalation from silicon to copper or zinc prior to the cross-coupling step 
also failed to provide the desired product (entry 2). However addition of a catalytic amount 
of CuCN.LiCl complex to the Pd(OAc)2/dppf catalyst system did successfully generate 
()-2.118, albeit in minor amount (entry 3). Totally unexpected, using 1.5 equiv of  
Table 2-2. Identification and Optimization of the CuCN-Mediated Cross-Coupling 
Reaction between Allyl Silane and Vinyl Iodide 
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CuCN.LiCl without the palladium catalyst and/or ligand improved the efficiency of the 
cross-coupling process (entry 4). The reaction temperature was found to play a crucial role 
in this cross-coupling reaction (entries 4-6). Slowly warming of the reaction mixture from 
78 °C to room temperature provided a mixture of the cross-coupling product and the 
quenched product in approximately a 1:3 ratio. On the other hand, the coupling reaction 
did not proceed when the temperature was kept at 5 °C for sixteen hours, even when the 
reaction mixture was warmed to room temperature afterward. Thus, the reactivity and/or 
stability of the allyl copper species generated from 2.116 by Si-to-Cu transmetalation using 
1.5 equiv of CuCN.LiCl complex seemed relatively low. The reaction temperature was 
found to be optimal at 10 °C when the reaction was run for at least a sixteen-hour time 
period. Particularly pleasing, removal of LiCl from the reaction mixture provided a higher 
yield of the cross-coupling product. Under these conditions the CuCN loading could be 
lowered to 0.75 equiv without affecting the efficiency of the process (entries 7 and 8). The 
efficiency of CuCN, compared with other commonly used Cu(I) salts such as CuI, CuBr, 
CuBr.Me2S, or CuCl, also proved remarkable. The use of copper(I)-thiophene-2-
carboxylate (CuTc), which has been found in widespread application in many different 
types of cross-coupling reactions and allylation reactions,32 proved less effective (entry 9). 
Also, air and moisture-stable N-heterocyclic carbene-copper complexes, such as 
(IPr)CuCl33 led to unproductive cross-coupling reactions (entry 10). Mechanistically, we 
reason that the allylsilane is activated by the adjacent alkoxide group, most likely via a 
pentavalent silicon-ate, prior to transmetalation to copper. The allyl-CuI species then 
undergoes oxidative addition with the alkenyl iodide, and the resulting copper complex 
then undergoes reductive elimination to provide the coupled products. Importantly, this is 
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the first report of a transition metal-mediated cross-coupling reaction between allylsilanes 
and alkenyl halides. The closest example is a Pd-catalyzed cross-coupling between 
allylsilane and styryl bromide that proceeds in 28% yield.34 
Pleasingly, application of the optimized cross-coupling condition in a “one-flask”-ARC 
tactic employing 1,3-dithiane, linchpin ()-2.115, and trans-alkenyl iodide ()-2.104 
yielded tri-component adduct ()-2.118 in 89% yield on gram scale (Scheme 2-23B), 
demonstrating the remarkable efficiency of the new CuCN-mediated reaction in a 
multicomponent union protocol. To explore further the scope of the Type II ARC/CuCN 
Cross-Coupling protocol, the commercially available aldehyde linchpin 2.115b was 
employed in a series of tri-component union reactions with different nucleophilic and 
electrophilic coupling partners (Scheme 2-31). Several noteworthy features of these 
couplings are apparent. Good yields were obtained across different types of nucleophilic 
coupling partners. Importantly, the stereochemical integrity of the olefinic part was 
completely maintained, and aryl iodides could be employed in addition to alkenyl iodides  
Scheme 2-31. Multicomponent Union Featuring a Type II ARC/CuCN Cross-
Coupling Protocol 
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as the electrophilic coupling partners. Equally impressive, highly reactive centers of 
electrophilicity, such as nitrile or methyl ester, were compatible. Significantly, the union 
of Type II Anion Relay Chemistry with CuCN-mediated cross-coupling reaction greatly 
expands the scope of the multicomponent “one-flask” linchpin protocol, showcasing the 
unique advantage of ARC in the rapid assembly of high levels of molecular complexity 
from simple building blocks. For example, compound 2.140d was readily assembled in one 
step employing all commercially available materials, including 4-phenyl-1-butyne, n-
butyllithium, aldehyde 2.115b, and methyl 4-iodobenzoate. 
Also noteworthy during the optimization of the cross-coupling reaction between 2.116 
and 2.104 was the observation of alkenyl nitrile 2.141 in the product mixture when the 
reaction was carried out in the presence of Pd(OAc)2 and CuCN (Scheme 2-32 A). This 
unexpected side product was presumably generated via a Pd-catalyzed cyanation of alkenyl 
iodide 2.104 with CuCN being the cyanide source. To test this hypothesis, alkenyl iodide 
1.49 was subjected to 1.5 equiv of CuCN in the presence of a catalytic amount of Pd(OAc)2 
and dppf (Scheme 2-32 B). The cyanation product 2.142 was indeed obtained in good yield  
Scheme 2-32. Identification of a Pd-Catalyzed Cyanation of Alkenyl Iodide  
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(70%, 95% brsm) with complete retention of the alkene geometry. Several synthetic routes 
to alkenyl nitriles are known, including a number of transition metal-catalyzed processes.35 
However, many of the reported procedures suffer from poor yields, limited stereocontrol, 
harsh reaction conditions, and/or the use of toxic and expensive cyanide sources. Our 
preliminary results suggest the possibility of developing a highly efficient method to 
construct alkenyl nitriles from the corresponding alkenyl halides, under mild reaction 
conditions, and especially by employing cheap CuCN as the cyanide source. 
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2-4: Conclusions  
We reported here a highly modular, convergent total synthesis of ()-mandelalide A 
(2.5) exploiting Anion Relay Chemistry. Through rational design of new linchpins and the 
strategic selection of coupling partners, the value of both Type I and Type II ARC tactics 
was demonstrated in this synthetic venture. The northern hemisphere was constructed via 
a novel three-component Type II ARC/CuCN cross-coupling protocol, while the southern 
hemisphere was secured via a highly eﬃcient four-component Type I ARC union, both 
performed on preparative scale employing commercially available and/or readily 
accessible building blocks. This work showcases ARC as a powerful synthetic tactic for 
the rapid union of multiple, structurally simple starting materials in a highly efficient, 
iterative and stereo-controlled fashion.  
The construction of the northern hemisphere demonstrates an important advantage of 
ARC that permits the synthetic organic chemists access to a wide variety of scaffolds via 
ready customization of the coupling partners with programmable, preloaded functionality 
and stereochemistry. Also noteworthy is the identification of a new CuCN mediated cross-
coupling reaction between allylsilanes with alkenyl and aryl iodides that is of signiﬁcant 
value for complex molecule synthesis. 
The advantages of the ARC tactic are evident in the short synthetic sequences employed. 
The synthesis of ()-mandelalide A (2.5), achieved with a longest linear reaction sequence 
of 17 steps, including a kinetic resolution, from known epoxide 2.115a in ca. 9% overall 
yield, compares quite favorably to all previous total syntheses (21-22 steps from known 
materials in ca. 2-4% yield). Furthermore, the excellent stereochemical control 
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demonstrated in this synthetic strategy holds the promise for all possible stereogenicities 
in the macrocyclic aglycon of mandelalide A, as well as access to other members of 
mandelalide family and analogs thereof.  
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2-6: Experimental Section 
2-6-a: General 
All moisture-sensitive reactions were performed using syringe-septum cap techniques 
under an inert atmosphere of N2. All glassware was flame dried or dried in an oven (140 
C) for at least 4 h prior to use. Reactions were magnetically stirred unless otherwise 
stated.  Tetrahydrofuran (THF), dichloromethane (CH2Cl2), diethyl ether (Et2O) and 
toluene were dried by passage through alumina in a Pure Solve™ PS-400 solvent 
purification system. THF was degassed vigorously via freeze-pump-thaw before being 
employed in Anion Relay Chemistry protocols. Unless otherwise stated, solvents and 
reagents were used as received.  Analytical thin layer chromatography was performed 
on pre-coated silica gel 60 F-254 plates (particle size 40-55 micron, 230-400 mesh) and 
visualized by a uv lamp or by staining with PMA (2 g phosphomolybdic acid dissolved 
in 20 mL absolute ethanol), KMnO4 (1.5 g of KMnO4, 10 g of K2CO3 and 2.5 mL of 5% 
aq. NaOH in 150 mL H2O), or CAM [4.8 g of (NH4)6Mo7O24·4H2O and 0.2 g of Ce(SO4)2 
in 100 mL of a 3.5 N H2SO4 solution]. Column chromatography was performed using 
silica gel (Silacycle Silaflash®) P60, 40-63 micron particle size, 230-300 mesh) and 
compressed air pressure with commercial grade solvents. Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.  
NMR spectra were recorded at 500 MHz/125 MHz (1H NMR/ 13C NMR) on a Bruker 
Avance III 500 MHz spectrometer at 300 K. Chemical shifts are reported relative to 
chloroform (δ 7.26), acetone (δ 2.05), methanol (δ 3.31), or benzene (δ 7.16) for 1H-NMR 
and chloroform (δ 77.16), acetone (δ 29.84), methanol (δ 49.00), or benzene (δ 128.06) 
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for 13C-NMR. 1H NMR spectra are tabulated as follows: chemical shift, multiplicity 
(s=singlet, d=doublet, t=triplet, q=quartet, dd=doublet of doublets, ddd= doublet of 
doublet of doublets, dddd= doublet of doublet of doublet of doublets, dt= doublet of 
triplets, m=multiplet, b=broad), coupling constant and integration. 1 3 C NMR spectra are 
tabulated by observed peak. Optical rotations were measured on a Jasco P-2000 
polarimeter. Melting points were determined using a Thomas-Hoover capillary melting 
point apparatus and are uncorrected.  Infrared spectra were measured on a Jasco FT/IR 
480 plus spectrometer.  High-resolution mass spectra (HRMS) were obtained at the 
University of Pennsylvania on a Waters GCT Premier spectrometer. GPC analysis of the 
polymer samples were done on a Perkin-Elmer Series 10 high-performance liquid 
chromatography (HPLC), equipped with an LC-100 column oven (30 oC), a Nelson 
Analytical 900 Series integration data station, a Perkin-Elmer 785 UV-vis detector (254 
nm), a Varian star 4090 refractive index detector, and three AM gel columns (500 Å, 5 µm; 
1000 Å, 5 µm; and 104 Å, 5 µm). THF (Fisher, HPLC grade) was used as eluent at a flow 
rate of 1 mL/min. SFC purifications were performed with a JASCO system equipped with 
a Chiralpak AD-H column (10 mm x 250 mm), a PU-280-CO2 plus CO2 Delivery System, 
a CO-2060 plus Intelligent Column Thermostat, an HC-2068-01 Heater Controller, a BP-
2080 plus Automatic Back Pressure Regulator, an MD-2018 plus Photodiode Array 
Detector (200-648 nm), and PU-2080 plus Intelligent HPLC Pumps. 
2-6-b: Experimental Procedures 
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2-6-b-1: Preparation of coupling partners for ARC 
 
 
A tared, septa-capped, 50 mL vial containing 25 mL MeCN and a stir bar was purged 
with propyne gas (1.36 g, 34.0 mmol) and weighed to determine the mass of dissolved 
propyne gas in solution. Liquid tert-butyldimethylsilane (1.9 mL, 11 mmol) was added via 
syringed and the resulting solution was solidified by cooling down to –78 oC. The septa 
was removed, solid catalyst Rh(acac)(CO)2 (29.2 mg, 0.113 mmol) was added and the vial 
was then quickly assembled into a Parr bomb and heated to 90 oC under an atmosphere of 
CO (500 psi) for 15 h. The solution was then cooled to room temperature and carefully 
removed from the Parr bomb. The resulting mixture was extracted with Et2O (2 x 100 mL). 
The combined organic layers were washed with brine, dried with MgSO4, and concentrated 
in vacuo. The crude product was purified by flash chromatography on silica gel (5% 
Et2O/Hexanes) to afford the desired aldehyde 2.94b as a yellow oil (2.06 g, 11.2 mmol, 
99%): IR (film, cm–1) 2939, 2854, 2738, 1687, 1594, 1470, 1362, 1323, 1252, 1029, 1008, 
841, 782, 705; 1H NMR (500 MHz, CDCl3) δ 9.82 (s, 1 H), 6.86 (q, J = 1.4 Hz, 1 H), 1.94 
(d, J = 1.4 Hz, 3 H), 0.93 (s, 9 H), 0.22 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 193.7, 
153.2, 150.4, 26.5, 19.2, 17.1, 2.9; HRMS (CI+) m/z (MMe)+: Calcd for C9H17OSi: 
169.1049, found: 169.1049. 
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Chloroiodomethane (2.85 mL, 39.1 mmol) was added to a stirred solution of aldehyde 
2.94b (2.405 g, 13.04 mmol) in 35 mL THF at –78 oC. A solution of n-BuLi (2.43 M, 16.1 
mL, 39.1 mmol) in hexanes was added dropwise via syringe over 15 min. The obtained 
solution was then stirred at –78 oC for 1 h, then tetrabutylamonium iodide (TBAI, 481.7 
mg, 1.304 mmol) was added and the solution was then stirred at room temperature for 15 
h. The solution was quenched with saturated aqueous NH4Cl (50 mL) and deionized H2O 
(50 mL). The resulting mixture was extracted with Et2O (2 x 100 mL). The combined 
organic layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel (2-5% Et2O/hexanes) to 
afford the desired epoxide 2.94a as a yellow oil (2.42 g, 11.2 mmol, 94%): IR (film, cm–1) 
2945, 2854, 1616, 1470, 1380, 1250, 895, 841, 761, 686; 1H NMR (500 MHz, CDCl3) δ 
5.64 (bs, 1 H), 3.59 (t, J = 3.2 Hz, 1 H), 2.86 (t, J = 4.8 Hz, 1 H), 2.79 (dd, J = 5.2, 2.8 Hz, 
1 H), 1.67 (d, J = 1.2 Hz, 3 H), 0.91 (s, 9 H), 0.14 (s, 3 H), 0.13 (s, 3 H); 13C NMR (125 
MHz, CDCl3) δ 150.8, 128.9, 53.4, 46.4, 26.5, 20.1, 17.1, 3.6, 3.7; HRMS (ES+) m/z 
(MH)+: Calcd for C11H23OSi: 199.1518, found: 199.1529. 
To a mixture of the pre-catalyst (R, R)-(–)-N, N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminocobalt(II) (379 mg, 0.628 mmol) in 1 mL toluene was added glacial 
acetic acid (72 µL, 1.3 mmol), and the resulting mixture was stirred at room temperature 
under air for 30 min. The volatile components were removed via rotary evaporation and 
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the remaining residue was dissolved in epoxide 2.94a (2.49 g, 12.6 mmol) and 2 mL THF. 
The solution was then cooled to 0 oC and H2O (160 µL, 8.79 mmol) was added via syringe. 
The resulting mixture was stirred at room temperature for 8 days, after which time Et2O 
(50 mL) was added, the mixture was filtered through a short pad of silica gel and 
concentrated in vacuo. Flash chromatography on silica gel (5% Et2O/hexanes), followed 
by Kugelrohr distillation (70 – 90 oC, 0.025 mmHg) afforded the desired epoxide 2.94 as 
a colorless oil (1.12 g, 5.65 mmol, 45%, >95% ee based on 1H NMR analysis of 2.105): 
[]20D 33.97 (c 1.04, CH2Cl2). 
 
 
 
 Chloroiodomethane (7.03 mL, 96.5 mmol) was added to a stirred solution of aldehyde 
2.115b (4.575 g, 32.15 mmol) in 100 mL THF at –78 oC. A solution of n-BuLi (2.5 M, 38.6 
mL, 96.5 mmol) in hexanes was added dropwise via syringe over 30 min. The obtained 
solution was then stirred at –78 oC for 1 h, then tetrabutylamonium iodide (TBAI, 1.19 g, 
3.22 mmol) was added and the solution was then stirred at room temperature for 15 h. The 
solution was then quenched with saturated aqueous NH4Cl (50 mL) and deionized H2O (50 
mL). The resulting mixture was extracted with Et2O (2 x 150 mL). The combined organic 
layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel (2-5% Et2O/hexanes) to afford 
the desired epoxide 2.115a as a pale yellow oil (4.77 g, 30.5 mmol, 95%): IR (film, cm–1) 
3049, 2955, 1637, 1419, 1249, 1160, 953, 891, 852; 1H NMR (500 MHz, CDCl3) δ 5.00 
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(bs, 1H), 4.75 (bs, 1 H), 3.26 (t, J = 3.0 Hz, 1 H), 2.86 (dd, J = 5.5, 4.2 Hz, 1 H), 2.60 (dd, 
J = 5.5, 2.6 Hz, 1 H), 1.45 (dd, J = 21.6, 14.1 Hz, 2 H), 0.04 (s, 9 H); 13C NMR (125 MHz, 
CDCl3) δ 143.5, 109.8, 54.3, 48.2, 21.3, 1.26; HRMS (CI+) m/z (MMe)+: Calcd for 
C8H16OSi: 156.0970, found: 156.0966. 
To a mixture of the pre-catalyst (R, R)-(–)-N, N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminocobalt(II) (147 mg, 0.244 mmol) in 1 mL toluene was added glacial 
acetic acid (28 µL, 0.49 mmol), and the resulting mixture was stirred at room temperature 
under air for 30 min. The volatile components were removed via rotary evaporation and 
the remaining residue was dissolved in epoxide 2.115a (3.806 g, 24.35 mmol) and 3.4 mL 
THF. The solution was then cooled to 0 oC and H2O (241 µL, 13.4 mmol) was added via 
syringe. The resulting mixture was stirred at room temperature for 5 days, after which time 
Et2O (30 mL) was added, the mixture was filtered through a short pad of silica gel and 
concentrated in vacuo. Flash chromatography on silica gel (5% Et2O/pentanes) afforded 
the desired epoxide 2.115 as a pale yellow oil (1.71 g, 11.0 mmol, 45%, >95% ee as 
determined via Supercritical Fluid Chromatography (SFC) analysis of alcohol 2.116a): 
[]20D 5.12 (c 0.083, CH2Cl2). Diol 2.115c (2.08 g, 49%) was also obtained following 
flash chromatography and could be converted to epoxide 2.115 in a three-step reaction 
sequence: 
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To a solution of 2.115c (4.28 g, 24.6 mmol) in 100 mL CH2Cl2 at 0
 oC was added 
pyridine (2.97 mL, 36.9 mmol) and pivaloyl chloride (3.33 mL, 27.0 mmol). The resulting 
solution was slowly warmed to room temperature over 15 h. The reaction mixture was then 
diluted with Et2O (100 mL) followed by quenching with saturated aqueous NH4Cl (50 mL). 
The resulting mixture was extracted with Et2O (2 x 150 mL). The combined organic layers 
were washed with saturated aqueous NaHCO3 and brine, dried with Na2SO4, and 
concentrated in vacuo. The obtained crude was then taken up in 150 mL CH2Cl2 at 0
 oC 
followed by addition of Et3N (8.56 mL, 61.4 mmol) and mesyl chloride (3.81 mL, 49.1 
mmol). The resulting solution was stirred at room temperature for 28 h. The solution was 
then quenched with saturated aqueous NH4Cl (50 mL). The resulting mixture was extracted 
with CH2Cl2 (2 x 100 mL). The combined organic layers were washed with brine, dried 
with Na2SO4, and concentrated in vacuo. The obtained crude was then directly taken in 250 
mL MeOH. Solid K2CO3 (7.5 g, 54 mmol) was added and the resulting mixture was stirred 
for 37 h. The reaction mixture was then diluted with Et2O (200 mL) followed by quenching 
with brine (100 mL) and deionized H2O (100 mL). The resulting mixture was extracted 
with Et2O (2 x 150 mL). The combined organic layers were washed with brine, dried with 
Na2SO4, and concentrated in vacuo. Purification by flash chromatography on silica gel (5% 
Et2O/pentanes) afforded the desired epoxide 2.115 as a pale yellow oil (2.50 g, 65% over 
the 3 steps).  
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A solution of n-BuLi (2.48 M, 508 µL, 1.26 mmol) in hexanes was added to a stirred 
solution of 1,3-dithiane (151.5 mg, 1.26 mmol) in 2 mL THF at –20 oC and stirred for 2 h. 
A solution of epoxide 2.115 (164.1 mg, 1.05 mmol) in 0.5 mL THF was added via cannula 
dropwise (followed with a 0.5 mL rinse with THF). The resulting solution was stirred at –
20 oC for 3 h then cooled to –78 oC and HMPA (183 µL, 1.05 mmol) was then added. The 
resulting mixture was warmed to –40 oC and stirred for another 2 h. The solution was then 
cooled to –78 oC and aqueous H2SO4 (1 N, 2 mL) was added dropwise. The resulting 
mixture was warmed to room temperature and extracted with Et2O (3 x 50 mL). The 
combined organic layers were washed with saturated aqueous NaHCO3, brine, dried with 
MgSO4, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel (20% Et2O/hexanes) to afford 2.116a as a colorless oil (232.3 
mg, 0.84 mmol, 80%, >95% ee via SFC analysis): []20D 7.75 (c 1.13, CH2Cl2); IR (film, 
cm–1) 3436, 2951, 2898, 1636, 1423, 1276, 1248, 1159, 1053, 886, 853, 692, 668; 1H NMR 
(500 MHz, CDCl3) δ 4.98 (s, 1 H), 4.70 (s, 1 H), 4.28-4.22 (m, 2 H), 2.95-2.82 (m, 4 H), 
2.17-2.10 (m, 1 H), 2.05-1.97 (m, 1 H), 1.94-1.85 (m, 2 H), 1.81-1.76 (m, 1 H), 1.63 (d, J 
= 14.1 Hz, 1 H), 1.41 (d, J = 13.9 Hz, 1 H), 0.04 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 
149.4, 107.6, 72.2, 44.3, 41.7, 30.4, 30.1, 26.1, 22.9, 1.08; HRMS (ES+) m/z (M+H)+: 
Calcd for C12H25OS2Si: 277.1116, found: 277.1110. 
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To a flask containing CrCl2 (18.65 g, 151.7 mmol) under N2 was added 140 mL 1,4-
dioxane and 23 mL THF. The mixture was stirred vigorously for 45 min at room 
temperature to obtain a homogeneous suspension. Recrystallized CHI3 (19.65 g, 49.91 
mmol) was added and the resulting mixture was stirred for 2 h at room temperature, at 
which time a solution of known aldehyde 2.104a (3.13 g, 21.7 mmol) in 7 mL 1,4-dioxane 
was added dropwise via cannula. The resulting mixture was stirred for 3 h at room 
temperature. The reaction was then quenched with 100 mL deionized H2O and extracted 
with hexanes (3 x 100 mL). The combined organic layers were washed with saturated 
aqueous Na2S2O3, brine, dried with Na2SO4, and concentrated in vacuo. The crude product 
was purified by flash chromatography on silica gel (5% Et2O/hexanes) to afford the desired 
alkenyl iodide 2.104 as a colorless oil (4.13 g, 15.4 mmol, 71%): []20D +6.45 (c 0.59, 
CHCl3); IR (film, cm
–1) 2984, 2934, 2877, 1607, 1370, 1212, 1153, 1065, 948, 835; 1H 
NMR (500 MHz, CDCl3) δ 6.52 (dt, J = 14.5, 7.3 Hz, 1 H), 6.16 (d, J = 14.5 Hz, 1 H), 4.15 
(m, 1 H), 4.03 (dd, J = 8.0, 6.0 Hz, 1 H), 3.57 (dd, J = 8.0, 6.8 Hz, 1 H), 2.40-2.25 (m, 2 
H), 1.41 (s, 3 H), 1.35 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 141.5, 109.4, 77.7, 74.4, 
68.8, 40.2, 27.0, 25.7; HRMS (CI+) m/z (MMe)+: Calcd for C7H10O2I: 252.9726, found: 
252.9715. 
 
 
To a 1 L round-bottomed flask containing 2.78 (6.12 g, 61.1 mmol) in 190 mL CH2Cl2 
at 0 °C was added pyridine (12.4 mL, 153 mmol), trityl chloride (34.1 g, 122 mmol), and 
DMAP (1.49 g, 12.2 mmol). The resulting solution was stirred at room temperature for 39 
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h, after which time TLC indicated complete consumption of 2.78. The reaction mixture 
was diluted with CH2Cl2 and water at 0 °C. The resulting mixture was washed with water 
twice, saturated aqueous NH4Cl twice, brine, dried over anhydrous sodium sulfate, and 
filtered. The organic solvents were removed under reduced pressure to give a crude residue, 
which was purified by silica gel column chromatography (3% EtOAc/hexanes) to afford 
2.96b as a colorless oil (14.9 g, 43.5 mmol, 71%): []20D +0.57 (c 0.83, CH2Cl2); IR (film, 
cm–1) 3061, 2916, 1636, 1491, 1448, 1153, 1072, 913, 744, 705; 1H NMR (500 MHz, 
CDCl3) δ 7.45 (d, J = 7.5 Hz, 6 H), 7.32-7.27 (m, 6 H), 7.25-7.21 (m, 3 H), 5.75-5.65 (m, 
1 H), 4.99-4.89 (m, 2 H), 2.97-2.89 (m, 2 H), 2.30-2.22 (m, 1 H), 1.96-1.79 (m, 2 H), 0.93 
(d, J = 6.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 144.6, 137.3, 128.9, 127.8, 126.9, 
115.9, 86.3, 68.0, 38.3, 34.0, 17.1; HRMS (ES+) m/z (M+Na)+: Calcd for C25H26ONa: 
365.1881, found: 365.1899. 
 
 
 
To a 1 L round-bottomed flask containing 2.96b (13.06 g, 38.1 mmol) and Na2HPO4 
(10.8 g, 38.1 mmol) in 380 mL CH2Cl2 at 0 °C was added mCPBA (<77% commercial 
supply, 12.0 g, ca. 53.5 mmol) and the resulting mixture was stirred at room temperature 
for 14 h, after which time TLC indicated complete consumption of 2.96b. The reaction was 
quenched with saturated aqueous NaHCO3 and saturated aqueous Na2SO3 (1:1 mixture, ca. 
300 mL) at 0 °C. The resulting mixture was extracted with CH2Cl2 three times and the 
combined organic extracts were washed with saturated aqueous NaHCO3, dried over 
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anhydrous sodium sulfate, and filtered. The organic solvents were removed under reduced 
pressure to give crude material, which was purified by silica gel column chromatography 
(10% Et2O/hexanes) to afford epoxide 2.96a as a colorless oil (12.6 g, 35.1 mmol, 92%): 
IR (film, cm–1) 3056, 2917, 1490, 1448, 1219, 1153, 1071, 899, 764, 746, 707; 1H NMR 
(500 MHz, CDCl3) δ 7.44 (d, J = 7.5 Hz, 6 H), 7.33-7.27 (m, 6 H), 7.25-7.20 (m, 3 H), 
3.02-2.94 (m, 2 H), 2.91-2.82 (m, 1 H), 2.72 (t, J = 4.5 Hz, 0.5 H), 2.64 (t, J = 4.5 Hz, 0.5 
H), 2.45-2.40 (m, 0.5 H), 2.37-2.33 (m, 0.5 H), 2.06-1.94 (m, 1 H), 1.78-1.67 (m, 1 H), 
1.43-1.31 (m, 1 H), 1.06 (d, J = 6.7 Hz, 1.5 H), 1.02 (d, J = 6.7 Hz, 1.5 H); 13C NMR (125 
MHz, CDCl3) δ 144.5, 144.4, 128.9, 127.9, 127.03, 127.02, 86.4, 68.3, 67.9, 51.5, 50.9, 
47.7, 47.2, 37.1, 36.9, 32.7, 32.1, 18.1, 17.4; HRMS (ES+) m/z (M+Na)+: Calcd for 
C25H26O2Na: 381.1831, found: 381.1829. 
 To a 50 mL two-necked round-bottomed flask containing pre-catalyst (R, R)-(–)-N, N′-
bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) (404 mg, 0.669 mmol) 
in 8.2 mL toluene was added glacial acetic acid (76.5 µL, 1.34 mmol), and the mixture was 
stirred at room temperature for 1 h. The volatile components were then removed and the 
residue was dried under high vacuum (~30 min). To the resulting residue was added a 
solution of epoxide 2.96a (12.0 g, 33.5 mmol) in 12 mL THF and the resulting mixture was 
cooled to 0 °C. To the solution was added H2O (332 µL, 18.4 mmol) and the mixture was 
stirred at room temperature for 3 days, after 1H-NMR indicated consumption of almost an 
isomer of 2.96a. The reaction mixture was purified by silica gel column chromatography 
(15% Et2O/hexanes) to afford the epoxide 2.96 (5.84 g, 16.3 mmol, 49%, >12:1 d.r. as 
determined by 1H-NMR analysis): []20D +2.52 (c 0.67, CH2Cl2); 1H NMR (500 MHz, 
CDCl3) δ 7.44 (d, J = 7.5 Hz, 6 H), 7.33-7.27 (m, 6 H), 7.25-7.20 (m, 3 H), 3.02-2.94 (m, 
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2 H), 2.91-2.86 (m, 1 H), 2.72 (t, J = 4.5 Hz, 1 H), 2.45-2.40 (m, 1 H), 2.06-1.94 (m, 1 H), 
1.78-1.72 (m, 1 H), 1.39-1.31 (m, 1 H), 1.02 (d, J = 6.7 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 144.5, 128.9, 127.8, 127.0, 86.4, 68.3, 50.9, 47.7, 36.9, 32.1, 17.4. Diol 2.96c 
(5.55 g, 44%) was also obtained following flash chromatography and could be converted 
to epoxide 2.96 in a three-step reaction sequence: 
 
To a solution of 2.96c (8.22 g, 21.8 mmol) in 87 mL CH2Cl2 at 0
 oC was added pyridine 
(2.64 mL, 32.6 mmol) and pivaloyl chloride (3.22 mL, 26.2 mmol). The resulting solution 
was slowly warmed to room temperature over 8 h. The reaction mixture was then diluted 
with Et2O (100 mL) followed by quenching with saturated aqueous NH4Cl (50 mL). The 
resulting mixture was extracted with Et2O (2 x 150 mL). The combined organic layers were 
washed with saturated aqueous NaHCO3 and brine, dried with Na2SO4, and concentrated 
in vacuo. The obtained crude was then taken up in 145 mL CH2Cl2 at 0
 oC followed by 
addition of Et3N (7.60 mL, 54.5 mmol) and mesyl chloride (3.37 mL, 43.5 mmol). The 
resulting solution was stirred at room temperature for 17 h. The solution was then quenched 
with saturated aqueous NH4Cl (50 mL). The resulting mixture was extracted with CH2Cl2 
(2 x 100 mL). The combined organic layers were washed with brine, dried with Na2SO4, 
and concentrated in vacuo. The obtained crude was then directly taken in 220 mL MeOH. 
Solid K2CO3 (6.63 g, 48.0 mmol) was added and the resulting mixture was stirred for 20 h. 
The reaction mixture was then diluted with Et2O (200 mL) followed by quenching with 
brine (100 mL) and deionized H2O (100 mL). The resulting mixture was extracted with 
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Et2O (2 x 150 mL). The combined organic layers were washed with brine, dried with 
Na2SO4, and concentrated in vacuo. Purification by flash chromatography on silica gel (10% 
Et2O/hexanes) afforded the desired epoxide 2.96 as a pale yellow oil (5.71 g, 73% over the 
3 steps). 
2-6-b-2: Procedure for Anion Relay Chemistry 
 
A solution of n-BuLi (2.4 M, 672 µL, 1.6 mmol) in hexanes was added to a stirred 
solution of 1,3-dithiane (193.9 mg, 1.613 mmol) in 4.5 mL THF and stirred for 5 min at 
room temperature. The solution was then cooled to –20 oC and a solution of epoxide 2.94 
(300 mg, 1.51 mmol) in 1.5 mL THF was added via cannula dropwise (followed with a 1.5 
mL rinse with THF). The resulting solution was slowly warmed up to room temperature 
over 5 h. The solution was then cannulated (followed with a 1.5 mL rinse with THF) into 
another flask containing CuI (384 mg, 2.02 mmol) that has been stirred in 12.0 mL of 
THF/HMPA mixture (1:1 in volume) at –20 oC for 20 min. The resulting suspension was 
stirred at room temperature for 30 min to obtain a homogeneous solution, which was then 
cannulated (followed with a 1.5 mL rinse with THF) into another flask containing a mixture 
of alkenyliodide 2.70 (270.2 mg, 1.008 mmol), Pd(OAc)2 (22.6 mg, 0.101 mmol), and dppf 
(111.8 mg, 0.202 mmol) that has been stirred in 3.0 mL THF at room temperature for 15 
min. The resulting solution was then stirred at room temperature for 17 h. The solution was 
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then quenched with saturated aqueous NH4Cl (10 mL) and deionized H2O (10 mL). The 
resulting mixture was extracted with Et2O (3 x 100 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel (5% Et2O/hexanes) to afford the desired 
three-component adduct 2.91 as a pale yellow oil (375 mg, 0.817 mmol, 81%): []20D 
21.41 (c 1.45, CH2Cl2); IR (film, cm–1) 2935, 2891, 2861, 1599, 1463, 1373, 1251, 1071, 
934, 835, 775; 1H NMR (500 MHz, CDCl3) δ 6.40 (t, J = 11.4 Hz, 1 H), 6.05 (d, J = 11.7 
Hz, 1 H), 5.41-5.33 (m, 1 H), 4.98 (dd, J = 8.6, 4.7 Hz, 1 H), 4.19-4.11 (m, 1 H), 4.05-3.94 
(m, 2 H), 3.60-3.53 (m, 1 H), 2.88-2.74 (m, 4 H), 2.58-2.50 (m, 1 H), 2.46-2.37 (m, 1 H), 
2.14-1.99 (m, 2 H), 1.95-1.84 (m, 1 H), 1.80-1.70 (m, 1 H), 1.76 (s, 3 H), 1.43 (s, 3 H), 
1.35 (s, 3 H), 0.88 (s, 9 H), 0.08 (s, 3 H), -0.01 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 
140.9, 125.7, 125.1, 121.2, 109.1, 75.6, 69.1, 67.0, 43.9, 41.9, 31.7, 30.4, 29.9, 27.1, 26.2, 
26.0, 25.8, 18.4, 18.3, 4.7, 4.9; HRMS (ES+) m/z (M+H)+: Calcd for C23H43O3S2Si: 
459.2423, found: 459.2422. 
 
 
A solution of n-BuLi (2.4 M, 381 µL, 0.91 mmol) in hexanes was added to a stirred 
solution of 1,3-dithiane (109.9 mg, 0.914 mmol) in 2.5 mL THF and stirred for 5 min at 
room temperature. The solution was then cooled to –20 oC and a solution of epoxide 2.94 
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(170 mg, 0.857 mmol) in 1 mL THF was added via cannula dropwise (followed with a 0.7 
mL rinse with THF). The resulting solution was slowly warmed up to room temperature 
over 5 h. The solution was then cannulated (followed with a 0.5 mL rinse with THF) into 
another flask containing CuI (217.5 mg, 1.142 mmol) that has been stirred in 6.8 mL of 
THF/HMPA mixture (1:1 in volume) at –20 oC for 20 min. The resulting suspension was 
stirred at room temperature for 30 min to obtain a homogeneous solution, which was then 
cannulated (followed with a 1.0 mL rinse with THF) into another flask containing a mixture 
of alkenyl iodide 2.104 (153 mg, 0.571 mmol), Pd(OAc)2 (12.8 mg, 0.0571 mmol), and 
dppf (63.3 mg, 0.114 mmol) that has been stirred in 1.5 mL THF at room temperature for 
15 min. The resulting solution was then stirred at room temperature for 19 h. The solution 
was then quenched with saturated aqueous NH4Cl (5 mL) and deionized H2O (5 mL). The 
resulting mixture was extracted with Et2O (3 x 50 mL). The combined organic layers were 
washed with brine, dried with MgSO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel (5% Et2O/hexanes) to afford the desired 
three-component adduct 2.105 as a pale yellow oil (212.2 mg, 0.463 mmol, 81%): []20D 
2.99 (c 0.82, CH2Cl2); IR (film, cm–1) 2979, 2929, 2893, 2856, 1472, 1369, 1252, 1210, 
1155, 1069, 1004, 965, 935, 837, 777, 668; 1H NMR (500 MHz, CDCl3) δ 6.43 (dd, J = 
14.9, 11.3 Hz, 1 H), 5.8 (d, J = 11.1 Hz, 1 H), 5.55 (dt, J = 14.9, 7.2 Hz, 1 H), 4.95 (dd, J 
= 8.0, 5.1 Hz, 1 H), 4.18-4.11 (m, 1 H), 4.05-4.00 (m, 1 H), 3.97 (dd, J = 8.6, 5.8 Hz, 1 H), 
3.60-3.54 (m, 1H), 2.88-2.77 (m, 4 H), 2.50-2.43 (m, 1H), 2.36-2.28 (m, 1 H), 2.15-2.07 
(m, 1 H), 2.06-2.00 (m, 1 H), 1.94-1.84 (m, 1 H), 1.81-1.74 (m, 1 H), 1.71 (s, 3 H), 1.42 (s, 
3 H), 1.35 (s, 3 H), 0.89 (s, 9 H), 0.08 (s, 3 H), 0.00 (s, 3 H); 13C NMR (125 MHz, CDCl3) 
δ 138.5, 128.2, 128.1, 126.4, 109.1, 75.5, 69.1, 67.3, 43.9, 41.9, 37.2, 30.3, 30.0, 27.0, 26.2, 
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26.0, 25.7, 18.3, 17.9, 4.68, 4.87; HRMS (ES+) m/z (M+Na)+: Calcd for 
C23H42O3NaS2Si: 481.2242, found: 481.2245. 
 
 
A solution of n-BuLi (2.5 M, 4.53 mL, 11 mmol) in hexanes was added to a solution 
of 1,3-dithiane (1.36 g, 11.3 mmol) in 15 mL THF at –20 oC and stirred for 2 h at this 
temperature. A solution of epoxide 2.115 (1.66 g, 10.6 mmol) in 13.5 mL THF (dried over 
anhydrous Na2SO4 and degassed via freeze-pump-thaw) was added via syringe dropwise 
(followed with a 6 mL rinse with THF). The solution was stirred at –20 oC for 3 h, then 
cooled to –78 oC and HMPA (1.85 mL, 10.6 mmol) was added dropwise. The resulting 
mixture was placed in –40 oC cold bath and stirred at this temperature for 1 h. The solution 
was then cooled to –78 oC and solid CuCN (476 mg, 5.31 mmol) was quickly added. The 
resulting bright yellow suspension was stirred at –78 oC for 45 min, then alkenyl iodide 
2.104 (1.90 g, 7.08 mmol) in 9 mL THF (dried over anhydrous Na2SO4) was added via 
syringe dropwise (followed with a 6 mL rinse with THF). The resulting yellow suspension 
was placed in +10 oC cold bath and stirred at this temperature for 20 h to give a dark, clear 
solution, which was slowly warmed to room temperature over 15 h. The solution was then 
added a solution of TBAF (1.0 M in THF, 42.5 mL, 42.5 mmol) and stirred at room 
temperature for 2 h, followed by addition of saturated aqueous NH4Cl (50 mL) and 
deionized H2O (50 mL). The resulting mixture was extracted with Et2O (3 x 150 mL). The 
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combined organic layers were washed with brine, dried with MgSO4, and concentrated in 
vacuo. The crude product was purified by flash chromatography on silica gel (30% 
Et2O/hexanes) to afford the desired three-component adduct 2.118 as a pale yellow oil 
(2.17 g, 6.30 mmol, 89%): []20D +4.61 (c 0.64, CH2Cl2); IR (film, cm–1) 3448, 2984, 2930, 
1423, 1369, 1214, 1155, 1060, 974, 909, 848; 1H NMR (500 MHz, CDCl3) δ 5.58-5.44 (m, 
2 H), 5.12 (s, 1 H), 4.90 (s, 1 H), 4.43-4.37 (m, 1 H), 4.23-4.18 (m, 1 H), 4.17-4.11 (m, 1 
H), 4.03 (dd, J = 8.0, 6.0 Hz, 1 H), 3.61-3.55 (m, 1 H), 2.95-2.80 (m, 5 H), 2.77-2.70 (m, 
1 H), 2.42-2.35 (m, 1 H), 2.30-2.23 (m, 1 H), 2.16-2.09 (m, 1 H), 2.00-1.85 (m, 4 H), 1.42 
(s, 3 H), 1.35 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 149.9, 130.8, 127.6, 111.5, 109.1, 
75.6, 71.5, 69.0, 44.1, 41.3, 37.0, 35.6, 30.4, 30.1, 27.0, 26.1, 25.8; HRMS (ES+) m/z 
(M+Na)+: Calcd for C17H28O3NaS2: 367.1378, found: 367.1390. 
 
A solution of TBS-dithiane 2.95a (406 mg, 1.73 mmol) in 5.4 mL THF was treated 
with a solution of n-BuLi (2.3 M, 0.826 mL, 1.9 mmol) in hexanes at room temperature 
and stirred for 5 min. The reaction mixture was then cooled to –40 °C and a solution of 
epoxide 2.96 (414 mg, 1.15 mmol) in 15 mL Et2O was added via syringe dropwise. The 
mixture was stirred at –40 °C and monitored by TLC (30% Et2O/Hexanes). After 30 min, 
TLC analysis showed complete consumption of dithiane. The reaction was then cooled to 
–78 °C and a solution of (S)-epichlorohydrin (266 mg, 2.87 mmol) in 5 mL Et2O (dried 
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over anhydrous Na2SO4) was added dropwise via syringe, followed by HMPA (0.327 mL, 
1.72 mmol). The reaction mixture was stirred at –78 °C for 5 min, then allowed to warm 
to 0 ºC using an ice/water bath over 1 hour. The cold bath was then removed and the 
reaction mixture was allowed to warm to room temperature for about 1 h. Freshly prepared 
vinylmagnesium bromide (1.0 M, 3.5 mL, 3.5 mmol) in THF was added to a suspension of 
CuI (110 mg, 0.58 mmol) in 11 mL Et2O at –78 °C via syringe. The reaction mixture 
containing the ARC product was then added via syringe over 5 min. The resulting mixture 
was stirred at –78 ºC for 30 min, and the reaction flask was then placed in an ice/water bath 
at 0 ºC and allowed to warm to room temperature for over 1.5 hour. An aqueous solution 
of Rochelle’s salt (15% w/v) was finally added and the resulting biphasic mixture was 
stirred at room temperature for 20 min, then extracted with EtOAc twice. The combined 
organic extracts were washed with water and brine, dried over anhydrous Na2SO4 and 
concentrated in vacuo. The crude material obtained was purified by silica gel column 
chromatography (5-30% Et2O/ hexanes) to afford 2.92 as a colorless oil (676 mg, 1.00 
mmol, 87%): []20D 13.7 (c 0.65, CH2Cl2); IR (film, cm–1) 3434, 3058, 2927, 2856, 1596, 
1490, 1472, 1448, 1255, 1069, 909, 836, 808, 774, 745, 707, 633; 1H NMR (500 MHz, 
CDCl3) δ 7.44 (d, J = 7.7 Hz, 6 H), 7.32-7.19 (m, 9 H), 5.89-5.77 (m, 1 H), 5.11-5.04 (m, 
2 H), 4.16-4.08 (m, 1 H), 4.04-3.98 (m, 1 H), 3.93-3.89 (m, 1 H), 3.02-2.96 (m, 1 H), 2.89-
2.69 (m, 4 H), 2.64-2.55 (m, 1 H), 2.30-2.03 (m, 6 H), 2.00-1.85 (m, 3 H), 1.66-1.59 (m, 1 
H), 1.47-1.39 (m, 1 H), 1.05 (d, J = 6.5 Hz, 3 H), 0.88 (s, 9 H), 0.12 (s, 3 H), 0.04 (s, 3 H); 
13C NMR (125 MHz, CDCl3) δ 144.5, 135.1, 128.9, 127.8, 126.9, 117.5, 86.4, 69.0, 68.6, 
67.6, 51.5, 45.4, 45.3, 44.0, 43.0, 31.2, 26.5, 26.4, 26.3, 25.1, 18.7, 18.2, 3.0, 4.0; HRMS 
(ES+) m/z (M+Na)+: Calcd for C40H56O3NaSiS2: 699.3338, found: 699.3328. 
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A solution of n-BuLi (2.5 M, 324 µL, 0.81 mmol) in hexanes was 
added to a solution of aldehyde 2.115b (108 mg, 0.759 mmol) in 2.5 mL THF at –78 oC 
and stirred for 1 h at this temperature. HMPA (132 µL, 0.759 mmol) was added dropwise 
and the resulting mixture was placed in –40 oC cold bath and stirred at this temperature for 
5 min to obtain a clear solution. The solution was then cooled to –78 oC and solid CuCN 
(34 mg, 0.38 mmol) was quickly added. The bright yellow suspension was stirred at –78 
oC for 45 min, then alkenyl iodide (E)-(4-iodobut-3-en-1-yl)benzene (130.6 mg, 0.506 
mmol) in 1 mL THF (dried over anhydrous Na2SO4) was added via syringe dropwise 
(followed with a 1.5 mL rinse with THF). The resulting yellow suspension was placed in 
+10 oC cold bath and stirred at this temperature for 20 h to give a dark, clear solution, 
which was slowly warmed to room temperature over 15 h. The above solution was then 
added a solution of TBAF (1.0 M in THF, 3.04 mL, 3.04 mmol) and stirred at room 
temperature for 2 h, followed by addition of saturated aqueous NH4Cl (5 mL) and deionized 
H2O (5 mL). The resulting mixture was extracted with Et2O (3 x 50 mL). The combined 
organic layers were washed with brine, dried with Na2SO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel (5% Et2O/hexanes) to 
afford the desired three-component adduct 2.140a as a colorless oil (107.2 mg, 0.415 mmol, 
82%): IR (film, cm–1) 3368, 3027, 2929, 2857, 1645, 1604, 1496, 1454, 1016, 971, 902, 
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743, 698; 1H NMR (500 MHz, CDCl3) δ 7.31-7.25 (m, 2 H), 7.21-7.16 (m, 3 H), 5.56-5.40 
(m, 2 H), 4.99 (s, 1 H), 4.78 (s, 1 H), 4.05 (bs, 1 H), 2.82-2.75 (m, 1 H), 2.73-2.63 (m, 3 
H), 2.39-2.32 (m, 2 H), 1.57-1.47 (m, 1 H), 1.39-1.21 (m, 5 H), 0.90 (t, J = 6.8 Hz, 3 H); 
13C NMR (125 MHz, CDCl3) δ 151.1, 142.1, 131.8, 128.6, 128.5, 128.4, 125.9, 110.7, 75.4, 
36.0, 35.2, 35.1, 34.4, 28.0, 22.8, 14.2; HRMS (ES+) m/z (M+Na)+: Calcd for C18H26ONa: 
281.1881, found: 281.1884. 
 
A solution of PhLi (1.7 M, 460 µL, 0.78 mmol) in dibutyl ether was 
added to a solution of aldehyde 2.115b (104 mg, 0.731 mmol) in 2.5 mL THF at –78 oC 
and stirred for 1 h at this temperature. HMPA (127 µL, 0.731 mmol) was added dropwise 
and the resulting mixture was placed in –40 oC cold bath and stirred at this temperature for 
5 min to obtain a clear solution. The solution was then cooled to –78 oC and solid CuCN 
(32.7 mg, 0.365 mmol) was quickly added. The bright yellow suspension was stirred at –
78 oC for 45 min, then (Z)-1-iodohept-1-ene (109.1 mg, 0.487 mmol) in 1 mL THF (dried 
over anhydrous Na2SO4) was added via syringe dropwise (followed with a 1.5 mL rinse 
with THF). The resulting yellow suspension was placed in +10 oC cold bath and stirred at 
this temperature for 20 h to give a dark, clear solution, which was slowly warmed to room 
temperature over 15 h. The above solution was then added a solution of TBAF (1.0 M in 
THF, 2.92 mL, 2.92 mmol) and stirred at room temperature for 2 h, followed by addition 
of saturated aqueous NH4Cl (5 mL) and deionized H2O (5 mL). The resulting mixture was 
extracted with Et2O (3 x 50 mL). The combined organic layers were washed with brine, 
dried with Na2SO4, and concentrated in vacuo. The crude product was purified by flash 
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chromatography on silica gel (5% Et2O/hexanes) to afford the desired three-component 
adduct 2.140b as a colorless oil (91.6 mg, 0.375 mmol, 77%): IR (film, cm–1) 3365, 3063, 
3010, 2956, 2927, 2856, 1648, 1493, 1453, 1247, 1189, 1025, 906, 840, 762, 700; 1H NMR 
(500 MHz, C6D6) δ 7.34 (d, J = 7.3 Hz, 2 H), 7.20-7.13 (m, 2 H), 7.11-7.05 (m, 1 H), 5.51-
5.42 (m, 2 H), 5.27 (s, 1 H), 5.04 (s, 1 H), 4.96 (d, J = 2.8 Hz, 1 H), 2.82-2.74 (m, 1 H), 
2.68-2.60 (m, 1 H), 1.91-1.83 (m, 2 H), 1.34 (d, J = 3.8 Hz, 1 H), 1.28-1.10 (m, 6 H), 0.85 
(t, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 150.6, 142.9, 132.0, 128.5, 127.7, 127.0, 
126.9, 110.8, 77.4, 31.8, 29.9, 29.6, 27.4, 22.9, 14.3; HRMS (CI+) m/z (M)+: Calcd for 
C17H24O: 244.1827, found: 244.1831. 
 
A solution of n-BuLi (2.5 M, 303 µL, 0.757 mmol) in hexanes 
was added to a solution of aldehyde 2.115b (101 mg, 0.71 mmol) in 2.5 mL THF at –78 oC 
and stirred for 1 h at this temperature. HMPA (124 µL, 0.71 mmol) was added dropwise 
and the resulting mixture was placed in –40 oC cold bath and stirred at this temperature for 
5 min to obtain a clear solution. The solution was then cooled to –78 oC and solid CuCN 
(31.8 mg, 0.355 mmol) was quickly added. The bright yellow suspension was stirred at –
78 oC for 45 min, then 4-iodobenzonitrile (108.3 mg, 0.473 mmol) in 1 mL THF was added 
via cannula (followed with a 1.5 mL rinse with THF). The resulting yellow suspension was 
placed in +10 oC cold bath and stirred at this temperature for 20 h to give a dark, clear 
solution, which was slowly warmed to room temperature over 15 h. The above solution 
was then added a solution of TBAF (1.0 M in THF, 2.8 mL, 2.8 mmol) and stirred at room 
temperature for 2 h, followed by addition of saturated aqueous NH4Cl (5 mL) and deionized 
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H2O (5 mL). The resulting mixture was extracted with Et2O (3 x 50 mL). The combined 
organic layers were washed with brine, dried with Na2SO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel (15% Et2O/hexanes) to 
afford the desired three-component adduct 2.140c as a pale yellow oil (87.9 mg, 0.383 
mmol, 81%): IR (film, cm–1) 3436, 3079, 2930, 2860, 2228, 1648, 1606, 1504, 1414, 1177, 
1116, 1019, 906, 857, 814; 1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 7.9 Hz, 2 H), 7.31 
(d, J = 7.9 Hz, 2 H), 5.15 (s, 1 H), 4.69 (s, 1 H), 4.08 (bs, 1 H), 3.51 (dA,B, J = 15.7 Hz, 1 
H), 3.38 (dA,B, J = 15.7 Hz, 1 H), 1.59-1.52 (m, 2 H), 1.48 (bs, 1 H), 1.41-1.22 (m, 4 H), 
0.89 (t, J = 6.9 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 150.3, 145.5, 132.3, 130.2, 119.2, 
113.3, 110.3, 75.0, 38.4, 35.3, 27.9, 22.7, 14.2; HRMS (ES-) m/z (MH)-: Calcd for 
C15H18NO: 228.1388, found: 228.1387. 
 
A solution of n-BuLi (2.5 M, 400 µL, 1.00 mmol) in hexanes 
was added to a solution of 4-phenyl-1-butyne (130.0 mg, 0.999 mmol) in 1.5 mL THF at –
78 oC and stirred for 1 h at this temperature. A solution of aldehyde 2.115b (133.3 mg, 
0.937 mmol) in 1.5 mL THF was cannulated dropwise into the above flask and the resulting 
solution was stirred at –78 oC. After 1 h, HMPA (163 µL, 0.937 mmol) was added dropwise 
and the resulting mixture was placed in –40 oC cold bath and stirred at this temperature for 
5 min to obtain a clear solution. The solution was then cooled to –78 oC and solid CuCN 
(42.0 mg, 0.469 mmol) was quickly added. The bright yellow suspension was stirred at –
78 oC for 45 min, then 4-iodomethylbenzoate (163.5 mg, 0.624 mmol) in 1.5 mL THF was 
added via cannula (followed with a 1.5 mL rinse with THF). The resulting yellow 
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suspension was placed in +10 oC cold bath and stirred at this temperature for 20 h to give 
a dark, clear solution, which was slowly warmed to room temperature over 15 h. The above 
solution was then added a solution of TBAF (1.0 M in THF, 3.7 mL, 3.7 mmol) and stirred 
at room temperature for 2 h, followed by addition of saturated aqueous NH4Cl (5 mL) and 
deionized H2O (5 mL). The resulting mixture was extracted with Et2O (3 x 50 mL). The 
combined organic layers were washed with brine, dried with Na2SO4, and concentrated in 
vacuo. The crude product was purified by flash chromatography on silica gel (10% 
EtOAc/hexanes) to afford the desired three-component adduct 2.140d as a pale yellow oil 
(146.1 mg, 0.437 mmol, 70%): IR (film, cm–1) 3439, 3057, 3021, 2946, 2922, 2845, 2214, 
1705, 1608, 1435, 1277, 1179, 1110, 1019, 912, 699; 1H NMR (500 MHz, CDCl3) δ 7.96 
(d, J = 8.1 Hz, 2 H), 7.33-7.19 (m, 7 H), 5.32 (s, 1 H), 4.80 (s, 1 H), 4.73 (d, J = 5.0 Hz, 1 
H), 3.91 (s, 3 H), 3.57-3.47 (m, 2 H), 2.82 (t, J = 7.5 Hz, 2 H), 2.53 (td, J = 7.4, 1.6 Hz, 2 
H), 1.86 (d, J = 5.9 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 167.2, 147.3, 144.7, 140.5, 
129.8, 129.4, 128.54, 128.53, 128.4, 126.5, 113.8, 86.7, 79.8, 65.2, 52.2, 38.6, 34.9, 20.9; 
(ES+) m/z (M+Na)+: Calcd for C22H22O3Na: 357.1467, found: 357.1467. 
2-6-b-3: Synthesis of mandelalide A northern hemisphere 
 
 
A solution of TBAF (1.0 M, 0.305 mL, 0.305 mmol) in THF was added to a stirred 
solution of compound 2.91 (55.9 mg, 0.122 mmol) in 2 mL THF at room temperature. 
After stirring at room temperature for 7 h, the solution was quenched with deionized H2O 
(10 mL). The resulting mixture was extracted with Et2O (2 x 30 mL). The combined organic 
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layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel (30% EtOAc/hexanes) to afford 
the desired alcohol 2.102 as a pale yellow oil (39.9 mg, 0.116 mmol, 95%): []20D 27.07(c 
1.04, CH2Cl2); IR (film, cm
–1) 3452, 3033, 2983, 2935, 2898, 1423, 1371, 1317, 1275, 
1244, 1214, 1155, 1063, 1002, 909, 849, 790, 755; 1H NMR (500 MHz, CDCl3) δ 6.37 (t, 
J = 11.4 Hz, 1 H), 6.09 (d, J = 11.7 Hz, 1 H), 5.41-5.33 (m, 1 H), 5.06-4.98 (m, 1 H), 4.15-
4.04 (m, 2 H), 4.03-3.95 (m, 1 H), 3.56-3.49 (m, 1 H), 2.89-2.76 (m, 4 H), 2.55-2.46 (m, 1 
H), 2.44-2.34 (m, 1 H), 2.15-2.02 (m, 3 H), 1.93-1.69 (m, 2 H), 1.79 (s, 3 H), 1.40 (s, 3 H), 
1.32 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 139.7, 125.7, 125.4, 122.1, 109.1, 75.5, 69.0, 
66.5, 43.9, 40.7, 31.7, 30.1, 30.0, 27.0, 26.0, 25.7, 18.3; HRMS (ES+) m/z (M+Na)+: Calcd 
for C17H28O3S2Na: 367.1378, found: 367.1371. 
 
 
 
 
A solution of TBAF (1.0 M, 1.23 mL, 1.23 mmol) in THF was added to a stirred 
solution of compound 2.105 (187.8 mg, 0.409 mmol) in 6 mL THF at room temperature. 
After stirring at room temperature for 3 h, the solution was quenched with deionized H2O 
(15 mL). The resulting mixture was extracted with Et2O (2 x 50 mL). The combined organic 
layers were washed with brine, dried with MgSO4, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel (30% EtOAc/hexanes) to afford 
the desired alcohol 2.110 as a pale yellow oil (136.7 mg, 0.397 mmol, 97%): []20D 12.86 
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(c 0.34, CH2Cl2); IR (film, cm
–1) 3745, 2979, 2934, 2901, 1424, 1370, 1214, 1155, 1059, 
961, 841, 668; 1H NMR (500 MHz, CDCl3) δ 6.43 (dd, J = 14.9, 11.3 Hz, 1 H), 5.87 (d, J 
= 11.1 Hz, 1 H), 5.58 (dt, J = 14.7, 7.2 Hz, 1 H), 5.03 (bs, 1 H), 4.17-4.10 (m, 2 H), 4.02 
(dd, J = 7.9, 5.9 Hz, 1 H), 3.59-3.54 (m, 1 H), 2.93-2.81 (m, 4 H), 2.49-2.41 (m, 1 H), 2.36-
2.28 (m, 1 H), 2.17-2.07 (m, 2 H), 1.95-1.80 (m, 2 H), 1.77 (s, 3 H), 1.41 (s, 3 H), 1.35 (s, 
3 H); 13C NMR (125 MHz, CDCl3) δ 137.3, 129.0, 127.8, 127.6, 109.1, 75.5, 69.1, 67.1, 
44.1, 40.8, 37.2, 30.2, 30.1, 27.1, 26.1, 25.8, 17.9; HRMS (ES+) m/z (M+Na)+: Calcd for 
C17H28O3S2Na: 367.1378, found: 367.1387. 
 
 
 
 
To a solution of alcohol 2.110 (39.7 mg, 0.115 mmol) in MeCN (4 mL) and deionized 
H2O (0.4 mL) was added MeI (108 µL, 1.73 mmol) and CaCO3 (173.2 mg, 1.73 mmol). 
After stirring at 65 oC for 6 h, the solution was then cooled to room temperature and filtered 
through a short pad of celite. The resulting mixture was extracted with Et2O (2 x 50 mL). 
The combined organic layers were washed with brine, dried with MgSO4, and concentrated 
in vacuo. The crude was then taken up in 2 mL MeOH and NaBH4 (21.8 mg, 0.576 mmol) 
was added at 0 oC. After stirring for 1 h at room temperature, the solution was quenched 
with deionized H2O (2 mL). The resulting mixture was extracted with Et2O (2 x 5 mL). 
The combined organic layers were washed with brine, dried with MgSO4, and concentrated 
in vacuo. The crude product was purified by flash chromatography on silica gel (50% 
EtOAc/hexanes) to afford diol 2.106 as a colorless oil (23.0 mg, 0.0897 mmol, 78%): []20D 
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36.47 (c 1.37, CH2Cl2); IR (film, cm–1) 3855, 2985, 2937, 2881, 1438, 1372, 1215, 1155, 
1059, 966, 848, 790; 1H NMR (500 MHz, CDCl3) δ 6.41 (dd, J = 14.9, 11.3 Hz, 1 H), 5.85 
(d, J = 11.1 Hz, 1 H), 5.56 (dt, J = 14.8, 7.4 Hz, 1 H), 4.93 (dd, J = 9.0, 4.3 Hz, 1 H), 4.16-
4.09 (m, 1 H), 4.00 (dd, J = 7.9, 5.9 Hz, 1 H), 3.85-3.75 (m, 2 H), 3.58-3.53 (m, 1 H), 2.57-
2.38 (m, 2 H), 2.35-2.27 (m, 1 H), 1.99-1.91 (m, 1 H), 1.78 (s, 3 H), 1.66-1.59 (m, 1 H), 
1.40 (s, 3 H), 1.34 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 138.3, 128.6, 127.9, 126.9, 
109.2, 75.6, 69.9, 69.0, 61.4, 37.2, 36.9, 27.0, 25.8, 18.2; HRMS (ES+) m/z (M+Na)+: 
Calcd for C14H24O4Na: 279.1572, found: 279.1561. 
 
 
 
To a solution of alcohol 2.118 (1.56 g, 4.53 mmol) in MeCN (150 mL) and deionized 
H2O (15 mL) was added MeI (4.20 mL, 67.9 mmol) and CaCO3 (6.80 g, 67.9 mmol). After 
stirring at 60 oC for 5 h, the solution was then cooled to room temperature and filtered 
through a short pad of celite. The resulting mixture was extracted with EtOAc (2 x 200 
mL). The combined organic layers were washed with brine, dried with MgSO4, and 
concentrated in vacuo. The crude was then taken up in 70 mL MeOH and NaBH4 (0.860 g, 
22.6 mmol) was added at 0 oC. After stirring for 30 min at room temperature, the solution 
was quenched with deionized H2O (50 mL). The resulting mixture was extracted with 
EtOAc (2 x 200 mL). The combined organic layers were washed with brine, dried with 
MgSO4, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel (50-100% EtOAc/hexanes) to afford diol 2.119 as a colorless 
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oil (1.06 g, 4.14 mmol, 91%): []20D 22.35 (c 0.25, CH2Cl2); IR (film, cm–1) 3399, 2984, 
2927, 2872, 1370, 1214, 1154, 1061, 973, 902; 1H NMR (500 MHz, CDCl3) δ 5.59-5.44 
(m, 2 H), 5.12 (s, 1 H), 4.90 (s, 1 H), 4.34 (dd, J = 7.6, 3.9 Hz, 1 H), 4.17-4.11 (m, 1 H), 
4.02 (dd, J = 7.9, 6.1 Hz, 1 H), 3.88-3.78 (m, 2 H), 3.61-3.55 (m, 1 H), 2.86-2.78 (m, 1 H), 
2.76-2.69 (m, 1 H), 2.53-2.32 (m, 3 H), 2.31-2.24 (m, 1 H), 1.88-1.75 (m, 2 H), 1.41 (s, 3 
H), 1.35 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 150.4, 130.9, 127.5, 110.9, 109.1, 75.6, 
74.8, 68.9, 61.6, 37.0, 36.9, 35.8, 27.0, 25.7; HRMS (ES+) m/z (M+Na)+: Calcd for 
C14H24O4Na: 279.1572, found: 279.1568. 
 
 
A solution of diol 2.119 (800 mg, 3.12 mmol) in 66 mL MeCN was added 46 mL pH 
6.5 phosphate buffer and stirred vigorously. To the mixture was added sequentially  
pyridine-N-oxide (593 mg in 8 ml MeCN, 6.24 mmol), citric acid monohydrate (492 mg in 
8 mL pH 6.5 phosphate buffer, 2.34 mmol), Cu(OTf)2 (1.13 g in 8 mL MeCN, 3.12 mmol) 
and solid K2OsO4.2H2O (230 mg, 0.624 mmol). The resulting mixture was stirred 
vigorously at room temperature for approximately 2 weeks, at which time 600 mL EtOAc 
was added and the organic layer was separated. The aqueous layer was extracted with 
EtOAc (2 x 300 mL). The combined organic layers were washed with brine, dried with 
Na2SO4, and concentrated in vacuo. The crude product was quickly purified by flash 
chromatography on neutral alumina (1% H2O/EtOAc) to recover starting material 2.119 
(88 mg, 0.34 mmol) and obtain desired product 2.120 as a colorless oil (663 mg, 2.43 mmol, 
78%, 88% b.r.s.m): []20D 68.87 (c 0.33, CH2Cl2); IR (film, cm–1) 3421, 2985, 2935, 2871, 
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1666, 1371, 1219, 1158, 1058, 881; 1H NMR (500 MHz, C6D6) δ 4.77 (s, 1 H), 4.60 (s, 1 
H), 4.37-4.28 (m, 2 H), 3.96-3.91 (m, 1 H), 3.69-3.42 (m, 5 H), 2.81 (bs, 1 H), 2.34-2.26 
(m, 1 H), 2.23-2.06 (m, 2 H), 1.76-1.68 (m, 1 H), 1.62-1.50 (m, 3 H), 1.43 (s, 3 H), 1.36 (s, 
3 H); 13C NMR (125 MHz, C6D6) δ 151.4, 108.7, 104.8, 82.1, 80.5, 74.0, 70.5, 70.2, 60.2, 
38.5, 37.8, 35.1, 27.4, 26.0; HRMS (ES+) m/z (M+Na)+: Calcd for C14H24O5Na: 295.1521, 
found: 295.1520. 
 
 
 
A solution of diol 2.120 (400 mg, 1.47 mmol) in 24 mL CH2Cl2 at –78 oC was added 
sequentially 2,6-lutidine (1.70 mL, 14.7 mmol) and TBSOTf (2.0 mL, 8.8 mmol) via 
syringe dropwise. The resulting mixture was warmed to 0 oC and stirred at this temperature 
for 4 h.  The solution was quenched with saturated aqueous NaHCO3 (20 mL). The 
resulting mixture was extracted with EtOAc (2 x 100 mL). The combined organic layers 
were washed with brine, dried with Na2SO4, and concentrated in vacuo. The crude product 
was purified by flash chromatography on silica gel (2-4% EtOAc/hexanes) to afford the 
desired product 2.120a as a colorless oil (721 mg, 1.44 mmol, 98%): []20D 63.04 (c 0.38, 
CH2Cl2); IR (film, cm
–1) 2982, 2956, 2929, 2857, 1472, 1369, 1252, 1101, 836, 777; 1H 
NMR (500 MHz, C6D6) δ 4.81 (bs, 1 H), 4.75 (bs, 1 H), 4.43-4.33 (m, 2 H), 4.10-4.04 (m, 
1 H), 3.92-3.83 (m, 3 H), 3.71 (dt, J = 9.90, 6.30 Hz, 1 H),3.41-3.35 (m, 1 H), 2.23-2.10 
(m, 2 H), 2.04-1.95 (m, 1 H), 1.86-1.77 (m, 1 H), 1.58-1.50 (m, 1 H), 1.44 (s, 3 H), 1.40-
1.33 (m, 1 H), 1.38 (s, 3 H), 1.06 (s, 9 H), 1.01 (s, 9 H), 0.25 (s, 6 H), 0.13 (s, 3 H), 0.12 
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(s, 3 H); 13C NMR (125 MHz, C6D6) δ 151.9, 109.0, 104.3, 82.1, 78.2, 72.6, 72.3, 70.1, 
60.5, 39.1, 37.6, 35.4, 27.5, 26.4, 26.2, 26.1, 18.60, 18.55, 3.8, 4.4, 5.05, 5.10; HRMS 
(ES+) m/z (M+Na)+: Calcd for C26H52O5NaSi2: 523.3251, found: 523.3263. 
 
 
 
To a 150 mL flask was added Wilkinson’s catalyst (76 mg, 0.082 mmol) under N2. A 
solution of alkene 2.120a (822 mg, 1.64 mmol) in toluene (70 mL, degassed by freeze-
pump-thaw) was added via cannula and the flask was purged with 10 cycles of H2 
gas/vacuum. A H2 balloon was attached and the resulting solution was stirred vigorously 
for 21 h at room temperature. The solution was then concentrated to obtain the crude as a 
mixture of diastereomers (d.r. = 6:1 by H-NMR). Purification by flash chromatography on 
silica gel (2-3% EtOAc/hexanes) afforded the desired product 2.121 as a colorless oil (685 
mg, 1.36 mmol, 83%): []20D 50.48 (c 0.27, CH2Cl2); IR (film, cm–1) 2953, 2928, 2856, 
1461, 1379, 1252, 1095, 836, 776; 1H NMR (500 MHz, CDCl3) δ 4.29-4.21 (m, 1 H), 4.04 
(dd, J = 7.7, 5.9 Hz, 1 H), 3.91-3.82 (m, 2 H), 3.81-3.75 (m, 1 H), 3.72-3.62 (m, 2 H), 3.51-
3.44 (m, 1 H), 2.32-2.20 (m, 1 H), 1.97 (dt, J = 12.4, 7.3 Hz, 1 H), 1.71-1.56 (m, 3 H), 
1.54-1.47 (m, 1 H), 1.39 (s, 3 H), 1.34 (s, 3 H), 1.24-1.18 (m, 1 H), 0.91 (d, J = 6.9 Hz, 3 
H), 0.89 (s, 9 H), 0.88 (s, 9 H), 0.09 (s, 6 H), 0.05 (s, 6 H); 13C NMR (125 MHz, CDCl3) 
δ 108.7, 81.8, 78.4, 72.8, 72.0, 70.2, 61.4, 37.2, 35.7, 35.5, 34.5, 27.3, 26.18, 26.15, 26.0, 
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18.5, 18.4, 15.8, 3.8, 4.6, 5.1, 5.2; HRMS (ES+) m/z (M+Na)+: Calcd for 
C26H54O5NaSi2: 525.3408, found: 525.3417. 
 
 
 
To a polyethylene bottle containing a solution of compound 2.121 (557 mg, 1.11 mmol) 
in 56 mL THF at 0 oC was added HF. pyridine (70%, 2.72 mL) via eppendorf pipette. After 
stirring for 4 h at 0 oC, the solution was quenched slowly with 130 mL saturated aqueous 
NaHCO3. The resulting mixture was then diluted with 50 mL EtOAc and stirred vigorously 
at room temperature for 15 min. The organic layer was separated and the aqueous layer 
was extracted with EtOAc (2 x 200 mL). The combined organic layers were washed with 
saturated aqueous CuSO4, brine, dried with Na2SO4, and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel (20% EtOAc/hexanes) to afford 
the desired product 2.121a as a colorless oil (414 mg, 1.065 mmol, 96%): []20D 46.72 (c 
0.52, CH2Cl2); IR (film, cm
–1) 3434, 2960, 2929, 2851, 1462, 1378, 1251, 1062, 837, 777; 
1H NMR (500 MHz, CDCl3) δ 4.26-4.19 (m, 1 H), 4.04 (dd, J = 7.6, 6.0 Hz, 1 H), 3.98 
(ddd, J = 10.5, 7.4, 2.6 Hz, 1 H), 3.95-3.90 (m, 1 H), 3.82-3.74 (m, 3 H), 3.51-3.46 (m, 1 
H), 2.53 (bs, 1 H), 2.33 (dt, J = 14.5, 7.2 Hz, 1 H), 1.99-1.91 (m, 1 H), 1.75-1.63 (m, 2 H), 
1.60-1.52 (m, 2 H), 1.39 (s, 3 H), 1.36-1.28 (m, 1 H), 1.33 (s, 3 H), 0.94 (d, J = 7.1 Hz, 3 
H), 0.89 (s, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 108.8, 82.2, 
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81.4, 72.7, 70.9, 70.1, 62.1, 37.4, 35.9, 35.1, 33.2, 27.2, 26.1, 25.9, 18.3, 15.5, 4.0, 4.5; 
HRMS (ES+) m/z (M+H)+: Calcd for C20H41O5Si: 389.2723, found: 389.2739. 
 
 
 
To a solution of alcohol 2.121a (336.7 mg, 0.866 mmol) in 30 mL CH2Cl2 at 0
 oC was 
added NaHCO3 (291.1 mg, 3.466 mmol) and Dess-Martin periodinane (735 mg, 1.73 
mmol). The resulting mixture was stirred at 0 oC for 5 min. The cold bath was then removed 
and the solution was stirred at room temperature for another 2 h. The solution was quenched 
with saturated aqueous NaHCO3 (30 mL) and saturated aqueous Na2S2O3 (30 mL). The 
resulting mixture was extracted with EtOAc (2 x 100 mL). The combined organic layers 
were washed with brine, dried with Na2SO4, and concentrated. The obtained crude was 
passed through a short pad of silica gel (wash with EtOAc), and concentrated in vacuo to 
afford the desired aldehyde, which was used directly in the next step. 
A solution of NaHMDS (1.0 M, 4.1 mL, 4.1 mmol) in THF was added dropwise to a 
solution of Ph3PCH2I2 (2.30 g, 4.33 mmol) in 10 mL THF at 0
 oC and the resulting solution 
was stirred at this temperature for another 15 min. The solution was then cooled to –78 oC 
and 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU, 0.87 mL, 7.2 mmol) 
was added via syringe dropwise. A solution of the above aldehyde in 5 mL THF was added 
via cannula dropwise and the resulting mixture was stirred at –78 oC for 2.5 h. The solution 
was then quenched with saturated aqueous NH4Cl (20 mL) and let warm to room 
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temperature over 45 min. The resulting mixture was extracted with EtOAc (3 x 100 mL). 
The combined organic layers were washed with brine, dried with Na2SO4, and concentrated 
in vacuo. The crude product was purified by flash chromatography on silica gel (3% 
EtOAc/hexanes) to afford the desired product 2.122 as a yellow oil (340.5 mg, 0.667 mmol, 
77% over 2 steps): []20D 40.89 (c 0.29, CH2Cl2); IR (film, cm–1) 2953, 2928, 2855, 1462, 
1369, 1252, 1092, 1065, 837, 777; 1H NMR (500 MHz, CDCl3) δ 6.35-6.29 (m, 1 H), 6.28-
6.24 (m, 1 H), 4.29-4.23 (m, 1 H), 4.04 (dd, J = 7.7, 5.9 Hz, 1 H), 3.96-3.86 (m, 2 H), 3.72 
(dt, J = 9.3, 6.4 Hz, 1 H), 3.53-3.47 (m, 1 H), 2.39-2.30 (m, 1 H), 2.27-2.20 (m, 2 H), 1.98 
(dt, J = 12.5, 7.0 Hz, 1 H), 1.71-1.65 (m, 1 H), 1.55-1.49 (m, 1 H), 1.40 (s, 3 H), 1.33-1.24 
(m, 1 H), 1.34 (s, 3 H), 0.98 (d, J = 7.1 Hz, 3 H), 0.88 (s, 9 H), 0.09 (bs, 6 H); 13C NMR 
(125 MHz, CDCl3) δ 139.1, 108.8, 83.5, 82.1, 80.1, 72.7, 71.8, 70.2, 37.2, 37.1, 35.8, 35.4, 
27.3, 26.2, 26.0, 18.4, 15.5, 3.8, 4.6; HRMS (ES+) m/z (M+Na)+: Calcd for 
C21H39O4NaSiI: 533.1560, found: 533.1570. 
 
 
 
To a solution of acetonide 2.122 (119.6 mg, 0.234 mmol) in a mixture of THF (2.6 mL) 
and MeCN (10.3 mL) was added solid CeCl3.7H2O (261.9 mg, 0.703 mmol) and a solution 
of oxalic acid dihydrate (1mg/mL in MeCN, 1.48 mL, 0.0117 mmol). The suspension was 
stirred vigorously at room temperature for 30 min, then quenched with saturated aqueous 
NaHCO3 (10 mL) and stirred for another 30 min. The resulting mixture was extracted with 
EtOAc (2 x 50 mL). The combined organic layers were washed with brine, dried with 
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Na2SO4, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel (20% EtOAc/hexanes) to afford diol 2.122a as a white solid 
(101 mg, 0.215 mmol, 92%): []20D 29.09 (c 0.20, CH2Cl2); IR (film, cm–1) 3398, 2959, 
2926, 2854, 1461, 1254, 1090, 837, 777; 1H NMR (500 MHz, CDCl3) δ 6.35-6.24 (m, 2 
H), 4.01-3.87 (m, 4 H), 3.64-3.57 (m, 2 H), 3.48-3.40 (m, 1 H), 2.42-2.33 (m, 1 H), 2.27-
2.22 (m, 2 H), 2.08-2.00 (m, 2 H), 1.81-1.72 (m, 1 H), 1.56-1.48 (m, 1 H), 1.29-1.23 (m, 1 
H), 0.99 (d, J = 6.9 Hz, 3 H), 0.90 (s, 9 H), 0.11 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 
138.9, 83.8, 81.3, 80.2, 73.9, 69.3, 67.4, 37.2, 36.3, 36.1, 35.8, 26.1, 18.3, 15.5, 4.1, 4.7; 
HRMS (ES+) m/z (M+H)+: Calcd for C18H36O4SiI: 471.1428, found: 471.1434. 
 
 
 
A solution of diol 2.122a (104.4 mg, 0.222 mmol) in 16 mL CH2Cl2 at 0
 oC was added 
sequentially a solution of imidazole (48 mg/mL in CH2Cl2, 1.63 mL, 1.15 mmol) and a 
solution of TBSCl (80 mg/mL in CH2Cl2, 1.63 mL,  0.865 mmol) via syringe dropwise. 
The resulting mixture was stirred at room temperature for 4.5 h.  The solution was 
quenched with saturated aqueous NH4Cl (25 mL). The resulting mixture was extracted with 
EtOAc (2 x 50 mL). The combined organic layers were washed with brine, dried with 
Na2SO4, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel (3% EtOAc/hexanes) to afford the northern hemisphere 2.19 
as a colorless oil (125 mg, 0.213 mmol, 96%): []20D 23.14 (c 0.58, CHCl3); IR (film, 
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cm–1) 3456, 2955, 2925, 2850, 1731, 1257, 1117, 837, 777, 668; 1H NMR (500 MHz, 
CDCl3) δ 6.35-6.30 (m, 1 H), 6.28-6.23 (m, 1 H), 3.96-3.89 (m, 2 H), 3.88-3.77 (m, 2 H), 
3.55-3.44 (m, 2 H), 2.96 (d, J = 2.8 Hz, 1 H), 2.39-2.30 (m, 1 H), 2.27-2.20 (m, 2 H), 2.05-
1.97 (m, 1 H), 1.60-1.50 (m, 2 H), 1.31-1.22 (m, 1 H), 0.98 (d, J = 6.9 Hz, 3 H), 0.90 (s, 9 
H), 0.89 (s, 9 H), 0.11 (s, 3 H), 0.10 (s, 3 H), 0.06 (bs, 6 H); 13C NMR (125 MHz, CDCl3) 
δ 139.1, 83.5, 81.9, 80.2, 73.0, 68.8, 67.8, 37.2, 36.7, 35.9, 35.8, 26.2, 26.1, 18.44, 18.41, 
15.5, 4.0, 4.7, 5.2; HRMS (ES+) m/z (M+H)+: Calcd for C24H50O4Si2I: 585.2292, found: 
585.2287. 
2-6-b-4: Synthesis of mandelalide A southern hemisphere 
 
 
 
 
A solution containing alcohol 2.92 (1.617 g, 2.39 mmol) and Et3N (1.032 mL, 7.41 
mmol) in 12.5 mL Et2O was added MsCl (0.555 mL, 7.17 mmol) at 0 °C. The resulting 
mixture was stirred at room temperature for 16 h, and monitored by TLC for complete 
consumption of 2.92. The reaction mixture was added TBAF (1.0 M in THF, 12.0 mL, 12.0 
mmol) and placed under reflux at 60 °C for 48 h. The reaction mixture was then cooled to 
room temperature and diluted with EtOAc and water. The organic layer was separated, 
washed with saturated aqueous NaHCO3, water and brine, dried over anhydrous Na2SO4, 
and filtered. The organic solvents were removed under reduced pressure to give crude 
material, which was purified by silica gel column chromatography (10-20% Et2O/hexanes) 
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to afford 2.128 as a colorless foam (0.812 g, 1.49 mmol, 62%): []20D 8.67 (c 1.05, 
CH2Cl2); IR (film, cm
–1) 3057, 2916, 1684, 1653, 1636, 1557, 1490, 1448, 1424, 1374, 
1339, 1266, 1220, 1152, 1070, 1002, 910, 742, 706; 1H NMR (500 MHz, CDCl3) δ 7.44 
(d, J = 7.5 Hz, 6 H), 7.32 –7.19 (m, 9 H), 5.85-5.74 (m, 1 H), 5.10-5.00 (m, 2 H), 3.80-3.66 
(m, 2 H), 3.02 (dd, J = 8.5, 5.4 Hz, 1 H), 2.90-2.82 (m, 3 H), 2.74-2.68 (m, 1 H), 2.30-2.08 
(m, 4 H), 2.07-1.97 (m, 3 H), 1.62-1.49 (m, 4 H), 1.27-1.19 (m, 1 H), 1.01 (d, J = 6.5 Hz, 
3 H); 13C NMR (125 MHz, CDCl3) δ 144.6, 134.7, 128.9, 127.8, 126.9, 117.0, 86.2, 72.3, 
70.6, 68.7, 48.3, 43.9, 42.9, 40.2, 39.9, 30.5, 26.1, 26.0, 17.5; HRMS (ES+) m/z (M+Na)+: 
Calcd for C34H40O2NaS2: 567.2367, found: 567.2372. 
 
 
 
 
A mixture of 2.128 (0.450 g, 0.826 mmol) in MeCN (10 mL) and water (3.4 mL) was 
added CaCO3 (372 mg, 3.71 mmol) and MeI (3.0 mL, 49 mmol) and stirred at room 
temperature over 2 days for complete consumption of 32 by TLC. The suspension was then 
diluted with Et2O and water. The aqueous layer was extracted with Et2O twice and the 
combined organic extracts were dried over anhydrous Na2SO4 and filtered. The filtrate was 
concentrated under reduced pressure to give material, which was purified by silica gel 
column chromatography (10-20% Et2O/hexanes) to afford ketone 2.129a (0.364 g, 0.80 
mmol, 97%) as a colorless oil: []20D 13.8 (c 1.0, CH2Cl2); IR (film, cm–1) 3057, 2916, 
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1719, 1642, 1596, 1491, 1449, 1359, 1329, 1221, 1154, 1067, 920, 764, 746, 707, 632; 1H 
NMR (500 MHz, CDCl3) δ 7.44 (d, J = 7.5 Hz, 6 H), 7.32 –7.20 (m, 9 H), 5.85-5.75 (m, 1 
H), 5.12-5.06 (m, 2 H), 3.61-3.51 (m, 2 H), 3.03-3.00 (m, 1 H), 2.96-2.93 (m, 1 H), 2.41-
2.16 (m, 6 H), 2.10-2.02 (m, 1 H), 1.79-1.70 (m, 1 H), 1.34-1.21 (m, 1 H), 0.99 (d, J = 6.5 
Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 207.6, 144.5, 133.7, 128.9, 127.8, 127.0, 117.8, 
86.3, 76.5, 75.0, 68.5, 48.5, 47.4, 40.6, 30.6, 17.4; HRMS (ES+) m/z (M+Na)+: Calcd for 
C31H34O3Na: 477.2406, found: 477.2391. 
 
 
 
 
A solution of 2.129a (0.325 g, 0.715 mmol) in 9 mL MeOH was cooled to –5 °C with 
an ice/brine bath. Solid NaBH4 (0.135 g, 3.57 mmol) was added and the reaction mixture 
was stirred at –5 °C for 40 min for complete consumption of 2.129a by TLC. The reaction 
was then quenched with 1.0 M aqueous HCl and diluted with saturated aqueous NH4Cl. 
The aqueous layer was extracted with ethyl acetate twice and the combined organic extracts 
were dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated under 
reduced pressure to give the crude material, which was purified by silica gel 
chromatography (10-25% EtOAc/hexanes) to afford the desired product 2.129 as a 
colorless oil (0.278 g, 0.609 mmol, 85%). The minor diastereomer was also obtained as a 
colorless oil (0.026 g, 0.077 mmol, 8%): []20D 6.02 (c 0.51, CH2Cl2); IR (film, cm–1) 
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3376, 2923, 2850, 1636, 1448, 1375, 1323, 1071, 706; 1H NMR (500 MHz, CDCl3) δ 7.44 
(d, J = 7.5 Hz, 6 H), 7.30 –7.21 (m, 9 H), 5.82-5.77 (m, 1 H), 5.07-5.01 (m, 2 H), 3.74-3.71 
(m, 1 H), 3.30-3.22 (m, 2 H), 3.03-3.00 (m, 1 H), 2.88 (dd, J = 8.5, 2.0 Hz, 1 H), 2.32-2.28 
(m, 1 H), 2.18-2.14 (m, 1 H), 2.03-1.99 (m, 1 H), 1.95-1.92 (m, 1 H), 1.88-1.84 (m, 1 H), 
1.65-1.59 (m, 1 H), 1.39 (d, J = 8.5, 5 Hz, 1 H), 1.27-1.22 (m, 1 H), 1.14-1.07 (m, 2 H), 
0.99 (d, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 144.6, 134.9, 128.9, 127.8, 126.9, 
116.8, 86.3, 75.2, 73.4, 68.7, 68.5, 41.9, 40.9, 40.6, 40.3, 30.6, 17.6; HRMS (ES+) m/z 
(M+Na)+: Calcd for C31H36O3Na: 479.2562, found: 479.2561. 
 
 
 
 
A solution of alcohol 2.129 (0.630 g, 1.38 mmol) in 6.5 mL DMF was added tert-BuOK 
(0.744 g, 6.90 mmol) at 0 °C. The resulting mixture was stirred at 0 ºC for 30 min, followed 
by addition of p-methoxybenzyl bromide (0.82 mL, 5.52 mmol). The obtained mixture was 
then allowed to warm to room temperature and stirred overnight at which point TLC 
analysis showed complete consumption of 2.129. The reaction was quenched with water. 
The aqueous layer was extracted with EtOAc. The organic extract was washed with water 
(twice), brine and dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated 
under reduced pressure. The residue was filtered through a pad of silica gel (20% 
Et2O/hexanes) and concentrated in vacuo to afford crude product, which was directly used 
in next step without further purification. 
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To a mixture of the above crude in 14 mL methanol was added pyridinium p-
toluenesulfonate (1.3 g, 5.2 mmol) at room temperature. The resulting mixture was stirred 
at room temperature overnight. The reaction was quenched with saturated aqueous 
NaHCO3 and diluted with water. The aqueous layer was extracted with EtOAc twice. The 
combined organic extracts were washed with saturated aqueous NaHCO3 and brine, dried 
over anhydrous Na2SO4 and filtered. The filtrate was concentrated under reduced pressure 
to give the crude material, which was purified by silica gel chromatography (25-30% 
EtOAc/hexanes) to afford primary alcohol 2.130a as a colorless oil (0.380 g, 1.14 mmol, 
83%): []20D 9.11 (c 0.51, CH2Cl2); IR (film, cm–1) 3415, 2919, 2850, 1613, 1513, 1248, 
1173, 1073, 1037, 916, 822; 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.5 Hz, 2 H), 6.89 
(d, J = 8.5 Hz, 2 H), 5.84-5.76 (m, 1 H), 5.11-5.06 (m, 2 H), 4.49 (s, 2 H), 3.82 (s, 3 H), 
3.58-3.52 (m, 2 H), 3.41-3.35 (m, 3 H), 2.39-2.34 (m, 1 H), 2.28-2.22 (m, 1 H), 2.07-2.04 
(m, 1 H), 2.00-1.97 (m, 1 H), 1.86-1.80 (m, 1 H), 1.63-1.57 (m, 1 H), 1.43-1.38 (m, 1 H), 
1.30-1.18 (m, 2 H), 0.91 (d, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 159.3, 134.3, 
130.7, 129.3, 117.7, 114.0, 75.6, 75.5, 74.3, 69.4, 68.5, 55.4, 41.7, 40.6, 39.1, 37.5, 34.9, 
18.4; HRMS (ES+) m/z (M+H)+: Calcd for C20H31O4: 335.2222, found: 335.2221. 
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Hoveyda-Grubbs 2nd gen. catalyst (40 mg, 0.064 mmol) was added to a solution of 
2.130a (0.268 g, 0.801 mmol) and methyl acrylate (0.433 mL, 4.8 mmol) in 12 mL CH2Cl2. 
The mixture was stirred for 18 h at room temperature. The resulting mixture was then 
concentrated to obtain the crude (E/Z > 20:1 based on 1H NMR integration), which was 
purified by silica gel chromatography (20-50% EtOAc/hexanes) to afford the desired single 
isomer 2.130 as a colorless oil (0.284 g, 0.727 mmol, 91%): []20D 5.96 (c 0.65, CH2Cl2); 
IR (film, cm–1) 3448, 2918, 1719, 1658, 1613, 1586, 1614, 1438, 1247, 1071, 823; 1H 
NMR (500 MHz, CDCl3) δ 7.25 (d, J = 9.0 Hz, 2 H), 6.98-6.91 (m, J = 1 H), 6.89 (d, J = 
9.0 Hz, 2 H), 5.90 (d, J = 15.5 Hz, 1 H), 4.49 (s, 2 H), 3.82 (s, 3 H), 3.75 (s, 3 H), 3.57-
3.37 (m, 5 H), 2.51-2.46 (m, 1 H), 2.42-2.36 (m, 1 H), 2.05-1.97 (m, 2 H), 1.86-1.80 (m, 1 
H), 1.64-1.58 (m, 1 H), 1.38-1.35 (m, 1 H), 1.30-1.21 (m, 2 H), 0.92 (d, J = 7.0 Hz, 3 H); 
13C NMR (125 MHz, CDCl3) δ 166.9, 159.3, 144.7, 130.6, 129.3, 123.5, 114.0, 75.2, 74.5, 
74.1, 69.5, 68.4, 55.4, 51.6, 41.0, 38.9, 38.7, 37.5, 34.2, 18.0; HRMS (ES+) m/z (M+Na)+: 
Calcd for C22H32O6Na: 415.2097, found: 415.2097. 
 
 
 
 
 
To a solution of alcohol 2.130 (276 mg, 0.703 mmol) in 13 mL CH2Cl2 at 0
 oC was 
added NaHCO3 (354.5 mg, 4.22 mmol) and Dess-Martin periodinane (894.8 mg, 2.11 
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mmol). The resulting mixture was stirred at 0 oC for 5 min. The cold bath was then removed 
and the solution was stirred at room temperature for another 3 h. The solution was quenched 
with saturated aqueous NaHCO3 (15 mL) and saturated aqueous Na2S2O3 (25 mL). The 
resulting mixture was extracted with EtOAc (2 x 100 mL). The combined organic layers 
were washed with brine, dried with Na2SO4, and concentrated. The obtained crude was 
passed through a short pad of silica gel (wash with EtOAc), and concentrated in vacuo to 
afford the desired aldehyde, which was used directly in the next step. 
A solution of NaHMDS (1.0 M, 0.91 mL, 0.91 mmol) in THF was added dropwise to 
a solution of sulfone 2.132 (236.4 mg, 1.055 mmol) in 6.5 mL THF at –78 oC and the 
resulting solution was stirred at this temperature for another 30 min. A solution of the above 
aldehyde in 12 mL THF was added via cannula dropwise and the resulting mixture was 
slowly warmed up to room temperature over 20 h. The solution was then quenched with 
deionized H2O (20 mL) and the resulting mixture was extracted with EtOAc (3 x 50 mL). 
The combined organic layers were washed with brine, dried with Na2SO4, and concentrated 
in vacuo. The crude product was purified by flash chromatography on silica gel (5% 
EtOAc/hexanes) to afford the desired product 2.133 as a colorless oil (245.9 mg, 0.633 
mmol, 90% over 2 steps): []20D 7.86 (c 0.73, CH2Cl2); IR (film, cm–1) 3073, 2999, 2919, 
2851, 1722, 1658, 1612, 1586, 1513, 1437, 1355, 1248, 1173, 1074, 1037, 912, 822, 762; 
1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2 H), 7.01-6.93 (m, 1 H), 6.88 (d, J = 
8.3 Hz, 2 H), 5.87 (d, J = 15.7 Hz, 1 H), 5.73 (ddd, J = 17.3, 10, 7.5 Hz, 1 H), 4.99-4.87 
(m, 2 H), 4.48 (s, 2 H), 3.80 (s, 3 H), 3.73 (s, 3 H), 3.56-3.47 (m, 1 H), 3.40-3.26 (m, 2 H), 
2.50-2.62 (m, 1 H), 2.38-2.29 (m, 2 H), 2.06-1.97 (m, 2 H), 1.66 (dt, J = 14.0, 7.3 Hz, 1 H), 
1.37-1.29 (m, 1 H), 1.28-1.13 (m, 2 H), 0.99 (d, J = 6.5 Hz, 3 H); 13C NMR (125 MHz, 
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CDCl3) δ 167.0, 159.3, 145.6, 144.6, 130.7, 129.3, 123.0, 114.0, 112.5, 74.4, 74.3, 73.8, 
69.4, 55.4, 51.6, 42.7, 39.0, 38.1, 38.0, 34.2, 20.0; HRMS (ES+) m/z (M+Na)+: Calcd for 
C23H32O5Na: 411.2147, found: 411.2150. 
 
 
 
 
To a solution of methyl ester 2.133 (208 mg, 0.535 mmol) in 16.1 mL THF was added 
aqueous LiOH solution (1.0 M, 5.4 mL) dropwise and the resulting mixture was stirred at 
room temperature for 34 h. The reaction mixture was then diluted with deionized H2O (50 
mL) and EtOAc (50 mL), cooled to 0 oC, followed by dropwise addition of aqueous HCl 
solution (1.0 M, 5.4 mL) to give an acidic solution (pH ~ 2 with pH paper). The resulting 
mixture was extracted with EtOAc (3 x 100 mL). The combined organic layers were 
washed with brine, dried with Na2SO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel (20% EtOAc/hexanes) to afford the desired 
product 2.90 as a colorless oil (186.5 mg, 0.498 mmol, 93%): []20D 6.36 (c 0.27, CH2Cl2); 
IR (film, cm–1) 3069, 2920, 2853, 1696, 1654, 1612, 1513, 1420, 1357, 1248, 1173, 1073, 
913, 821; 1H NMR (500 MHz, CDCl3) δ 11.50-10.50 (bs, 1 H), 7.25 (d, J = 8.5 Hz, 2 H), 
7.13-7.03 (m, 1 H), 6.88 (d, J = 8.5 Hz, 2 H), 5.88 (d, J = 15.7 Hz, 1 H), 5.73 (ddd, J = 
17.3, 10.1, 7.5 Hz, 1 H), 4.99-4.88 (m, 2 H), 4.49 (s, 2 H), 3.8 (s, 3 H), 3.57-3.49 (m, 1 H), 
3.42-3.34 (m, 1 H), 3.34-3.27 (m, 1 H), 2.53-2.45 (m, 1 H), 2.41-2.29 (m, 2 H), 2.06-1.98 
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(m, 2 H), 1.70-1.63 (m, 1 H), 1.37-1.29 (m, 1 H), 1.28-1.12 (m, 2 H), 0.99 (d, J = 6.7 Hz, 
3 H); 13C NMR (125 MHz, CDCl3) δ 170.8, 159.3, 148.3, 144.6, 130.7, 129.3, 122.5, 114.0, 
112.6, 74.3, 74.1, 73.8, 69.5, 55.5, 42.7, 39.0, 38.12, 38.09, 34.2, 20.0; HRMS (ES+) m/z 
(M+Na)+: Calcd for C22H30O5Na: 397.1991, found: 397.1993. 
2-6-b-5: Fragment union 
 
 
 
 
 
 
 
A solution of carboxylic acid 2.90 (31.0 mg, 0.0827 mmol) in 0.56 mL toluene was 
added a solution of Et3N (13% v/v in toluene, 0.800 mL, 0.744 mmol) and a solution of 
2,4,6-trichlorobenzoylchloride (4.6% v/v in toluene, 0.560 mL, 0.165 mmol) via syringe 
dropwise. The solution was stirred at room temperature for 5 h, at which time a solution of 
alcohol 2.19 (32.2 mg, 0.0551 mmol) in 2 mL toluene was added via cannula. A solution 
of DMAP (20.2 mg, 0.165 mmol) in 0.56 mL toluene was added and the resulting mixture 
was stirred for 27 h at room temperature. The solution was then quenched with saturated 
aqueous NH4Cl (5 mL) and the resulting mixture was extracted with EtOAc (3 x 20 mL). 
The combined organic layers were washed with brine, dried with Na2SO4, and concentrated 
in vacuo. The crude product was purified by flash chromatography on silica gel (5% 
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EtOAc/hexanes) to afford the desired product 2.134 as a colorless oil (44.1 mg, 0.0468 
mmol, 85%): []20D 26.97 (c 0.35, CH2Cl2); IR (film, cm–1) 2955, 2926, 2855, 1717, 1655, 
1614, 1559, 1539, 1511, 1459, 1363, 1250, 1173, 1090, 837, 776; 1H NMR (500 MHz, 
CDCl3) δ 7.25 (d, J = 8.5 Hz, 2 H), 6.99-6.91 (m, 1 H), 6.88 (d, J = 8.5 Hz, 2 H), 6.35-6.29 
(m, 1 H), 6.27-6.23 (m, 1 H), 5.88 (d, J = 15.7 Hz, 1 H), 5.71 (ddd, J = 17.3, 10.1, 7.5 Hz, 
1 H), 5.05-4.99 (m, 1 H), 4.98-4.89 (m, 2 H), 4.52-4.45 (m, 2 H), 3.95-3.89 (m, 1 H), 3.80 
(s, 3 H), 3.79-3.74 (m, 2 H), 3.71-3.66 (m, 2 H), 3.56-3.49 (m, 1 H), 3.41-3.27 (m, 2 H), 
2.51-2.43 (m, 1 H), 2.38-2.29 (m, 3 H), 2.27-2.21 (m, 1 H), 2.06-1.97 (m, 3 H), 1.88-1.81 
(m, 1 H), 1.71-1.62 (m, 2 H), 1.37-1.13 (m, 5 H), 1.01-0.97 (m, 6 H), 0.87 (bs, 18 H), 0.05-
0.01 (m, 12 H); 13C NMR (125 MHz, CDCl3) δ 166.1, 159.3, 145.3, 144.6, 139.1, 130.8, 
129.3, 123.6, 114.0, 112.6, 83.5, 81.8, 80.2, 74.4, 74.3, 73.8, 72.0, 71.2, 69.4, 64.7, 55.4, 
42.7, 39.0, 38.1, 38.0, 37.1, 35.7, 35.3, 34.4, 34.1, 26.2, 26.0, 20.0, 18.39, 18.35, 15.5, 3.8, 
4.8, 5.2; HRMS (ES+) m/z (M+H)+: Calcd for C46H78O8Si2I: 941.4280, found: 941.4301. 
 
 
 
 
 
 
A solution of 2.134 (27.4 mg, 0.0291 mmol) in 0.7 mL CH2Cl2 and 0.156 mL pH 7 
phosphate buffer (0.5 M) was added a solution of DDQ (recrystallized over CHCl3, 19.8 
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mg, 0.0873 mmol) in 1.5 mL CH2Cl2 dropwise at 0 
oC. After stirring at 0 oC for 2.5 h, the 
mixture was then quenched with pH 7 phosphate buffer (5 mL) and the resulting mixture 
was extracted with CH2Cl2 (3 x 30 mL). The combined organic layers were washed with 
brine, dried with Na2SO4, and concentrated in vacuo. The crude product was purified by 
flash chromatography on silica gel (10% EtOAc/hexanes) to afford the desired product 
2.137 as a colorless oil (22.7 mg, 0.0276mmol, 95%): []20D 30.53 (c 0.40, CH2Cl2); IR 
(film, cm–1) 3424, 3075, 2951, 2928, 2856, 1719, 1655, 1462, 1362, 1255, 1177, 1102, 
1006, 911, 837, 777, 668; 1H NMR (500 MHz, CDCl3) δ 6.99-6.91 (m, 1 H), 6.36-6.30 (m, 
1 H), 6.29-6.24 (m, 1 H), 5.88 (d, J = 15.7 Hz, 1 H), 5.71 (ddd, J = 17.3, 10.0, 7.5 Hz, 1 
H), 5.05-4.98 (m, 1 H), 4.98-4.90 (m, 2 H), 3.95-3.89 (m, 1 H), 3.82-3.74 (m, 3 H), 3.71-
3.66 (m, 2 H), 3.43-3.29 (m, 2 H), 2.50-2.43 (m, 1 H), 2.38-2.29 (m, 3 H), 2.27-2.21 (m, 1 
H), 2.04-1.90 (m, 3 H), 1.88-1.80 (m, 1 H), 1.70-1.63 (m, 2 H), 1.46 (bs, 1 H), 1.38-1.26 
(m, 2 H), 1.21-1.07 (m, 2 H), 1.02-0.96 (m, 6 H), 0.94-0.85 (m, 1 H), 0.87 (s, 9 H), 0.86 (s, 
9 H), 0.06-0.00 (m, 12 H); 13C NMR (125 MHz, CDCl3) δ 166.1, 145.2, 144.5, 139.1, 
123.7, 112.7, 83.6, 81.8, 80.1, 74.2, 73.7, 72.0, 71.2, 68.3, 64.6, 42.6, 41.1, 41.0, 38.8, 37.1, 
35.7, 35.3, 34.4, 34.1, 26.2, 26.0, 20.1, 18.39. 18.35, 15.5, 3.8, 4.7, 5.2; HRMS (ES+) 
m/z (M+H)+: Calcd for C38H70O7Si2I: 821.3705, found: 821.3697. 
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A flask containing activated 4A MS powder (380 mg) was added sugar donor 2.12 
(90.1 mg, 0.175 mmol) in 1.2 mL Et2O and 2,6-di-t-butyl-4-methylpyridine (77.0 mg, 
0.375 mmol) in 0.56 mL Et2O and the resulting mixture was stirred at room temperature 
for 1 h. The flask was the cooled to –78 oC and a solution of Tf2O (25.2 µL, 0.15 mmol) in 
0.3 mL Et2O was added dropwise and the mixture was stirred at –78 oC for 20 min. A 
solution of alcohol 2.137 (20.4 mg, 0.0248 mmol) in 2.4 mL Et2O was added via cannula 
dropwise. The resulting mixture was stirred at –78 oC for 1 h, then at –40 oC for 2 h and at 
–35 oC for 1 h. The flask was then cooled to –78 oC and the reaction was quenched with 
deionized H2O (7 mL), diluted with EtOAc (10 mL) and allowed to warm to room 
temperature. The reaction mixture was filtered, extracted with EtOAc (3 x 20 mL). The 
combined organic layers were washed with brine, dried with Na2SO4, and concentrated in 
vacuo. The crude product was purified by flash chromatography on silica gel (3-5% 
EtOAc/hexanes) to afford the desired product 2.138 as a colorless oil (26.1 mg, 0.0216 
mmol, 87%): []20D 46.92 (c 0.40, CH2Cl2); IR (film, cm–1) 2954, 2928, 2856, 1720, 1656, 
1471, 1362, 1255, 1097, 1049, 1005, 837, 776, 668; 1H NMR (500 MHz, CDCl3) δ 7.00-
6.91 (m, 1 H), 6.35-6.30 (m, 1 H), 6.29-6.23 (m, 1 H), 5.88 (d, J = 15.7 Hz, 1 H), 5.76-5.67 
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(m, 1 H), 5.05-4.98 (m, 1 H), 4.99-4.89 (m, 2 H), 4.88 (d, J = 2.2 Hz, 1 H), 3.95-3.90 (m, 
1 H), 3.87-3.84 (m, 1 H), 3.80-3.66 (m 5 H), 3.60-3.52 (m, 2 H), 3.45 (s, 3 H), 3.42-3.30 
(m, 3 H), 2.50-2.42 (m, 1 H), 2.38-2.31 (m, 3 H), 2.26-2.22 (m, 1 H), 2.05-1.91 (m, 3 H), 
1.88-1.81 (m, 1 H), 1.71-1.61 (m, 2 H), 1.36-1.11 (m, 8 H), 1.02-0.96 (m, 6 H), 0.92 (s, 9 
H), 0.89 (s, 9 H), 0.87 (s, 9 H), 0.86 (s, 9 H), 0.12-0.00 (m, 24 H); 13C NMR (125 MHz, 
CDCl3) δ 166.1, 145.2, 144.6, 139.1, 123.6, 112.6, 83.6, 81.8, 80.1, 74.2, 73.7, 73.5, 73.4, 
72.0, 71.2, 70.5, 64.6, 58.9, 42.7, 39.3, 39.0, 37.6, 37.1, 35.7, 35.3, 34.4, 34.0, 26.5, 26.3, 
26.2, 26.0, 20.0, 18.8, 18.5, 18.4, 18.3, 18.2, 15.5, 3.6, 3.8, 3.99, 4.04, 4.8, 5.2; 
HRMS (ES+) m/z (M+Na)+: Calcd for C57H109O11NaSi4I: 1231.5990, found: 1231.6014. 
 
 
 
 
 
 
 
 
To a solution of compound 2.138 (25.0 mg, 0.0207 mmol) in 3 mL anhydrous DMF 
(degassed via freeze-pump-thaw) was added a solid mixture of Pd(OAc)2 (8.4 mg, 0.037 
mmol) and Cs2CO3 (13.5 mg, 0.0414 mmol), followed by a solution of Et3N (4.3 µL, 0.031 
mmol) in 0.43 mL DMF. The resulting solution was stirred at room temperature for 2 days. 
The reaction was quenched with deionized H2O (10 mL), extracted with EtOAc (3 x 20 
mL). The combined organic layers were washed with brine, dried with Na2SO4, and 
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concentrated in vacuo. The crude product was purified by flash chromatography on silica 
gel (3-4% EtOAc/hexanes) to afford the desired product 2.138a as a colorless oil (17.9 mg, 
0.0165 mmol, 80%): []20D 13.44 (c 0.03, CH2Cl2); IR (film, cm–1) 2952, 2928, 2892, 
2856, 1720, 1653, 1471, 1389, 1359, 1254, 1126, 1096, 1047, 863, 838, 777, 668; 1H NMR 
(500 MHz, CDCl3) δ 6.97-6.89 (m, 1 H), 6.28 (dd, J = 14.9, 11.1 Hz, 1 H), 6.05-5.94 (m, 
2 H), 5.46 (dd, J = 14.9, 8.9 Hz, 1 H), 5.28 (td, J =10.7, 4.8 Hz, 1 H), 5.07-5.01 (m, 1 H), 
4.89 (d, J = 2.4 Hz, 1 H), 4.02-3.96 (m, 1 H), 3.88-3.84 (m, 1 H), 3.83-3.72 (m, 2 H), 3.66-
3.29 (m, 11 H), 2.50-2.30 (m, 5 H), 2.05-1.98 (m, 1 H), 1.98-1.88 (m, 3 H), 1.73-1.56 (m, 
3 H), 1.31-1.19 (m, 7 H), 1.02 (d, J = 6.7 Hz, 3 H), 0.94-0.91 (m, 12 H), 0.89 (s, 9 H), 0.87 
(s, 9 H), 0.85 (s, 9 H), 0.10 (s, 9 H), 0.08 (s, 3 H), 0.01 (s, 3 H), 0.01 (s, 6 H), 0.05 (s, 3 
H); 13C NMR (125 MHz, CDCl3) δ 166.1, 145.8, 140.5, 130.2, 128.1, 125.1, 123.7, 83.3, 
81.3, 73.9, 73.7, 73.34, 73.30, 72.8, 71.6, 70.6, 64.7, 58.9, 43.6, 39.7, 39.4, 38.1, 36.7, 36.5, 
36.0, 33.5, 31.4, 29.9, 26.4, 26.2, 26.0, 18.9, 18.8, 18.5, 18.4, 18.3, 18.2, 14.7, 3.7, 4.0, 
4.1, 5.0, 5.27, 5.32; HRMS (ES+) m/z (M+H)+: Calcd for C57H109O11Si4: 1081.7047, 
found: 1081.7057. 
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To a solution of 2.138a (7.0 mg, 0.0065 mmol) in 0.9 mL THF in a polypropylene tube 
at 0 oC was added 0.9 mL pyridine and 0.9 mL HF.Pyridine complex (70% HF) dropwise 
via Eppendorf pipette. The resulting solution was stirred at 0 oC for 5 min. The cold bath 
was then removed and the resulting solution was stirred at room temperature for another 
29 h. The reaction was then quenched with 20 mL sat. aq. NaHCO3 solution slowly and 
stirred at room temperature for 30 min. The organic phase was extracted with CH2Cl2 (3 x 
30 mL). The combined organic layers were dried with Na2SO4, and concentrated in vacuo. 
The crude product was purified by flash chromatography on silica gel (4% MeOH/CH2Cl2) 
to afford the natural product 2.5 as colorless amorphous solid (3.8 mg, 0.0061 mmol, 94%) 
which displayed spectral properties identical in all respects to those reported for the natural 
product: []20D 53.92 (c 0.25, MeOH); IR (film, cm–1) 3433, 2961, 2920, 2852, 1717, 
1656, 1461, 1374, 1315, 1222, 1180, 1105, 1043, 731, 604; 1H NMR (600 MHz, CDCl3, 
residual solvent peak set at δ 6.24 ppm) δ 6.97 (ddd, J = 15.1, 10.4, 4.6 Hz, 1 H), 6.28 (dd, 
J = 14.3, 11.4 Hz, 1 H), 6.05 (t, J = 10.8 Hz, 1 H), 6.01 (d, J = 15.4 Hz, 1 H), 5.45 (dd, J = 
14.7, 10.3 Hz, 1 H), 5.28 (td, J = 10.5, 5.7 Hz, 1 H), 5.25-5.20 (m, 1 H), 5.02 (s, 1 H), 4.0-
3.95 (m, 1 H), 3.85-3.78 (m, 2 H), 3.71-3.65 (m, 1 H), 3.66-3.59 (m, 3 H), 3.46 (s, 3 H), 
3.44-3.29 (m, 5 H), 2.63-2.57 (m, 1 H), 2.57-2.49 (m, 1 H), 2.43-2.19 (m, 7 H), 2.05-1.99 
(m, 2 H), 1.91-1.85 (m, 2 H), 1.76 (t, J = 12.7 Hz, 1 H), 1.63-1.43 (m, 2 H), 1.26 (d, J = 
6.2 Hz, 3 H), 1.25-1.15 (m, 4 H), 1.02 (d, J = 7.0 Hz, 3 H), 0.85 (d, J = 6.6 Hz, 3 H); 13C 
NMR (125 MHz, CDCl3, residual solvent peak set at δ 77.23 ppm) δ 167.4, 147.1, 141.5, 
131.3, 126.9, 123.9, 123.1, 94.2, 83.2, 81.0, 80.8, 74.2, 73.9, 73.1, 73.0, 72.5, 72.3, 71.7, 
68.2, 66.1, 59.1, 43.1, 39.7, 38.8, 37.6, 37.4, 36.8, 34.2, 34.1, 31.1, 18.3, 17.7, 14.5; HRMS 
(ES+) m/z (M+Na)+: Calcd for C33H52O11Na: 647.3407, found: 647.3411. 
193 
 
APPENDIX I 
Spectral Data of New Compounds 
1H-NMR, 13C-NMR and IR 
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APPENDIX II 
X-Ray Data 
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AII-1: X-ray Structure Determination of Compound 1.22 
 
 
Compound 1.22, C15H16SiO, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=11.4541(6)Å, b=7.2648(3)Å, c=16.2468(7)Å, 
=98.293(2)°, V=1337.79(11)Å3, Z=4, and dcalc=1.193 g/cm3 . X-ray intensity data were collected 
on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 1387 frames were collected 
with a crystal to detector distance of 37.600 mm, rotation widths of 0.5° and exposures of 10 
seconds:  
scan type     frames 
 -15.50 258.48 -351.72 19.46 739 
 -15.50 -19.20 -18.89 -63.64 99 
 19.50 59.55 -11.29 -26.26 443 
 9.50 =40.98 -60.64 88.14 106 
Rotation frames were integrated using SAINT, producing a listing of unaveraged F2 and (F2) 
values which were then passed to the SHELXTL program package for further processing and 
OSi
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structure solution. A total of 16354 reflections were measured over the ranges 2.53  25.18°, -
13  h  13, -8  k  8, -18  l  19 yielding 2393 unique reflections (Rint = 0.0218). The intensity 
data were corrected for Lorentz and polarization effects and for absorption using SADABS 
(minimum and maximum transmission 0.6908, 0.7452). 
The structure was solved by direct methods (SHELXS-97). Refinement was by full-matrix 
least squares based on F2 using SHELXL-97. All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ (0.0428P)2 + 0.6032P] where P = (Fo 2 + 2Fc2)/3. Non-
hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0314 and wR2=0.0838 for 2187 observed reflections for which F > 
4(F) and R1=0.0345 and wR2=0.0864 and GOF =1.056 for all 2393 unique, non-zero reflections 
and 157 variables. The maximum  in the final cycle of least squares was 0.002 and the two most 
prominent peaks in the final difference Fourier were +0.280 and -0.294 e/Å3. 
Table 1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  Anisotropic 
thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and bond angles.  Figure 
1. is an ORTEP representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
Figure 1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 1. Summary of Structure Determination of Compound 1.22 
Empirical formula  C15H16SiO 
Formula weight  240.37 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/c      
Cell constants:   
a  11.4541(6) Å 
b  7.2648(3) Å 
c  16.2468(7) Å 
 98.293(2)° 
Volume 1337.79(11) Å3 
Z 4 
Density (calculated) 1.193 Mg/m3 
Absorption coefficient 0.157 mm-1 
F(000) 512 
Crystal size 0.48 x 0.24 x 0.08 mm3 
Theta range for data collection 2.53 to 25.18° 
Index ranges -13  h  13, -8  k  8, -18  l  19 
Reflections collected 16354 
Independent reflections 2393 [R(int) = 0.0218] 
Completeness to theta = 25.18° 99.5 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6908 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2393 / 0 / 157 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0314, wR2 = 0.0838 
R indices (all data) R1 = 0.0345, wR2 = 0.0864 
Largest diff. peak and hole 0.280 and -0.294 e.Å-3 
Table 2. Refined Positional Parameters for Compound 1.22 
  Atom x y z Ueq, Å2 
C1 0.21662(12) 0.80355(19) 0.57188(9) 0.0260(3) 
C2 0.16266(13) 0.8933(2) 0.50037(9) 0.0325(3) 
C3 0.22224(13) 1.0283(2) 0.46345(9) 0.0348(3) 
C4 0.33539(13) 1.0800(2) 0.49849(9) 0.0311(3) 
C5 0.39033(12) 0.99327(18) 0.56955(8) 0.0257(3) 
C6 0.33182(11) 0.85309(17) 0.60519(8) 0.0222(3) 
C7 0.38651(11) 0.74452(18) 0.68121(8) 0.0226(3) 
C8 0.49986(11) 0.64896(17) 0.66751(8) 0.0206(3) 
C9 0.60741(12) 0.71099(19) 0.70819(8) 0.0256(3) 
C10 0.71172(12) 0.6264(2) 0.69408(9) 0.0301(3) 
C11 0.70916(12) 0.4808(2) 0.63934(9) 0.0300(3) 
C12 0.60207(13) 0.41735(19) 0.59882(8) 0.0279(3) 
C13 0.49813(12) 0.50072(18) 0.61287(8) 0.0240(3) 
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C14 0.05719(14) 0.7086(3) 0.70500(12) 0.0455(4) 
C15 0.12455(17) 0.3996(2) 0.59595(12) 0.0485(4) 
O1 0.30144(8) 0.61100(13) 0.69996(6) 0.0284(2) 
Si1 0.17028(3) 0.62557(5) 0.64250(3) 0.02761(14) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
 
Table 3. Positional Parameters for Hydrogens in Compound 1.22 
  Atom x y z Uiso, Å2 
H2 0.0861 0.8619 0.4775 0.043 
H3 0.1865 1.0849 0.4149 0.046 
H4 0.3743 1.1731 0.4741 0.041 
H5 0.4658 1.0285 0.5933 0.034 
H7 0.4037 0.8291 0.7284 0.030 
H9 0.6099 0.8094 0.7450 0.034 
H10 0.7836 0.6682 0.7217 0.040 
H11 0.7791 0.4254 0.6297 0.040 
H12 0.6000 0.3187 0.5622 0.037 
H13 0.4264 0.4574 0.5856 0.032 
H14a 0.0540 0.6269 0.7510 0.068 
H14b -0.0185 0.7118 0.6708 0.068 
H14c 0.0776 0.8301 0.7255 0.068 
H15a 0.1820 0.3581 0.5625 0.073 
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H15b 0.0493 0.4117 0.5618 0.073 
H15c 0.1187 0.3120 0.6394 0.073 
 
Table 4. Refined Thermal Parameters (U's) for Compound 1.22 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0235(7) 0.0220(7) 0.0324(7) -0.0016(6) 0.0038(5) 0.0010(5) 
C2 0.0267(7) 0.0302(8) 0.0381(8) 0.0006(6) -0.0034(6) 0.0020(6) 
C3 0.0393(8) 0.0311(8) 0.0326(8) 0.0066(6) 0.0009(6) 0.0085(7) 
C4 0.0353(8) 0.0237(7) 0.0364(8) 0.0054(6) 0.0123(6) 0.0036(6) 
C5 0.0234(6) 0.0215(7) 0.0331(7) -0.0015(5) 0.0071(5) 0.0006(5) 
C6 0.0223(6) 0.0196(6) 0.0255(7) -0.0031(5) 0.0060(5) 0.0034(5) 
C7 0.0211(6) 0.0226(6) 0.0246(6) -0.0010(5) 0.0052(5) -0.0009(5) 
C8 0.0216(6) 0.0210(6) 0.0195(6) 0.0033(5) 0.0044(5) 0.0006(5) 
C9 0.0255(7) 0.0246(7) 0.0268(7) -0.0027(6) 0.0039(5) -0.0031(6) 
C10 0.0203(7) 0.0372(8) 0.0324(7) 0.0016(6) 0.0023(6) -0.0030(6) 
C11 0.0257(7) 0.0350(8) 0.0308(7) 0.0064(6) 0.0097(6) 0.0084(6) 
C12 0.0360(8) 0.0247(7) 0.0243(7) -0.0012(5) 0.0087(6) 0.0043(6) 
C13 0.0253(7) 0.0245(7) 0.0217(6) -0.0009(5) 0.0013(5) -0.0013(5) 
C14 0.0271(8) 0.0498(10) 0.0626(11) 0.0032(9) 0.0168(7) 0.0021(7) 
C15 0.0495(10) 0.0315(9) 0.0618(11) -0.0022(8) -0.0015(9) -0.0115(8) 
O1 0.0227(5) 0.0290(5) 0.0349(5) 0.0086(4) 0.0086(4) -0.0005(4) 
Si1 0.0211(2) 0.0234(2) 0.0388(2) 0.00203(16) 0.00597(16) -0.00205(14) 
The form of the anisotropic displacement parameter is: 
exp[-2(a*2U11h
2+b*2U22k
2+c*2U33l
2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table 5. Bond Distances in Compound 1.22, Å 
C1-C2  1.396(2) C1-C6  1.3991(18) C1-Si1  1.8562(14) 
C2-C3  1.380(2) C3-C4  1.390(2) C4-C5  1.384(2) 
C5-C6  1.3905(19) C6-C7  1.5221(18) C7-O1  1.4383(16) 
C7-C8  1.5167(17) C8-C9  1.3866(18) C8-C13  1.3940(18) 
C9-C10  1.3916(19) C10-C11  1.380(2) C11-C12  1.385(2) 
C12-C13  1.3838(19) C14-Si1  1.8582(16) C15-Si1  1.8509(17) 
O1-Si1  1.6539(10)     
 
Table 6. Bond Angles in Compound 1.22, ° 
C2-C1-C6 118.78(13) C2-C1-Si1 135.05(11) C6-C1-Si1 106.13(10) 
C3-C2-C1 120.40(13) C2-C3-C4 120.27(13) C5-C4-C3 120.24(14) 
C4-C5-C6 119.48(13) C5-C6-C1 120.77(12) C5-C6-C7 123.42(12) 
C1-C6-C7 115.81(12) O1-C7-C8 110.04(10) O1-C7-C6 108.02(10) 
C8-C7-C6 112.27(10) C9-C8-C13 118.99(12) C9-C8-C7 120.12(12) 
C13-C8-C7 120.88(11) C8-C9-C10 120.19(13) C11-C10-C9 120.39(13) 
C10-C11-
C12 
119.78(13) C13-C12-
C11 
120.01(13) C12-C13-C8 120.64(12) 
C7-O1-Si1 115.16(8) O1-Si1-C15 110.76(7) O1-Si1-C1 94.36(5) 
C15-Si1-C1 117.03(8) O1-Si1-C14 111.12(7) C15-Si1-C14 109.43(9) 
C1-Si1-C14 113.31(7)     
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AII-2: X-ray Structure Determination of Compound 1.28 
 
 
Compound 1.28, C16H18SiO2, crystallizes in the orthorhombic space group Pna2 
(systematic absences h0l: h=odd and 0kl: k+l=odd) with a=19.5679(13)Å, b=12.7704(9)Å, 
c=5.7734(4)Å, V=1442.71(17)Å3, Z=4, and dcalc=1.245 g/cm3 . X-ray intensity data were collected 
on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-K radiation 
(=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 3253 frames were collected 
with a crystal to detector distance of 49.972 mm, rotation widths of 0.5° and exposures of 20 
seconds:  
scan type     frames 
 -23.00 303.54 13.41 30.75 732 
 -23.00 336.61 24.44 52.47 739 
 27.00 330.69 59.97 48.96 141 
 -10.50 270.92 44.26 50.72 186 
 -20.50 330.77 338.05 -61.99 716 
 24.50 1.93 15.97 36.30 739 
 Rotation frames were integrated using SAINT, producing a listing of unaveraged F2 and 
(F2) values which were then passed to the SHELXTL program package for further processing and 
OSi
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structure solution. A total of 24483 reflections were measured over the ranges 1.90  25.43°, -
23  h  23, -15  k  15, -6  l  6 yielding 2647 unique reflections (Rint = 0.0672). The intensity 
data were corrected for Lorentz and polarization effects and for absorption using SADABS  
(minimum and maximum transmission 0.5018, 0.7452). 
The structure was solved by direct methods (SHELXS-97). Refinement was by full-matrix 
least squares based on F2 using SHELXL-97. All reflections were used during refinement. The 
weighting scheme used was w=1/[2(Fo2 )+ (0.0591P)2 + 0.2548P] where P = (Fo 2 + 2Fc2)/3. Non-
hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0361 and wR2=0.0928 for 2530 observed reflections for which F > 
4(F) and R1=0.0379 and wR2=0.0946 and GOF =1.086 for all 2647 unique, non-zero reflections 
and 176 variables. The maximum  in the final cycle of least squares was 0.001 and the two most 
prominent peaks in the final difference Fourier were +0.378 and -0.316 e/Å3. 
Table 1. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  Anisotropic 
thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and bond angles.  Figure 
1. is an ORTEP representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
 
 
 
 
Figure 1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 1. Summary of Structure Determination of Compound 1.28 
Empirical formula  C16H18SiO2 
Formula weight  270.39 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  Pna21    
Cell constants:   
a  19.5679(13) Å 
b  12.7704(9) Å 
c  5.7734(4) Å 
Volume 1442.71(17) Å3 
Z 4 
Density (calculated) 1.245 Mg/m3 
Absorption coefficient 0.158 mm-1 
F(000) 576 
Crystal size 0.30 x 0.18 x 0.08 mm3 
Theta range for data collection 1.90 to 25.43° 
Index ranges -23  h  23, -15  k  15, -6  l  6 
Reflections collected 24483 
Independent reflections 2647 [R(int) = 0.0672] 
Completeness to theta = 25.43° 99.7 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 0.7452 and 0.5018 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2647 / 1 / 176 
Goodness-of-fit on F2 1.086 
Final R indices [I>2sigma(I)] R1 = 0.0361, wR2 = 0.0928 
R indices (all data) R1 = 0.0379, wR2 = 0.0946 
Absolute structure parameter 0.98(12) 
Largest diff. peak and hole 0.378 and -0.316 e.Å-3 
Table 2. Refined Positional Parameters for Compound 1.28 
  Atom x y z Ueq, Å2 
C1 0.60184(9) 0.14361(14) 0.4615(3) 0.0268(4) 
C2 0.55846(10) 0.09166(15) 0.3075(4) 0.0301(4) 
C3 0.48840(10) 0.09339(15) 0.3386(3) 0.0301(4) 
C4 0.46045(9) 0.14718(14) 0.5251(4) 0.0293(4) 
C5 0.50166(9) 0.20148(14) 0.6792(4) 0.0276(4) 
C6 0.57243(9) 0.19864(15) 0.6436(3) 0.0260(4) 
C7 0.35982(10) 0.18918(19) 0.7410(4) 0.0410(5) 
C8 0.62225(9) 0.25606(15) 0.8041(3) 0.0274(4) 
C9 0.60928(9) 0.37189(15) 0.8106(3) 0.0266(4) 
C10 0.57508(9) 0.41746(16) 0.9955(4) 0.0325(4) 
C11 0.56084(9) 0.52357(17) 0.9979(4) 0.0369(4) 
C12 0.58121(10) 0.58651(17) 0.8161(4) 0.0386(5) 
C13 0.61614(11) 0.54148(17) 0.6318(4) 0.0370(5) 
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C14 0.62983(10) 0.43647(16) 0.6282(3) 0.0319(4) 
C15 0.74398(10) 0.21911(18) 0.2618(4) 0.0345(5) 
C16 0.73802(10) 0.03043(17) 0.5848(4) 0.0408(5) 
O1 0.39022(7) 0.14188(11) 0.5425(3) 0.0363(4) 
O2 0.69033(6) 0.23489(12) 0.7224(3) 0.0300(3) 
Si1 0.69611(2) 0.15453(4) 0.49796(9) 0.02735(15) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
 
Table 3. Positional Parameters for Hydrogens in Compound 1.28 
  Atom x y z Uiso, Å2 
H2 0.5769 0.0555 0.1825 0.040 
H3 0.4600 0.0586 0.2348 0.040 
H5 0.4829 0.2386 0.8023 0.037 
H7a 0.3799 0.1605 0.8788 0.062 
H7b 0.3116 0.1755 0.7410 0.062 
H7c 0.3675 0.2634 0.7369 0.062 
H8 0.6175 0.2279 0.9611 0.036 
H10 0.5615 0.3760 1.1197 0.043 
H11 0.5374 0.5526 1.1226 0.049 
H12 0.5717 0.6579 0.8170 0.051 
H13 0.6304 0.5833 0.5092 0.049 
H14 0.6531 0.4077 0.5029 0.042 
H15a 0.7240 0.2863 0.2301 0.052 
378 
 
H15b 0.7420 0.1765 0.1250 0.052 
H15c 0.7908 0.2281 0.3076 0.052 
H16a 0.7840 0.0446 0.6340 0.061 
H16b 0.7388 -0.0167 0.4553 0.061 
H16c 0.7130 -0.0008 0.7099 0.061 
 
Table 4. Refined Thermal Parameters (U's) for Compound 1.28 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0225(9) 0.0290(9) 0.0289(11) 0.0030(7) -0.0002(8) -0.0014(7) 
C2 0.0278(9) 0.0312(10) 0.0314(10) -0.0006(8) 0.0004(8) -0.0012(8) 
C3 0.0259(9) 0.0304(10) 0.0340(11) 0.0019(8) -0.0092(8) -0.0038(7) 
C4 0.0178(8) 0.0301(9) 0.0399(12) 0.0094(8) -0.0035(8) -0.0016(6) 
C5 0.0216(9) 0.0278(10) 0.0334(11) 0.0015(7) 0.0012(7) -0.0002(7) 
C6 0.0206(9) 0.0290(10) 0.0284(10) 0.0052(8) -0.0022(7) -0.0008(7) 
C7 0.0205(9) 0.0489(13) 0.0537(14) 0.0051(11) 0.0008(9) 0.0018(8) 
C8 0.0180(9) 0.0392(10) 0.0248(9) 0.0015(8) 0.0009(7) -0.0021(7) 
C9 0.0159(8) 0.0369(10) 0.0271(9) -0.0030(8) -0.0054(7) -0.0042(7) 
C10 0.0229(8) 0.0457(11) 0.0291(10) -0.0044(10) 0.0017(8) -0.0060(7) 
C11 0.0267(9) 0.0442(11) 0.0397(11) -0.0120(11) 0.0006(10) 0.0000(8) 
C12 0.0314(10) 0.0324(11) 0.0519(13) -0.0079(10) -0.0100(9) -0.0001(8) 
C13 0.0332(11) 0.0377(11) 0.0402(12) 0.0022(10) -0.0029(9) -0.0076(8) 
C14 0.0262(9) 0.0407(11) 0.0289(10) -0.0037(8) -0.0003(8) -0.0027(8) 
C15 0.0228(9) 0.0511(12) 0.0295(11) 0.0001(9) 0.0011(8) -0.0015(8) 
C16 0.0300(10) 0.0403(11) 0.0521(13) 0.0029(10) -0.0005(9) 0.0088(9) 
O1 0.0169(6) 0.0405(8) 0.0514(10) 0.0011(7) -0.0044(6) -0.0020(5) 
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O2 0.0168(6) 0.0428(8) 0.0304(7) -0.0018(6) -0.0021(5) 0.0014(5) 
Si1 0.0183(2) 0.0348(3) 0.0289(3) 0.0001(2) -0.0007(2) 0.00147(17) 
The form of the anisotropic displacement parameter is: 
exp[-2(a*2U11h
2+b*2U22k
2+c*2U33l
2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
  Table 5. Bond Distances in Compound 1.28, Å 
C1-C6  1.389(3) C1-C2  1.397(3) C1-Si1  1.8618(19) 
C2-C3  1.383(3) C3-C4  1.389(3) C4-O1  1.379(2) 
C4-C5  1.386(3) C5-C6  1.401(3) C6-C8  1.532(3) 
C7-O1  1.426(3) C8-O2  1.439(2) C8-C9  1.501(3) 
C9-C10  1.388(3) C9-C14  1.396(3) C10-C11  1.383(3) 
C11-C12  1.381(3) C12-C13  1.389(3) C13-C14  1.368(3) 
C15-Si1  1.848(2) C16-Si1  1.854(2) O2-Si1  1.6567(15) 
 
Table 6. Bond Angles in Compound 1.28, ° 
C6-C1-C2 118.05(17) C6-C1-Si1 106.68(14) C2-C1-Si1 135.19(15) 
C3-C2-C1 120.81(18) C2-C3-C4 119.92(17) O1-C4-C5 123.87(19) 
O1-C4-C3 115.11(17) C5-C4-C3 121.03(17) C4-C5-C6 117.91(18) 
C1-C6-C5 122.26(18) C1-C6-C8 115.87(15) C5-C6-C8 121.88(17) 
O2-C8-C9 110.48(14) O2-C8-C6 107.50(15) C9-C8-C6 112.27(15) 
C10-C9-C14 118.10(19) C10-C9-C8 120.92(18) C14-C9-C8 120.97(17) 
C11-C10-C9 121.0(2) C12-C11-
C10 
120.3(2) C11-C12-
C13 
118.90(19) 
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C14-C13-
C12 
120.9(2) C13-C14-C9 120.75(19) C4-O1-C7 116.96(16) 
C8-O2-Si1 115.85(12) O2-Si1-C15 109.58(9) O2-Si1-C16 110.39(10) 
C15-Si1-C16 110.90(10) O2-Si1-C1 93.85(7) C15-Si1-C1 116.89(9) 
C16-Si1-C1 113.88(9)     
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